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iABSTRACT
Elastic scattering spectroscopy (ESS), is a non-invasive and real-time in vivo
optical diagnosis technique sensitive to changes in the physical properties of human
tissue, and thus able to detect early cancer and precancerous changes. This thesis
focuses on the statistical issue on how to eliminate irrelevant variations in the high-
dimensional ESS spectra and extract the most useful information to enable the
classification of tissue as normal or abnormal.
Multivariate statistical methods have been used to tackle the problems, among
which principal component discriminant analysis and partial least squares
discriminant analysis are the most explored throughout the thesis as general tools for
supervised dimension reduction and classification. Customized multivariate methods
are proposed in the specific context of ESS.
When ESS spectra are measured in vivo by a hand-held optical probe, differences
in the angle and pressure of the probe are a major source of variability between the
spectra from replicate measurements. A customized spectral pre-treatment called error
removal by orthogonal subtraction (EROS) is designed to ameliorate the effect of this
variability. This pre-treatment reduces the complexity and increases both the accuracy
and interpretability of the subsequent classification models when applied to early
detection of cancer risk in Barrett’s oesophagus.
For the application of ESS to diagnosis of sentinel lymph node metastases in
breast cancer, an automated ESS scanner was developed to take measurements from a
larger area of tissue to produce ESS images for cancer diagnosis. Problems arise due
to the existence of background area in the image with considerable between-node
variation and no training data available. A partially supervised Bayesian multivariate
finite mixture classification model with a Markov random field spatial prior in a
reduced dimensional space is proposed to recognise the background area
automatically at the same time as distinguishing normal from metastatic tissue.
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1CHAPTER 1
INTRODUCTION
This chapter gives an overview of the logical structure of the thesis by introducing the
background to this work, describing the major problems studied, and presenting the
statistical methodologies used and the proposed solutions to the problems.
1.1 Context
This thesis is based on a joint project by National Medical Laser Centre and Statistical
Science Department of UCL to examine the problem of medical diagnosis using high-
dimensional elastic scattering spectroscopic (ESS) data. The aim of the project is to
use elastic scattering spectroscopy to detect pre-cancerous and early cancerous
changes in human tissue, with current application in Barrett’s oesophagus, colon
lesions and sentinel lymph nodes. In ESS a lamp delivers to the tissue light spanning a
broad range of wavelengths. There is evidence that normal and abnormal tissue have
different patterns of scattering and absorbance. It should be possible to use measured
scattering and absorbance spectra to classify an area of tissue as normal or abnormal,
or even to grade the level of abnormality.
Although the ESS measurement is simple to perform, ESS spectra often contain
major sources of variation that are of little or no predictive value for the property of
interest and thus can hinder the recognition of normal or abnormal tissue. The main
statistical issue of this project is how to eliminate the irrelevant variations and extract
2the most useful information from high-dimensional spectroscopic data for
classification and clinical diagnostic purposes. This is a challenging problem.
The overall aims of this research are twofold: a) to find approaches to tackle the
problems in ESS clinical applications described above and contribute to patient care,
and (b) to make some methodological contributions to the area of classification with
high-dimensional data as a whole, in the following areas: spectral pre-treatment,
dimension reduction, classification and discrimination, and image analysis.
1.2 Optical diagnosis and elastic scattering spectroscopy
There is little doubt that detection of early cancer or pre-cancerous change is of
crucial importance for achieving a positive outcome for cancer therapy. The
conventional clinical diagnosis procedure of diagnosing certain types of cancer by
taking biopsies from the patient is time consuming, labour intensive and has a low
detection rate for some high risk cancers. The challenge for clinicians and scientists is
to develop new technologies for detecting patients at high risk of progression to
cancer. Ideally this would be accurate, easy to use, inexpensive, and provide results
rapidly, preferably without the need to remove tissue.
The application of optical technology to problems in clinical diagnosis is a
rapidly growing field. In a diagnostic application, the goal is to learn something about
the physiology or pathology of the tissue through its interaction with light. For
example, the light reflected by tissue after absorption and scattering is characteristic
of its chemical and morphological composition which, in turn, can depend on the
nature and stage of certain diseases such as cancer. Absorption and scattering are two
of the fundamental optical processes that can be exploited for diagnostic information.
This thesis focuses on elastic scattering spectroscopy (ESS), also known as
diffuse reflectance spectroscopy, measured in the visible and near-infrared ranges of
the electromagnetic spectrum, which is a cheap, fast and simple-to-use tool compared
with other spectroscopic techniques. ESS, a novel optical diagnostic technique, is
3sensitive to the changes in the physical properties of tissue such as nuclear size,
density and changes in the nucleus. Since these physical properties change with
dysplasia, this technique could be used as a noninvasive and real-time in vivo test for
early cancer or for precancerous detection. More details about the technical aspects of
elastic scattering spectroscopy and its interaction with human tissues are presented in
Chapter 2.
1.3 Statistical aspects of ESS
1.3.1 Multivariate methods for ESS
From physical and chemical points of view, the ESS spectrum, as a visible and NIR
spectrum from a diffuse measurement, is a mixture of several physical effects (the
strong dependence of reflectance on the scattering properties of the tissue sample,
particularly on the particle size) and chemical effects (absorbances by molecular
bonds) resulting in many overlapping and often broad peaks which are the product of
complex patterns of scattering and absorption by numerous structural and biochemical
components. These spectra are difficult or impossible to interpret using univariate
methods. In most applications of ESS technology the number of variables
(wavelengths) p of the spectral matrix is usually much larger than the number of
observations (samples or subjects) n. A typical study includes variables from 1800
dimensions for only 300 spectra. These variables are collinear since there are high
correlations and near linear relations among them. Investigating the association of
spectral absorption and scattering properties with specific clinical outcomes from such
high-dimensional data is a difficult and challenging task.
This thesis focuses on the analysis of ESS spectra, applying dimension reduction
techniques as well as supervised and partially supervised classification. Most of the
topics of multivariate statistics relevant to this thesis, regarding spectral pretreatment,
dimension reduction, classification and discrimination, feature extraction, wavelength
selection, etc., are reviewed in Chapter 3.
4Among all these multivariate techniques, principal component discriminant
analysis (PCDA) and partial least squares discriminant analysis (PLSDA) are the most
explored as tools for dimension reduction and supervised classification. Both methods
project the high-dimensional spectral variables onto a low-dimensional space spanned
by components constructed as linear combinations of the original variables. The linear
coefficients (loadings) are potentially interpretable for the intensity contribution to the
classification at each wavelength. Both methods are described in Chapter 3 and are
exploited in Chapter 4 with applications to detection of cancer or pre-cancerous
change in Barrett’s esophagus and colon lesions.
1.3.2 Spectral pretreatments for ESS
When ESS spectra are used for quantitative or qualitative analysis, data pre-treatment
can be an important step in the construction of an effective regression or classification
model.
When ESS spectra are measured in vivo by an optical probe in physical contact
with human tissue, although the taking of each measurement is very simple to perform,
ESS spectral acquisition under accurate control is very difficult in the clinical setting,
even for experienced endoscopists. Therefore ESS spectra often contain major sources
of variations caused by small changes in the angle and pressure of the probe used to
acquire the spectra. These factors cause considerable measurement variability between
replicated spectra taken at the same site, and can hinder the development of a
diagnostic model for cancer risk. A customised pretreatment called error removal by
orthogonal subtraction (EROS) is proposed in Chapter 4 to model the measurement
variability and ameliorate the effects of it on the spectra as a pre-treatment step. Two
applications of this method to the clinical diagnosis of colon lesions and high grade
dysplasia or cancer in Barrett’s oesophagus are presented in Chapter 4. For the
purpose of model interpretation, an experiment was designed to find how pressure and
angle of the probe influence the variations in measured spectral data collected under
controlled conditions and to explain the measurement variability removed by EROS.
51.3.3 ESS images
For the application of ESS to the diagnosis of sentinel lymph node metastases in
breast cancer, an automated two-dimensional ESS scanning device was developed to
take measurements from the entire cut surface of the excised nodes. Instead of
determining whether an individual point of tissue is abnormal or not, the ESS scanner
examines a larger area of tissue by taking measurements at 400 points (pixels) in a
2020 grid, and has the ability to produce diagnostic images to assess the cancer risk.
Although using the ESS scanner avoids experimental variation caused by angle or
pressure of a hand-held probe and produces much more information, additional
problems arise in the analysis and interpretation of the ESS scanning data. There is no
reference pathology available for individual pixels in the image, which causes
problems in deriving an algorithm to classify pixels. We do have manual
measurements on other nodes taken at an earlier stage of this research, where we do
have reference pathology for spectra from normal and metastatic tissue. The obvious
approach is to use the manual measurement data to train a classification algorithm for
use with the scanning data, though it is possible that the manually measured points are
not completely representative of the data obtained in the scans. A further difficulty
comes from the existence of a third group in the scanning data, which is a non-nodal
group from a background area, possibly contaminated by blood or lipid. No training
data are available for this non-nodal group and these background areas are very
variable from node to node.
One opportunity also arises in the ESS scanning data analysis. The scanner
generates a spectral image, and it should therefore be possible to use smoothness
assumptions to improve the classification of individual pixels.
In Chapter 5, two different options for dimension reduction (for both manual and
scanning data) are explored before constructing a classification model. One uses PCA
on individual nodes, the other includes a common dimension, the canonical variable
from a linear discriminant analysis on the manual data. A partially supervised image
6classification algorithm employing a Bayesian multivariate finite mixture model is
then developed on the low-dimensional data to model three unknown groups (normal,
metastatic and non-nodal) in the images from scanned measurements. Prior
distributions for the parameters of the normal and metastatic groups are derived from
the manually measured data.
In Chapter 6 we take into consideration the spatial correlation between adjacent
pixels of image and a Markov random field (MRF) spatial prior is then incorporated
into the model proposed in Chapter 5 in order to represent the continuity of the image.
An implementation of the whole model system for a rapid intraoperative sentinel
lymph node diagnosis is presented and discussed in Chapter 7.
7CHAPTER 2
ELASTIC SCATTERING SPECTROSCOPY
This chapter gives a brief description of the basics of elastic scattering spectroscopy
(ESS). It describes the light absorption and scattering properties of materials and in
particular biological tissues, and the practical aspects of ESS. In the applications
studied in this thesis, ESS is employed as an in vivo point measurement and an ex vivo
imaging system for detection of early cancer and pre-cancerous changes in human
tissues. The background provided in this chapter can be used for further physical
understanding and interpretation of spectral features in the rest of the thesis.
2.1 Visible and NIR radiation
The discovery of invisible radiation was made by Herschel in 1800 when he observed
that the relative heating effect of different portions of the spectrum of sunlight
generated by a prism continued to increase when he placed a thermometer beyond the
red end of the visible spectrum. The existence of near infrared (NIR) energy was
proved by this classic experiment and subsequent discoveries led to the idea of the
continuous electromagnetic spectrum. The NIR region spanning from 780 to 2500nm
(nanometers) has become divided into two sub-regions mainly due to instrumental
considerations: 780~1100nm and 1100~2500nm. The second region has been widely
used in a variety of applications. However, there is increasing interest in the first
subregion which is sometimes called the Herschel region in honour of its discover.
8The spectra in this thesis range from 300 to 920 nm covering some of the ultraviolet
(UV), the visible (Vis) and some of the near infrared (NIR) regions, the positions of
which in the electromagnetic spectrum are shown in Figure 2.1. Among these regions,
only a narrow band from about 400 to 750nm is visible to the human eye. The NIR
region of the electromagnetic spectrum was little used in spectroscopy until the late
1950’s when visible region spectrometers extended their range into the NIR region.
Figure 2. 1: Electromagnetic spectrum. (1meter = 910 nanometer)
2.2 Elastic scattering of light and its interaction with
tissue
2.2.1 Mie theory and elastic scattering
Scattering is the process by which small particles suspended in a medium of a
different refractive index diffuse incident radiation in all directions.
Mie theory is a mathematical theory of the scattering of electromagnetic radiation
by homogeneous spherical particles, developed by Gustav Mie in 1908. Mie theory
applies to scattering by particles of a size comparable to the wavelength of the light
being scattered. A particle, for the purposes of elastic scattering, can be defined as an
aggregation of material that has a different refractive index to its surroundings. This is
the appropriate theory for the scattering of light by the organelles of living cells. The
9shorter the wavelength of light, the greater the degree of scatter. For example blue
light is scattered more than red by particles in the earth’s stratosphere. Therefore, red
light (especially when the sun is low in the sky) is seen to be coming directly from the
sun, whereas blue light is scattered in all directions and make the whole sky blue on a
sunny day.
In biomedical optics, scattering of photons is an important event and potentially
has diagnostic value. The light scattered by a tissue has interacted with its
ultrastructure which encompasses membranes and collagen fibers through to nuclei
and cellular components.
Elastic scattering spectroscopy is a measure of both the elastic scattering of light
via Mie theory and the absorptive components of tissue. In elastic scattering, there is
no energy transfer and no change in the wavelength of the light; there is only a change
in the spatial distribution of the radiation. The total intensity of the scattered light
remains comparable to that of the incident light, reduced only by light that has been
absorbed. In contrast, with the various forms of inelastic scattering, such as
fluorescence and Raman spectroscopy (Bigio and Mourant 1997), light is absorbed at
the incident wavelength and re-emitted at a different wavelength. Thus, the use of
elastic rather than inelastic scattering allows for a large optical signal, approximately
100 times stronger than fluorescence and 1000 probably more like 10,000 times
greater than Raman scattering.
The beauty of elastic scattering is its simplicity compared with other optical
spectroscopic techniques. A pulse of white light is shone into the tissue, and this light
is scattered by the tissue components (see Figure 2.2). The elastic scatter signal that is
detected is due to light that has entered the tissue, been scattered one or more times,
and exited nearby on the same side of the tissue. The degree of light scatter at each
wavelength is dependent on the size of cellular organelles and the density of cellular
packing. Only light that has undergone a 180o turn due to multiple scattering events is
detected by the detection fiber.
Elastic scattering spectroscopy uses a white light source, so spectral analysis of
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the light scattered back from tissue can include all wavelengths from the blue to the
near infrared part of the spectrum. This gives a great deal of information about the
tissue up to about 1 mm from where the probe is touching the surface of the tissue
being interrogated. Elastic scattering spectroscopy (ESS) (Lovat and Bown 2004) is
also known as diffuse reflectance spectroscopy (Georgakoudi et al. 2001). For
simplicity these phenomena will be referred to collectively as ESS from now on.
Figure 2.2: Schematic representation of elastic scattering spectroscopy probe. (Lovat and
Bown 2004)
2.2.2 ESS instrumentation system and operations in practice
The ESS system used to make the measurements studied in this thesis consists of
a pulsed xenon arc lamp, an optical probe, a spectrometer, and a computer to control
various components and record the spectra (Figure 2.3). The arc lamp, spectrometer
and their power supply are mounted in a briefcase size unit which is portable and can
be easily connected to a laptop computer (Figure 2.4).
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Figure 2.3: Schematic diagram of elastic scattering spectroscopy (ESS) system.
Figure 2.4: Picture of the ESS System.
In operation, short pulses of white light (320-920 nm) from the xenon arc lamp
are directed through a flexible optical fibre (400m diameter) which is gently placed
in contact with the tissue under examination. For safety reasons ultraviolet B & C
(100-315nm) light is filtered out to avoid the risk to patients. A collection fibre
(200m diameter) collects the light back-scattered from the upper layers of the tissue.
These two fibres are encased in an outer sheath (outer diameter 2.0mm) and the fibres
are separated by a distance of 50m with a fixed centre-centre separation distance of
350 m (Figure 2.5). This makes it convenient to place the optic fibre down the
biopsy channel of a standard endoscope if the technique is to be used during
Xenon
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Spectrometer
Tissue
Optical
fibres
Computer
& Interface
Electronics
12
endoscopy. It has been shown that the smaller the optical fibre separation the greater
the sensitivity of ESS to the size of scatterers in the tissue (Mourant et al. 1997). The
light is propagated into the spectrometer by the collection optical fibre and the output
spectrum of light is recorded in a laptop computer for further analysis. In total each
reading (collection and recording of a single spectrum) takes less than 200
milliseconds to perform. The fibre can be cleaned with the endoscope.
Before any tissue spectra are taken, a white reference spectrum is recorded from
the flat surface of a Spectralon standard, whose elastic scattering is spectrally flat
between 250 and 1000nm, allowing the system to account for spectral variations in
the light source, spectrometer, fibre transmission, and fibre coupling. Each tissue
spectrum is divided by this standard reference to give the system-independent
spectrum of the site being investigated prior to any statistical processing.
Figure 2.5: Picture of optical fibre (400-200m) with calibration pot and schematic cross-
section.
Immediately prior to (100 milliseconds before) any spectral measurement
(Spectralon or tissue), the automated system records a “dark” spectrum (without
triggering the lamp), which is subtracted from the spectrum (with lamp) that follows.
Thus, the tissue spectrum that is stored and displayed is determined by the expression
refref
tissuetissue
DS
DS


,
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where ref indicates a measurement with the Spectralon reference material, S indicates
a spectrum recorded with the lamp triggered and D indicates a dark recording without
the lamp. In this manner, the site-specific ambient light at the moment of
measurement and detector dark current are accounted for.
What the reference measurement cannot correct for are changes in the angle and
pressure of the probe in contact with the tissue. This problem will be discussed and
solved from statistical point of view in Chapter 4.
2.2.3 Light interaction with tissue
In ESS light interaction with tissue involves scattering and absorption. Incident light
is delivered to the tissue surface, part of which is absorbed in the tissue, whereas the
non-absorbed part is subject to multiple elastic scattering and eventually emerges
from the surface as diffuse reflectance carrying quantitative information about tissue
structure and composition. A certain fraction of this emerging light is collected by the
probe, whereas the remaining part escapes undetected. The amount of the light
collected depends on the optical properties of scattering and absorption coefficients,
as well as on the probe radius.
The absorption coefficient is directly related to the concentration of
physiologically relevant absorbers in the tissue, which include oxygenated and
deoxygenated haemoglobin. The scattering coefficient reflects information on the size
and density of scattering centers in tissue, such as cells and nuclei, which is a very
important factor that changes when cells become malignant (Webb and Jones 2004).
At wavelengths shorter than 600nm (in the UV and visible region) light is
strongly attenuated in tissue due to absorption and therefore fails to penetrate more
than approximately 1mm of tissue. However in the 600~800 nm range (in the NIR
region) the absorption of light is significantly lower and scattering plays a key role in
the spectral features. Below 370nm the xenon arc lamp has a low light output, causing
very low signal to noise ratio of the spectra, thus only the window between 370 and
890 nm is explored in the ESS analysis here.
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2.2.3.1 ESS and light absorption in tissues
Light from 350nm-450nm (in the UV region) has been shown to be mainly absorbed
by haemoglobin. This absorption feature, which dominates the spectrum of light at
these wavelengths, has been called the Soret band, with peak absorption at 414nm.
In the visible spectrum region (450nm-700nm) oxy- and deoxyhaemoglobin have
been described as the biggest absorbers of light in biological tissue. This absorption
occurs between 500-630nm with the peak for oxyhaemoglobin (HbO) and
deoxyhaemoglobin (Hb) at 542nm, and a second peak for oxyhaemoglobin at 577nm.
These absorption features have been termed the Q Bands of haemoglobin. Again, up
to 630nm, haemoglobin has a smaller but significant effect on the ESS spectra. The
relative absorption strengths of these chromophores and other principal tissue
chromophores have been compiled in Figure 2.6. In the near infrared region, when
wavelength is above 900nm, the absorption by water is the strongest contributor to
tissue absorption with an increase in its absorption exceeding haemoglobin above
930nm with a small peak at 976nm (VandenBerg and Spekreijse 1997) as shown in
Figure 2.6. Realistically, the ESS system is limited to a maximum wavelength of
1100nm because of very intense water absorption above this wavelength.
Figure 2.6: Compilation of absorption spectra of principle chromophores in tissue. (Hale and
Querry 1973, VandenBerg and Spekreijse 1997, Zijlistra et al. 2000)
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An example ESS spectrum measured in vivo using our ESS system from a patient
with Barrett’s esophagus is given in Figure 2.7. It shows that haemoglobin has a
marked effect on the ESS spectrum with strong presence of the Soret band and Q
bands of oxy- and deoxyhaemoglobin. The strong absorption of haemoglobin in the
visible wavelengths of blue and green light is the reason that blood appears as a vivid
red colour. More interpretations on absorption are addressed in Chapter 4 and 5 with
applications to Barrett’s oesophagus and sentinel lymph node for diagnostic purposes.
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Figure 2.7: An example ESS Spectrum with the Soret and Q bands marked.
2.2.3.2 ESS and light scattering in tissues
One of the principal cellular scatterers for ESS is the nucleus. Several properties of
the nucleus are known to change the pattern of elastic scattering. The first and
potentially simplest to measure is nuclear size which particularly affects high angle
scattering (Mourant et al. 2000). Secondly, nuclear density has also been shown to
change the ESS spectra (Zonios et al. 1999) and nuclear chromatin content has been
shown to affect the spectra of scattered light (Backman et al. 2000, Mourant et al.
2000). Finally, the nucleus:cytoplasmic ratio, along with other intracellular changes,
has been shown to have a significant effect on scattering in Monte Carlo modeling
(Drezek et al. 1999).
Soret band of Hb
Q bands of HbO and Hb
Increased noise of
Xenon Lamp
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Another group of principle scatterers in cells, the mitochondria, and the cellular
packing density have also been shown to change the elastic scattering of light in ESS
(Mourant et al. 2000, Wallace et al. 2000).
2.3 ESS and early-cancerous and pre-cancerous changes
in tissue
As described above ESS is sensitive to the changes in the physical properties of
biological tissue. Some clinical pilot studies show that these physical properties do
change with premalignant or malignant conditions, which suggests that ESS can be
used as an non-invasive and real-time in vivo test to detect early cancer or
precancerous change in human tissues.
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Figure 2.8: Representative spectra from patients with Barrett’s oesophagus.
In diagnosing high grade dysplasia (HGD) in Barrett’s oesophagus (BE) (which is
the current most robust predictor of future cancer risk in patients with BE and is
described in Chapter 4), nuclear size has been shown to change by up to 50% in HGD
compared to low grade dysplasia (LGD) nuclei (Polkowski et al. 1998). Cellular
packing and nucleus:cytoplasmic ratio are also used as criteria by histologists for the
definition of HGD. Representative spectra from BE data are shown in Figure 2.8. The
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absolute values in the ultraviolet (reflecting haemoglobin absorption peaks) and the
relative gradient (reflecting some scattering effect) in the red and near-infra-red parts
of the spectrum discriminate between nondysplastic and HGD Barrett’s mucosa.
Histological findings are correlated with the spectral patterns. A comprehensive study
on diagnosis of HGD in BE using ESS is explored in Chapter 4.
2.4 ESS as a point or imaging measurement for cancer
detection
With the advantages of being cheap, simple-to-use, robust, with minimal and
uncomplicated calibration, and fast in measurement acquisition, ESS is currently
usable in the endoscopy room. For any optical diagnostic test used endoscopically,
one of the important issues is whether this technique looks at a single point of tissue
(an “optical biopsy”) or whether it can survey the whole lining of the gastrointestinal
tract, as an endoscope does. ESS, in its present form, is only a point measurement as
an in vivo optical biopsy technique, but preliminary work shows that it may be
possible to develop this concept to a field imaging detection technique. Although
simple in principle, this requires the capability to image at many wavelengths
simultaneously (or rapidly in succession) over a fairly wide spectral range and to do
this fast enough and at low enough cost to be clinically acceptable. If this proves
possible in practice, the technique may become an invaluable tool to endoscopists.
In this thesis, ESS is first employed as an in vivo manual point measurement in
Chapter 4 for clinical diagnosis in Barrett’s esophagus. ESS is then studied as an ex
vivo imaging system using an ESS scanner in Chapters 5-7 for sentinel lymph node
metastases diagnosis in breast cancer. Although the ESS scanner still uses point
measurement technology in a somewhat crude fashion, the imaging analysis method
developed for that may become a very useful statistical software solution for later use
for ESS in vivo field detection device technology.
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CHAPTER 3
MULTIVARIATE METHODS FOR ESS
This chapter gives a review of the multivariate statistical methods used in this thesis
for ESS spectral data analysis. The methods of smoothing, scattering correction and
normalization are applied in Chapter 4 and Chapter 7 as standard tools for spectral
pretreatments. The methods of principal component discriminant analysis and partial
least squares discriminant analysis are used in Chapter 4 as general tools for
supervised dimension reduction and classification, and also provide a basis for the
partially supervised dimension reduction method developed in Chapters 5, 6 and 7.
The methods of data validation and assessment are applied throughout the thesis as
criteria for choosing models and assessing classification performance. This chapter is
intended not only to provide background knowledge for the following chapters, but
also to give a self-contained if brief overview of these interesting fields of research.
3.1 Need for multivariate methods for ESS
As described in Chapter 2, elastic scattering spectroscopy (ESS) measures a mixture
of several physical and chemical effects. These effects result in spectra with many
overlapping and often broad peaks which are the product of complex patterns of
scattering and absorption by numerous structural and biochemical components. It is
difficult or impossible to interpret these spectra using univariate methods. Use of
multivariate methods is therefore necessary to reveal specific and useful information
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from ESS spectra. Investigating the association of spectral absorption and scattering
properties with specific clinical outcomes from such high-dimensional data for
qualitative and quantitative assessment of human tissue is a difficult and challenging
task.
3.2 Spectral pre-treatment
Spectral pre-treatment is an essential step for success before constructing an effective
regression or classification model. This is especially true in biomedical studies where
the material, e.g. human tissue, under study with very complex structures often gives
spectra containing much variability that is of little or no predictive value for the
property of interest. This section reviews some widely used spectral pre-treatment
methods, with a focus on scattering correction and smoothing, aimed at removing
noise and other non-useful spectral variation.
3.2.1 Scatter corrections
Diffuse reflectance spectra typically show the sort of variability seen in Figure 3.1
(top panel). There are small differences in shape between the spectra and large
differences in level and slope. In most applications the latter variations carry little
useful information, and a range of so-called scatter corrections have been designed to
remove them. Of course there is always the risk of removing signal rather than noise,
but even in this application, where the general level of scattering may be informative,
their use appears to be beneficial.
3.2.1.1 Multiplicative scatter correction (MSC)
The multiplicative scatter correction (MSC) method (Geladi et al. 1985) corrects
differences between samples due to multiplicative and additive effect of light scatter
by fitting a linear regression to the relationship between the spectrum of interest and
an average spectrum. For different samples different regression lines are interpreted as
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differences due to scatter effects while the deviations from the regression lines are
interpreted as the chemical information in the spectra. The MSC model for each
individual spectrum is
iiii xbax  (3.1)
where ix is the 1p spectral vector of sample i, the scalars ia and ib represent the
additive effect and multiplicative effect for sample i, x , 1p , is the mean of the set
of spectra, and the error vector, i , corresponds to all spectral effects in the sample i
that cannot be modeled by an additive and multiplicative constant.
By using MSC transform, the corrected spectral vector *ix of sample i is
expressed as below:
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*
i bˆ/)aˆx(x  (3.2)
where iaˆ , ibˆ are estimated by least squares, and most of the dominating additive and
multiplicative effects have been eliminated.
3.2.1.2 Standard normal variate (SNV)
The standard normal variate (SNV) method, described by Barnes et al. (1989), is a
mathematical transformation method of the spectra used to put spectra on a common
scale. Each spectrum is corrected individually by first centring the spectral values (i.e.
subtracting the mean intensity value of the whole spectrum from intensity value at
each wavelength) and then scaling the centred spectra by dividing by the standard
deviation calculated from the individual spectral values. The transformed value is
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*
i s/)mx(x  (3.3)
where ix is the p-dimensional spectral vector of sample i, im is the mean of the p
spectral measurements for sample i and is is the standard deviation of the same p
measurements. The effect of the SNV transform is that, on the vertical scale, each
spectrum is centered on zero and varies roughly from -2 to +2.
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Figure 3.1: Top: the colon spectra before scatter correction; middle: the colon spectra after
SNV transform; bottom: the colon spectra after MSC transform.
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To compare the effects of these different scatter correction methods, some typical
spectra are selected from the colon data that will be described later in Chapter 4. As
presented in Figure 3.1 (top), the blue and green spectra are from two different sites of
hyperplastic polyps; the red and orange spectra are from adenomatous polyps. The
corresponding effects of SNV transform and MSC transform are illustrated in Figure
3.1 (middle and bottom). As can be seen SNV has an effect very much like that of
MSC apart from the different scaling. Most of the variation among the spectra is
eliminated after transform, i.e. the dominating additive and multiplicative effects have
been removed. The main practical difference is that SNV standardizes each spectrum
using only the data from that spectrum while MSC uses the mean of a set of spectra.
As already noted, there is a risk in using such pre-treatments that we will remove
useful information. However, inspection of spectra shows that they contain
considerable variability of the sort removed by these pre-treatments, and that this
variability appears to be unrelated to the diagnosis of the tissue. For the reasons of
normalizing the scale, throughout the thesis we use SNV as a spectral normalization
step.
3.2.2 Derivatives
Spectral derivatives are widely used to remove variable baselines and slopes from
spectra. The first derivative spectrum is the slope at each point of the original
spectrum. It has peaks where the original has maximum slope, and crosses zero at
peaks in the original. The second derivative is the slope of the first derivative. It is
more similar to the original in some ways, having peaks in roughly the same places,
although they are inverted in direction. It is a measure of the curvature in the original
spectrum at each point. Taking the first derivative removes an additive baseline. The
spectra parallel to each other but shifted upwards or downwards would have the same
first derivative spectrum since the slope would be the same everywhere. Taking a
second derivative removes a linear baseline.
As the measured spectrum is not a continuous mathematical curve, but a series of
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measurements at equally spaced discrete points, the obvious way to calculate
derivatives with such data would be to use differences between the values at adjacent
points. In practice it is almost always necessary to incorporate some smoothing (for
instance, Savitzky Golay smoothing described below) into the derivative calculation.
3.2.3 Smoothing
Savitzky Golay smoothing, described by Savitzky and Golay (1964), essentially
performs a local polynomial regression of degree k on at least k+1 equally spaced
points to determine the smoothed value for each point. It is also used to compute
smoothed first and second derivatives.
A narrow window (say 7 to 20 points) is taken centred at the wavelength of
interest and a low-order polynomial is fitted to the data points in the window using
least squares. The choice of window size (or fitted length) involves a trade-off
between noise reduction or smoothing (for which we want as wide a window as
possible) and distortion of the curve (which will happen if the window is too wide).
The effect of using too wide a window is to round off the peaks and troughs. One way
to find a suitable width is to start with three points and increase the window width
until the smoothed (fitted) spectra are not visibly noisy. The smoothed value or
derivative is then computed from the polynomial.
The Savitzky-Golay approach is preferable to the use of simple moving averages,
tending to preserve features of the spectra such as relative maxima, minima and width.
If the two methods are compared on artificial examples it is clear that Savitzky-Golay
gives a less distorted estimate of the original spectra.
3.3 Dimension reduction
Dimension reduction plays a key role in constructing a multivariate
classification/dicrimination model by reducing a large number of spectroscopic
variables, say 1800, to, a small number of variables, say 10, with little or no loss of
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information. Using linear discriminant analysis (LDA), p+1 samples can be classified
by p variables perfectly into two groups. However, for ESS spectra the number of
variables (wavelengths) of the spectral matrix X often exceeds the number of samples.
Directly applying LDA to the spectral data causes an exact collinearity problem. Even
if the number of samples exceeds the number of variables there is still a serious
problem: the same or similar spectral information may be reflected at different
wavelengths, which means some of the variables can be written approximately as
linear functions of other variables. All these lead to exact and near collinearity among
the variables in the matrix X and LDA runs into the same problem as multiple
regression in this situation. Directly employing the unreduced spectral data in LDA
allows too much scope for discrimination to be achieved by chance, in directions that
mainly represent noise. Overfitting thus happens easily and prediction performance
may be unstable and poor.
Two kinds of approaches of solving the collinearity problem are commonly used
to reduce the dimensions of the spectral data. They are the methods using regression
or classification for a few selected variables, and the methods constructing new
components and factors by a few linear combinations of the original variables in the
matrix X. Throughout the thesis the latter kind of dimension reduction methods is
most explored for tackling the collinear problem in high-dimensional spectral data.
The former kind of dimension reduction method by wavelength selection is mentioned
with an example in Section 4.8.4 of Chapter 4.
3.3.1 Principal component analysis (PCA)
Principal component analysis (PCA) is the most common dimension reduction
technique. From a large number of variables measured on a given set of samples, it
extracts a small to moderate number of new variables which account for most of the
variability between samples. The new variables, called principal components, are
linear combinations of all the original spectral measurements and are uncorrelated to
each other. The first principal component captures as much as possible of the
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variability in all the original ones, and each successive principal component accounts
for as much of the remaining variability as possible. A very large of proportion of the
variability in high-dimensional data may often be described with a modest number, a,
of these new variables. Mathematically, PCA relies on an eigenvector decomposition
of the covariance matrix of the original data matrix. The eigenvectors then become
the weight vectors for construction of the new variables, and the corresponding
eigenvalues tell how much of the original variance has been captured in each new
variable. The decomposition of spectral matrix X by PCA can be written as
X
T EˆPˆTˆX  (3.5)
where Tˆ is score matrix whose columns are the a most dominating principal
component scores of X, Pˆ is the corresponding matrix of loadings and residual matrix
XEˆ is the unexplained part of X . Pˆ is an orthogonal matrix whose columns are the
unit length eigenvectors of the matrix XX T , ordered according to the magnitude
(value) of the corresponding eigenvalues. The scores matrix Tˆ can easily be found by
PˆXTˆ  . More details on PCA can be found in Mardia et al. (1979).
PCA often works well in spectral analysis. However there is no guarantee that the
scores with large variance are necessarily the best new variables for classification. In
ESS spectroscopy it might well be that the large variation is due to scatter that reflects
measurement artefacts rather than the variation of variable of interest. Large variation
due to measurement variability may lead to principal component scores that are poor
classifiers. This is studied in Chapter 4 with applications to early cancer and
precancerous detection in Barrett’s esophagus and colon lesions.
3.3.2 Partial least squares (PLS)
Partial least squares (PLS) (Martens and Næs 1998) is a dimension reduction
technique that seeks to find a small to modest number of latent variables that
maximize the covariance between these new spectral variables and the response
variable y. Each latent variable is obtained by maximizing the covariance between y
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and all possible linear functions of X , which leads to variables more directly related
to variability in y than the principal components.
PLS decomposes X and y into the form
X
T EPTX ˆˆˆ  (3.6)
YEqTy ˆˆˆ  (3.7)
where Tˆ is a matrix of the extracted a score vectors, Pˆ is a loading matrix, qˆ is a
loading vector, and XEˆ and YEˆ are residual matrices. The direction of the first PLS
component denoted by 1wˆ (with unit length and called the first loading weight vector)
is obtained by maximizing the covariance criterion. The scores along this axis are
computed as 11 wˆXtˆ  . By regressing X on 1tˆ and y on 1tˆ the loading vector 1pˆ and
the regression coefficient 1qˆ can be obtained. The product of 1tˆ and 1pˆ is then
subtracted from X , and 11qˆtˆ is subtracted from y. The second direction is found in the
same way as the first, but using the residuals TpˆtˆX 11 instead of the original data X .
The process is continued in the same way until the desired number of components, a,
has been extracted.
The Equations (3.6)-(3.7) are sometimes called bilinear since they are linear in
both loadings and scores. The estimated parameters in both (3.6) and (3.7) can be
combined into the regression vector to be used in the PLS prediction equation
bˆXbˆyˆ  0 (3.8)
where the intercept 0bˆ becomes equal to y when using mean-centred X variables, bˆ
represents the regression coefficient vector, which is given by
qˆ)WˆPˆ(Wˆbˆ T 1 (3.9)
where the Wˆ is the matrix of loading weights.
Using factors (PLS components) determined by employing both X and y in the
estimation directly, PLS avoids the dilemma in PCA of deciding which components to
later use in regression or classification.
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3.4 Multivariate classification
As described in Section 2.4, ESS is sensitive to the changes in the physical properties
of tissue such as scatter that reflects nuclear size, density and changes in the nucleus
and to the chemistry of hemoglobin. Since these properties change with dysplasia, and
there is evidence that normal and abnormal tissue show different spectral patterns of
scattering and absorbance, reference pathologies (for normal or abnormal tissues) are
found to correlate with the spectra. Appropriate multivariate analysis enables ESS to
be a useful tool for early cancer or precancerous detection, by investigating the
association of spectral absorption and scattering properties with specific clinical
outcomes. Qualitative classification is explored in this thesis since the quantity
(reference pathology) to be predicted is not a continuous measurement value, but a
categorical group variable. The problem studied in this thesis is to assign samples to
classes or groups on the basis of spectral measurements taken on the samples. It
means deciding whether a particular sample tissue is normal or abnormal using a
spectral measurement. Two different types of classification are addressed in this
chapter: supervised and unsupervised classification. Supervised classification is
applied in Chapter 4 for clinical diagnosis of cancer or pre-cancerous change in
Barrett’s esophagus and colon lesions. A partially supervised method developed from
both supervised and unsupervised classification models is introduced in Chapter 5-6
and are exploited in Chapter 7 with an application to sentinel lymph node diagnosis.
General knowledge on multivariate classification can be found in textbooks by Næs,
Isaksson, Fearn and Davies (2002), McLachlan (1992), Ripley (1996) and Mardia et
al. (1979).
3.4.1 Supervised classification/ Discrimination
Supervised classification, also known under the name of discriminant analysis or
supervised pattern recognition, is a class of methods primarily used to learn
classification rules from training data belonging to known groups. These rules are
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later used on test data to assign new and unknown samples to the most probable
groups.
3.4.1.1 Linear discriminant analysis (LDA)
The classical method of linear discriminant analysis (LDA), described by Fisher for
two classes and extended to more by Rao, is called Fisher’s linear discriminant
analysis or canonical variate analysis (CVA). It seeks a linear combination aX ˆ of the
spectral variables which maximizes the ratio of between-group variance to within-
group variance, which is equivalent to finding a direction defined by the vector aˆ in
multivariate space, that maximises the quantity
aWaaBa TT ˆˆ/ˆˆ (3.10)
where W is the within-group sum of squares and products (SSP) matrix, and B is the
between-group SSP matrix, defined by
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where jX is the pn  spectral matrix for samples from group j, jx is the average
spectrum for samples from group j, x is the average spectrum for the whole dataset,
jN is the sample size of group j ( 


G
j
jNN
1
), and 1 is an 1n vector of 1’s. The W
and B matrices are proportional to the within-group and between-group variance
matrices, the proportionality constant having no effect on the solution of Equation
(3.10).
The definition of B in Equation (3.12) weights the groups by their size jN in the
training set. An alternative is to weight the samples in group j by jN , where j is a
prior probability of group j, in forming B, W and x .
The vector a can be found as the eigenvector of BW 1 which corresponds to the
largest eigenvalue, called the first canonical variate (CV). When there are more than
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two groups, we need more than one discriminant axis (canonical variate) to
discriminate between them. In the general case, to discriminate between G groups, we
normally need G-1 canonical variates which correspond to the successive
eigenvectors of BW 1 .
The value of the new variable, the canonical variate, aXz ˆ can then be
calculated and used for assigning samples to groups. A cutoff point is needed by the
discriminant rule. The obvious choice is the value of z midway between the two mean
z values for the two groups case. Other choices of cutoff can be set to favour either
higher specificity or higher sensitivity in some specific clinical diagnosis situations, as
is the case in the application of Barrett’s data and colon data in Chapter 4.
An alternative approach to develop a discriminant rule is by use of Bayes’ rule.
Based on the normal distribution assumption with identical covariance matrices of the
two (or more) groups, the Bayes’ rule derived from the posterior probability of the
groups is to allocate a new sample with measured vector x to the group j with the
smallest value of
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 (3.13)
where jx is the sample mean vector for group j, j is the prior probability for group j,
and ˆ is the pooled within-groups sample covariance matrix. The first term on the
right of Equation (3.13) is known as the Mahalanobis distance from x to the group
mean. It can be seen that the difference kj LL  (for groups j and k) can be reduced to
a linear function of x, that is, in the two groups case the allocation rule is indicated by
a straight line separating the two groups, which gives the name LDA.
When the covariance matrices jˆ are different for different groups, Bayes’ rule is
to allocate a new sample x to the group for which
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 (3.14)
is the smallest. This is called quadratic discriminant analysis (QDA), because we now
have a quadratic function of x for the difference kj LL  . Thus curved lines in the
multivariate space are used to separate the groups of samples.
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It can be shown that using LDA based on Bayes’ rule by jL in (3.13) to assign to
groups is equivalent (when the prior probabilities are equal) to using the canonical
variable z with a cutoff midway between the scores of the two group means when they
are projected onto the CV. Thus LDA based on Bayes’ rule gives another derivation of
what is the same way of assigning to groups as Fisher’s LDA. Using the pooled
covariance matrix, LDA often gives robust and reliable, though not always optimal,
classification results, even for training data sets with moderate sample size and
covariance matrices that may not be equal. In this thesis the discriminant analyses are
based on Fisher’s LDA which is available in R.
3.4.1.2 Principal component discriminant analysis (PCDA)
Principal component discriminant analysis (PCDA) is used for classification on the
spectroscopic data with large numbers of variables. This involves a PCA on the
spectral data as a data reduction step followed by a LDA as a classification step
(McLachlan 1992). Using PCA the variance in the original high-dimensional spectral
variables can be effectively captured in 10 or 20 PCs with little or no loss of
information. Using the scores on these 10 or 20 PCs as the raw data for input to a
discriminant analysis, we find canonical variates to display the data and use
discriminant functions to assign new samples. PCA projects the raw data onto a low
dimensional space composed of 10-20 principal components capturing a mixture of
between- and within-group variance. The data separation along individual PCs might
be very poor unless this combined variation is dominated by the variation between
groups. LDA projects the data onto the axis of canonical variate, along which the
separation reaches its optimum by maximizing the ratio of between-group to within-
group variance.
The PC scores are linear combinations of the original spectral variables via the
loading matrix Pˆ , and the canonical variate scores are, in turn, linear combinations of
the PC scores defined by the vector aˆ in Equation (3.10), so that by combining the
loadings from the two steps we can find the effective loading, aP ˆˆ , called the LDA
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loading here, of each of the original spectral variables in constructing a canonical
variable.
3.4.1.3 Partial least squares discriminant analysis (PLSDA)
An alternative approach is partial least squares discriminant analysis (PLSDA)
(Barker and Rayens 2003). This involves a PLS regression on the spectral data using
as y a dummy variable, typically coded as 0/1 in the two-group case. This
preliminary data reduction step is followed by LDA, taking the scores on the PLS
factors as input to the LDA.
In the same way as for the PCDA loading, combining the loadings from the PLS
regression and LDA gives the PLSDA loading of the original variables in constructing
a canonical variate. Both PLSDA and PCDA loadings show the contribution of each
wavelength to the classification and may enable the interpretation of the canonical
variate.
Though PCDA is better understood than PLSDA, PLSDA sometimes appears to
do a better job than PCDA (though the difference is not usually large), giving
comparable prediction results but using fewer optimal number of components in
constructing the canonical variate. However, when the difference between two groups
is subtle and there are large variabilities existing within the groups, PLSDA is not
necessarily better than PCDA. Examples and comparisons will be given in Chapter 4.
3.4.2 Unsupervised classification
Unsupervised classification, also known as cluster analysis, is a class of methods used
to identify groups from spectral patterns of the samples without the knowledge of
group assignments of samples and possibly even without knowing the number of
groups.
The aim of this technique is to find or identify tendencies of samples to cluster in
subgroups, which may be very useful at an early stage of an investigation. It uses
distances between the objects to identify samples that are close to each other. Before
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the actual computation of distances PCA is often performed for visual inspection and
understanding of the group structure. A more comprehensive and general description
of cluster analysis can be found in Kaufman and Rousseeuw (1990) and Mardia et al.
(1979).
An alternative approach to unsupervised classification is based on parametric
mixture models (Titterington et al. 1985, McLachlan and Peel 2000, Fraley and
Raftery 2002). The idea is to model the distribution of the diagnostic variables by a
mixture of parametric distributions, simultaneously estimating with the parameters of
the distributions and the group membership of the samples. More details on finite
mixture model are addressed in Chapter 5 with applications to sentinel lymph node
diagnosis given in Chapter 7.
3.5 Validation and assessment
When doing classification and prediction, the performance of a rule or formula is
typically estimated using subsampling (sample-reuse) techniques when the sample
sizes are not large enough to use a separate withheld test set. Such methods include k-
fold cross-validation, leave-one-out cross-validation, bootstrap methods and repeated
holdout (Dudoit et al. 2002, Braga-Neto and Dougherty 2004, Molinaro 2005). The
estimates of the performance are then used for model selection, parameter tuning,
feature selection, or performance evaluation in empirical comparisons of
discrimination methods.
3.5.1 Repeated holdout
Repeat holdout, also known as random splitting, isolates a proportion a of the data
into the test set and uses the remaining proportion 1-a of the data for training. The
commonly used technique is to choose 1/3 as proportion for a. To ensure statistical
robustness, that is to say, to ensure that the results obtained are not training-set
specific and to lower the variance of area under the curve (AUC) described in Section
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3.5.3, this process is repeated a large number of times with different randomly
selected training and test sets. The final estimate is calculated by averaging the
estimates from different runs. To reduce the bias, stratified repeated holdout is
suggested to sample independently from each of the classes in the test sets using the
proportion as close as possible to the overall class proportions. In our implementation,
the holdout method used in Chapter 4 divides the data into two sets: 80% of the total
amount of data is used for training and the remaining 20% is used for testing, with 50
replications.
3.5.2 Cross-Validation
Two kinds of cross-validation are commonly used: they are k-fold cross-validation
and leave-one-out cross-validation (Stone 1974).
In k-fold cross-validation the whole set of dataset X is randomly or systematically
divided into k subsets 1X , 2X ,…, kX . After the division each subset in turn is used
for testing and the remaining subsets are combined and used for training. This means
that in k-fold cross-validation the training and testing is repeated k times. Final
estimation, in our case a measurement of classification accuracy, is calculated by
averaging the estimates from each of the training and testing runs. To guarantee that
each class is properly represented in both training and testing sets, we use stratified k-
fold cross-validation which means that the division into k subsets takes the classes of
samples into account. In our case, each cross-validation subset contains the same
proportion of samples from different classes as the original data set.
Leave-one-out cross-validation (LOOCV), also known as complete cross-
validation, can be represented as n-fold cross-validation where n is the total number of
all samples in the original data set. Leave-one-out cross-validation does not use
random splitting of the whole dataset because all of the samples are used alternately
for testing and the remaining for training. A problem with the method is its time
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consumption. The computational costs may become large, if complete cross-
validation is applied to large datasets.
In this thesis LOOCV are used in Chapter 4.
3.5.3 ROC curve and AUC
For comparing and assessing the performance of classification algorithms, the
receiver operating characteristic curve (ROC) and the associated area under the ROC
curve (AUC) are frequently used measures of performance.
The ROC shows the trade-off between sensitivity and specificity for a two-class
classifier or diagnostic system by generating a plot of the true positive rate (sensitivity)
against the false positive rate (1-specificity) for the different possible cutoffs of a
diagnostic test. It has long been used in medical diagnosis (Swets 1988) and has
become widely used in evaluating machine learning algorithms.
The AUC (Bradley 1997, Hanley and McNeil 1982) summarises the ROC and
provides a single measure of the performance of a classifier and the discriminability
of a model: a random model has an AUC of 0.5 and a perfectly discriminable model
has AUC of 1.0. The AUC has an important statistical property: the AUC of a
classifier is equivalent to the probability that the classifier will rank a randomly
chosen positive instance higher than a randomly chosen negative instance. This is
equivalent to the Wilcoxon test of ranks (Hanley and McNeil 1982).
When combining the results of the replicates of a validation procedure to compute
an overall estimate of the ROC curve or AUC, there are two main approaches: the
pooling and averaging strategies (Swets and Pickets 1982, Bradley 1997, Fawcett
2004, Witten and Frank 2005).
The pooling strategy involves collecting the classifier scoring outputs determined
on each test set，and a series of sensitivities and specificities are found with varying
cut off scores to generate a ROC curve and then calculate the AUC. Here the pooling
strategy for the ROC curve and the AUC calculation assumes that the classifier
outputs across all the replicates are comparable and thus can be globally ordered, this
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is often not the case and can lead to test samples in different replicates being ranked in
the wrong order. The pooling strategy is often used in cross validation, and
particularly for LOOCV it is the only method of measuring the AUC and calculating
the ROC curve.
In the averaging strategy, for each replicate a series of sensitivities and
specificities for each cut off canonical score are used to trace a ROC curve. A separate
AUC is computed for each test set, and the mean of these AUCs over all the replicates
is calculated with its standard deviation; for each replicate the cut off score
discriminating two classes from test set can be adjusted to meet the same criteria
(either giving a balanced sensitivity and specificity, or favoring a fixed value of
sensitivity or specificity). Averaging sensitivity and specificity from all the replicates
gives the mean sensitivity and the mean specificity with its standard deviation. The
mean sensitivity, mean specificity and the average AUC are then used as
measurements to assess the performance of the classification. The problem with this
averaging approach is that it does not give an average ROC curve. The averaging
strategy is often used in repeated holdout validation.
Both strategies are used in practice and the current literature is equivocal about
which approach is to be recommended. Both approaches are described as valid
estimates of AUC and ROC curves (Witten and Frank 2005, Fawcett 2004, Flach
2004). Witten and Frank (2005) noted that the pooling strategy has the advantage that
it is easier to implement. Also, it is expected to have a lower variance assuming that
the results of each replicate are samples from the same population (Swets and Pickets
1982). However in practice, this assumption is generally not valid for cross-validation
and can lead to large pessimistic biases.
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CHAPTER 4
SPECTRAL PRETREATMENT
4.1 Introduction
This Chapter is based on the paper “Error removal by orthogonal subtraction (EROS):
a customised pre-treatment for spectroscopic data” (Zhu, Fearn et al. 2008).
When reflectance spectra are used for quantitative analysis, data pre-treatment
can be an important step in the construction of an effective regression or classification
model. The ESS spectra often contain major sources of variation that are of little or no
predictive value for the property of interest and may thus hinder the development of a
diagnostic model. An appropriate pre-treatment can help to reduce this variability.
For example, when diffuse reflectance spectra are measured on powdered or ground
samples, the variability in the spectra between samples is typically dominated by
scatter effects caused by variations in particle size. Pre-treatments such as
multiplicative scatter correction (MSC) (Geladi et al. 1985, Næs et al. 2002) are
commonly applied to the spectra to reduce this variability. This allows the spectral
variability due to differences in the chemical composition of the samples, which is
usually of primary interest, to be seen more easily, both by eye and by the
chemometric approaches commonly used for calibration in these situations.
Although off-the-shelf pre-treatments such as MSC are very useful, there may be
situations where it is desirable to construct a pre-treatment that is tailored to remove
variability from a specific identified source. The work described here was motivated
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by the variability observed in ESS spectra measured using a probe in physical contact
with human tissue. When the measurements were replicated by removing and then
replacing the probe in an attempt to take a spectrum at exactly the same point there
was considerable variability between the replicate spectra. Small changes in angle and
pressure are amongst the possible causes of this variability.
In this chapter a customized pre-treatment called EROS, for Error Removal by
Orthogonal Subtraction, was constructed to remove this measurement variability
before the development of a diagnostic model. The approach was explored in two
applications involving in vivo measurement of dysplasia in Barrett’s oesophagus and
in vivo measurement of polyps in the human colon. To understand the measurement
variability removed by EROS, an experiment was carried out to find how pressure and
angle of the probe influence the variations in measured spectral data collected under
controlled conditions. An independent dataset was also used to test the model
prediction performance.
4.2 Measurement variability
Two major potential sources of measurement variability when collecting data in vivo
include differences in pressure of the probe on the tissue and the angle at which the
probe is held to the tissue. The importance of pressure applied and the angle of
approach to the in vivo BE have been noted before (Gonzalez-Correa et al. 2000). As
pressure and angle of the probe are difficult to control by hand and even small
changes of these factors may have a big influence on the spectra, it may be beneficial
to remove or at least reduce this influence with a pre-treatment.
4.3 Spectral pretreatment method
To ameliorate the effects of measurement variability, a customised spectral pre-
treatment method called error removal by orthogonal subtraction (EROS) is proposed
here. EROS projects the spectra onto a subspace orthogonal to the subspace in which
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most of the measurement variability occurs, so that the subsequent classification step
is robust to this measurement variability.
4.3.1 Orthogonal projection
The orthogonal projection used by EROS to subtract interfering variability works as
follows. Let X be an n × p matrix whose rows are the spectra of n samples, and let P
be a p × k matrix whose columns are mutually orthogonal vectors of unit length. Then
T( )X X I PP  , (4.1)
where I is the identity matrix, is the projection of X onto the kp  dimensional
subspace orthogonal to the columns of P. Writing this as PX X X  where
T
PX XPP emphasizes that this is a subtraction from X of the part PX that lies in the
subspace defined by P.
A number of existing approaches employ this simple method of subtracting
variability, the differences between them being in the way P is chosen. It is useful to
distinguish between methods that use the dependent variable y in the construction of P
and those that do not. The former are an integral part of the calibration process, with
important implications for validation, while the latter can be regarded as pre-
treatments.
4.3.1.1 Approaches that use y
The original method of this type is orthogonal signal correction (OSC), which was
introduced by Wold et al. (1998) and developed by Sjöblom et al. (1998), Fearn
(2000), Westerhuis et al. (2001) and Trygg and Wold (2002) among others. The idea
of OSC and related methods is to construct factors that account for a large amount of
spectral variation whilst being uncorrelated with the dependent variable y. The
loadings for these factors form the columns of P, and this variability is subtracted
from X. The details vary, and some of the procedures involve the sequential
subtraction of single dimensions, but the basic idea of subtracting directions
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uncorrelated with y is common to all these approaches. The involvement of y means
that OSC, in all its versions, is part of the calibration process, as indeed it is explicitly
presented in the OPLS method of Trygg and Wold (2002). One important
consequence is that it is vital that the construction and subtraction of OSC factors
needs to be included in any cross-validation procedure, and not done outside the loop,
or there is a risk of overfitting. The main advantage usually claimed for OSC is that its
use with PLS improves the interpretability of the PLS model, because the PLS factors
do not need to account for the interfering variability that has been subtracted.
4.3.1.2 Approaches that do not use y
A very different way of selecting directions to subtract from X is used by independent
interference reduction (IIR), Hansen (2001), and external parameter orthogonalization
(EPO), Roger et al. (2003). Both IIR and EPO use spectra from a set of dedicated
experiments to identify structured variations resulting from interfering factors, and
choose P to be an orthogonal basis for the space in which these variations lie. They do
not use y, and therefore are genuine pre-treatments.
In IIR, which builds on work by Sun (1997), spectra are measured on samples
that do not contain the analyte of interest, but are otherwise variable. PCA is applied
to the matrix Z of these spectra to find the principal dimensions in which they vary,
and the loading vectors of the first k principal components become the columns of P.
IIR is an attempt to identify and remove all sources of interfering variability from the
spectra. The success of this is clearly dependent on the extent to which Z represents
these sources of variability, and implies that it must include a substantial number of
samples. It will, of course, not always be possible to find such samples.
In contrast, EPO is more focused on removing interfering variability from one
particular source. In the EPO experiment a small number of samples are taken and
each is measured under a range of conditions. For example Roger et al. (2003)
measured the samples at different temperatures, and Andrew and Fearn (2004)
measured the samples on different instruments. A matrix Z of difference spectra may
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then be constructed in which between-sample variability has been eliminated and
which represents variability due to the changing conditions. The columns of P are
then the loadings for the first k principal components of Z. In the applications
described the results were calibrations robust to sample temperature (Roger et al.
2003) and calibrations transferable between instruments (Andrew and Fearn 2004),
but the idea could be applied in any situation where the required experiment is
feasible.
4.3.2 Error Removal by Orthogonal Subtraction (EROS)
A method called error reduction by orthogonal subtraction (EROS) is proposed to
ameliorate the effects of measurement variability in in-vivo ESS spectra. EROS also
uses the projection in Equation (4.1) to subtract variability from the spectral matrix X,
but introduces yet another way of constructing P. In some situations there can be
considerable variability between the spectra obtained in replicate measurements of
what is nominally the same sample. A common way of dealing with this is to take
several replicates and average them to reduce this variability. If the variability behaves
like white noise then this is probably the best that can be done. If, however, it has
some structure, it may be beneficial to identify this structure and subtract appropriate
dimensions by projection.
Suppose we have replicate spectral measurements on each of m samples. Let Ri
be the ri  p matrix whose rows are the ri replicate spectra for the ith sample, and let
Zi be this same matrix after centring by subtraction of the column means, i.e. after
subtracting from each row the mean spectrum for the sample. Then
)mr/(ZZW i
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, is the pooled within-sample covariance matrix of the spectra. W
describes the variability between replicate measurements, the variability between
samples having been removed by the centring.
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The basic idea of EROS is to use the first k eigenvectors of W, for suitably chosen
k, as the columns of P for the projection of Equation (4.1). If the replicate variability
contains structure, i.e. if it is concentrated in particular directions in the spectral space,
these eigenvectors will lie in those directions, and subtracting them will remove this
variability.
4.4 Applications and results
Two applications of EROS pre-treatment to the clinical diagnosis of colon lesions and
high grade dysplasia or cancer in Barrett’s oesophagus are presented here to illustrate
the use of EROS for the construction of an effective classification model.
4.4.1 Detection of cancer risk in Barrett’s oesophagus
(Barrett’s data)
4.4.1.1 Background and introduction
The incidence of oesophageal adenocarcinoma has increased dramatically since the
1970s, and it is now the fifth commonest cause of cancer death in the UK. The five
year survival rate for this cancer is less than 10% (Newnham et al. 2003, Toms 2004).
Barrett's oesophagus (BE) is a pre-malignant condition in which the normal squamous
epithelium of the oesophagus is replaced by metaplastic columnar epithelium (Phillips
and Wong 1991), increasing the risk of developing adenocarcinoma by 30-125 times
(Hameeteman 1989, Williamson et al. 1991) when compared to the general population.
Systematic endoscopic surveillance of BE has been shown to detect oesophageal
adenocarcinoma at an early and curable stage (Levine et al. 1993). High grade
dysplasia (HGD) is the current most robust predictor of future cancer risk in patients
with BE, with around 50% progressing to adenocarcinoma at five years if it is not
treated (Rabinovitch et al. 2001, Sharma et al. 2007)
Endoscopic surveillance relies on regularly spaced, but essentially random,
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biopsies being taken from the four quadrants of the Barrett’s segment every 2cm. It is
time consuming, labour intensive and has a low detection rate for HGD even when
abnormalities exist (Sandick et al. 1998, Messmann et al. 1999). The challenge for
clinicians and scientists is to develop new technologies for detecting patients at high
risk of progression to cancer. Ideally this would be accurate, easy to use, inexpensive,
and provide results rapidly, preferably without the need to remove tissue.
As described in Chapter 2 elastic scattering spectroscopy (ESS) is an in vivo
optical point measurement which, using an appropriate optical geometry, is sensitive
to changes in properties of tissue (Lovat and Bown 2004). The optical probe is passed
through the working channel of an endoscope and is placed in direct contact with
tissue. A flash of light interrogates a cylinder of tissue approximately 0.5mm in
diameter and 1 mm deep. Results are available within milliseconds. Since the
technology uses white light and produces a strong backscattered signal, components
are inexpensive and the system is simple to manufacture. It is also safe because only
visible light is used for illumination with ultraviolet light being filtered out. Many of
the features that pathologists look for in diagnosing HGD have also been shown to
affect light scattering including the nuclear: cytoplasmic ratio (Drezek et al. 1999);
the cellular packing density (Wallance et al. 2000); and the nuclear size (Zonios et
al.1999). The nuclear chromatin content has also been shown to affect the spectra of
both singly scattered light (Gurjar et al. 2001, Beckman et al. 2000) and high angle
scatter in ESS (Mourant et al. 2000).
The problem is how to maximise the discrimination between ESS spectra taken
from high and low risk sites in order to accurately detect the patients at high future
cancer risk. The difficulty is that the spectral differences between normal and
abnormal tissue are very subtle. At the same time, ESS spectra often contain major
sources of variation that are of little or no predictive value for the detection of cancer
risk. In the clinical setting it is extremely difficult even for experienced endoscopists
to accurately control all aspects of ESS spectral acquisition especially with respect to
the angle and pressure of the optical probe in relation to the tissue with which they are
in contact.
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4.4.1.2 Spectral acquisition
This study was approved by the joint University College London/University College
London Hospitals (UCLH) ethics committee. During the routine endoscopy, optical
measurements were taken, followed immediately by biopsy from the same site. A
total of 152 matched optical and histological biopsy sites were collected from 81
patients referred to our tertiary referral centre between 2000-2003 for the management
of HGD (high grade dysplasia) or early cancer in BE. Informed consent was obtained
from all patients prior to their participation in the study.
Before any tissue spectra were taken, a white reference spectrum was recorded
from the flat surface of a Spectralon reference. The ESS spectral data used in our
analysis is the ratio of the spectral intensity of backscattered light from the tissue to
that of the standard reference spectrum from Spectralon. Each spectrum was made up
of 1801 points spanning the wavelength range 320-920nm, which lies in the visible
and near infrared (NIR) regions.
Measurements were replicated by removing and replacing the probe in an attempt
to take a spectrum at exactly the same point. Repeated measurements were taken from
1-3 biopsy sites per patient with a median of four spectra from each site (mean 3.3).
Routine quadrantic biopsies were taken every 2 cm as standard practice for
management of patients with suspected HGD in BE. Of the 152 matched optical and
histological biopsies (corresponding to 506 spectra), 122 (corresponding to 413
spectra) were from low grade dysplasia or no dysplasia (low risk) and 30
(corresponding to 93 spectra) were from high grade dysplasia or cancer (high risk).
Each biopsy was assessed and assigned as either high or low risk by three pathologists
who met to agree a consensus in cases of disagreement.
All raw spectra were visually examined for any obvious outliers caused by
acquisition errors, poor contact of the optical probe with the tissue, or other artefacts;
such spectra were excluded from subsequent analysis.
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4.4.1.3 Statistical analysis
Standard data pre-processing was carried out on the spectra to improve signal quality
(Næs et al. 2002, Lovat et al. 2006). The spectra were first smoothed using a
Savitzky-Golay filter (Savitzky and Golay 1964), using a 7-point window below 620
nm and a 20-point window above 620 nm where noise was greater. To speed
subsequent manipulation, the smoothed data were then reduced from the 1801 points,
corresponding to the spectrometer resolution, by taking alternate points only. To
remove the regions of the spectra with low signal-to-noise ratios arising from the
lower light intensity emitted by the Xenon arc lamp at the extremes of its output
spectrum, only the wavelengths between 370 and 800nm, with 637 points, were used
in the analysis. Using the standard normal variate (SNV) (Barnes et al. 1989) method,
the spectra were then normalized by setting the mean intensity of each spectrum to
zero and the variance to one. The mean spectral patterns from high risk and low risk
sites after standard pre-processing are shown in the left panel of Figure 4.1. It
illustrates that both high risk and low risk sites spectra are of very similar shape with
the mean spectra showing small between-class differences.
EROS, as described in Section 4.3, was then applied to the spectra, using the
replication to derive the projection. Various choices of k, the dimension of P in
Equation (4.1), were investigated.
Classification rules were derived from both the original spectra and the EROS
pre-treated spectra using principal component discriminant analysis (PCDA), and
partial least squares discriminant analysis (PLSDA). The PCDA involves an initial
PCA on the pre-treated spectra followed by linear discriminant analysis (LDA) on the
first q PC scores. The PLSDA involves a PLSR on the pre-treated spectra followed by
LDA on the first q PLS latent variable scores. EROS and PCDA or PLSDA were
carried out for a grid of values of k and q, with k ranging from 0 (no dimensions
subtracted) to 7 and q from 2 to 30. A method called stratified repeated holdout ,
described in Section 3.5.1, trained the algorithm on stratified randomly sampled 80%
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of the data and tested it on the remaining 20% of the data with 50 repetitions of the
split. In each split all the replicated spectra from a particular biopsy site were
allocated to either the training set or the testing set (to prevent bias being introduced
through non-independence of data) and there were the same proportion of sites
belonging to each class in the training set as in the whole data set.
For each test set a separate AUC was calculated, and a specific cut off canonical
score discriminating the two classes in the test set was chosen to give the same value
of sensitivity in each set. The mean sensitivity, mean specificity and the average AUC
with its standard deviation were then calculated from the 50 replications to assess the
performance of the classification. As mentioned in Section 3.5.3, this approach does
not generate an average ROC curve.
All the above analysis was carried out on a per-site-base since this usually gives
more reliable results than a per-spectra analysis. In per-site analysis, if any one of the
spectra from a particular biopsy site is classified as a spectrum from a high risk site
(i.e. the maximum canonical score of the spectra from a particular biopsy site is
higher than the cut off score), the whole biopsy site may be regarded as a high risk
one. An alternative criterion is that if the average canonical score of the spectra from a
particular biopsy site is higher than the cut off score, the whole biopsy site may be
classified as one with high risk. Our experience is that for repeated holdout validation
choosing mean canonical score rather than maximum canonical score on a per-site-
base can give better classification results. So we chose this mean-score-per-site
criteria for the analysis of the Barrett’s data.
All the computation and analysis for EROS, PCDA and PLSDA was performed
using the R statistical language.
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4.4.1.4 Principal component discriminant analysis (PCDA) model
Table 4.1 shows the repeated holdout validation results for detection of HGD or
cancer for various combinations of k, the number of dimensions removed by the
EROS pre-treatment, and q, the number of principal components used in the
construction of the PCDA diagnostic rule. The specificity and AUC results are plotted
in Figure 4.2. In deriving the rule, the cut off canonical score between the high risk
and low risk sites was adjusted to give a sensitivity of at least 90%. This high
sensitivity comes at the expense of specificity but it was felt to be a greater omission
to potentially miss patients at high risk than to have to collect a few additional
biopsies. Conventional biopsies would only be taken if the ESS spectrum was
indicative of dysplasia or cancer.
Trying to avoid the temptation to over interpret small differences in performance,
it seems reasonable to draw the following conclusions:
 Pre-treatment with EROS substantially reduces the number of PC scores q
needed to attain the best levels of accuracy in the classification, and this
reduction in number is greater than k, the number of dimensions removed by
EROS. Thus the total number of factors involved, even if one counts those in
the EROS pre-treatment, is reduced.
 For this Barrett’s dataset, k should be at least 3, with the choices 3, 5 and 7 all
being reasonable ones.
Before pre-treatment with EROS (k = 0), the choice q = 20 gives the best results
with sensitivity, specificity and AUC of 92%, 63% and 85%, respectively. After pre-
treatment with EROS, the combinations of k = 3, 5, 7 with q from 5 to 7, all give the
better results with fewer factors. Amongst these choices, the combination k = 5, q = 5
gives the best results with the fewest factors, with sensitivity, specificity and AUC of
92%, 75% and 87%, respectively, and subsequent discussion is based on this choice.
The two panels of Figure 4.1 show the mean spectra for the high risk and low risk
biopsy sites, before and after pre-treatment with EROS, in which k = 5 dimensions
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were removed. The differences between the means are much more evident in the right
hand panel after pre-treatment than they are before pre-treatment.
Figures 4.3-4.4 compare the loadings for the PCDA discriminant functions using k
= 0, q = 20 (no EROS) in the left panel and k = 5, q = 5 in the right panel. These
loadings show the contribution at each wavelength to the linear diagnostic rule, and
thus permit interpretation of its spectral basis. After using EROS, and thus being able
to attain acceptable levels of accuracy with far fewer factors in the classification
model, the loading vector is much less noisy and can be related much more easily to
features in the spectra. The first few PCs’ loadings of PCDA model after EROS pre-
treatment in Figure 4.5 show that the first five to seven PCs are most responsible for
both the EROS pre-treated spectral difference between two types and the shape of the
spectra. After EROS employing large number of PCs in construction of PCDA model
may include interference spectral variation which can be seen from the noisy structure
of 8th, 9th PC. This gives some evidence that PCDA model with q = 5 or 7 can achieve
optimal accuracy after EROS with k = 5.
As can be seen in Figure 4.4, the most obvious feature is a large positive PCDA
loading in the region of 650~800nm, corresponding to clear differences between the
mean spectra, which means the measurements in this range contribute strongly to the
classification. Physically this might be explained as the effect of scattering differences
between the spectra of normal and abnormal tissues in this region. Absorption also
seems to play a key role in the spectral differences and the classification between two
types of tissue in some specific region of spectra. The region around the 760nm stands
out as the most prominent spectral feature with highest PCDA loading. This is
consistent with the finding by Jöbsis (1977) that there exists a broad peak at 760 nm
characteristic of deoxyhaemoglobin absorption. Two peaks in the PCDA loading
around 540 and 580nm might be due to absorption dips of HbO2 at 542 and 577nm in
the spectra of high risk cancer due to increased Hb presence (as described in Section
2.3.3.1). It is known that cancers and pre-cancerous tissues are characterized by
increased microvascular volume, hence increased blood content (Jain 1988).
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Figure 4.1: Mean spectra from low risk (solid line) and high risk (dotted line) sites of
Barrett’s data. Left: with standard pre-processing only. Right: with standard pre-processing
and EROS (k = 5).
The gain in accuracy through the use of EROS is fairly modest one, but the gain
in interpretability, and very probably in robustness, of the classification rule is
substantial. That the changes are so dramatic is not surprising when one considers that
the pre-treatment removes 96.6% of the variability in the spectra. If the information
for the classification is in the remaining 3.4%, as it appears to be, it will be much
more prominent after pre-treatment. From these result it appears that the EROS pre-
treatment has removed much of the undesirable measurement variation, and that the
variation left in the spectra is more representative of the spectral features relevant to
the detection of high risk cancer. The nature of this measurement variation was
explored in a designed experiment described in a later Section 4.5.
49
Table 4.1: Results of repeated holdout PCDA classification on Barrett’s dataset using various
combinations of k (number of dimensions removed by EROS pre-treatment) and q (number of
PC scores used in the LDA).
Prediction Accuracy
k (EROS) q (PCDA)
Sensitivity (%) Specificity (%) AUC.mean AUC.sd
0 2 91 19 0.61 0.08
0 3 91 16 0.62 0.09
0 5 91 39 0.72 0.11
0 7 91 41 0.72 0.11
0 10 92 34 0.71 0.11
0 15 92 55 0.83 0.10
0 20 92 63 0.85 0.07
0 30 90 59 0.80 0.09
2 2 91 14 0.67 0.11
2 3 91 38 0.79 0.12
2 5 90 57 0.85 0.09
2 7 92 49 0.83 0.09
2 10 90 57 0.82 0.09
2 15 91 53 0.81 0.09
2 20 91 58 0.82 0.08
2 30 92 59 0.80 0.09
3 2 90 34 0.79 0.11
3 3 90 39 0.83 0.09
3 5 90 66 0.85 0.10
3 7 91 69 0.83 0.08
3 10 91 59 0.80 0.09
3 15 91 60 0.83 0.10
3 20 92 56 0.82 0.08
3 30 92 52 0.82 0.11
5 2 92 56 0.81 0.09
5 3 91 67 0.86 0.08
5 5 92 75 0.87 0.08
5 7 90 74 0.86 0.08
5 10 93 60 0.84 0.09
5 15 92 62 0.82 0.09
5 20 91 65 0.83 0.10
5 30 92 55 0.79 0.10
7 2 90 48 0.83 0.11
7 3 91 66 0.85 0.08
7 5 90 67 0.85 0.09
7 7 91 66 0.85 0.07
7 10 92 55 0.80 0.10
7 15 92 48 0.76 0.12
7 20 92 43 0.76 0.11
7 30 91 43 0.78 0.09
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Figure 4.2: Repeated holdout PCDA classification accuracy of Barrett’s data as measured by
specificity and AUC. The five lines correspond to the choices of k, the x-axis to the choice of
q.
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Figure 4.3: PCDA loadings for discrimination between low risk and high risk sites of
Barrett’s data using model with k = 0, q = 20 (no EROS). The PCDA loading is shown in
green, with the mean spectra for the two types superimposed (low risk solid blue line, high
risk dotted red line).
Figure 4.4: PCDA loadings for discrimination between low risk and high risk sites of
Barrett’s data using model with k = 5, q = 5. The PCDA loading is shown in green, with the
mean spectra for the two types superimposed (low risk solid blue line, high risk dotted red
line).
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Figure 4.5: The first nine PC loadings based on the EROS pretreated spectra from Barrett’s
data with k = 5. PC loadings are shown in green line, with the mean spectra for the two types
superimposed (low risk in solid blue line, high risk in dotted red line).
4.4.1.5 Partial least squares discriminant analysis (PLSDA) model
Table 4.2 shows the repeated holdout validation results on the per-site base for various
combinations of k, the number of dimensions removed by EROS pre-treatment, and q,
the number of PLS latent variable scores used in the construction of the PLSDA
diagnostic rule. The specificity and AUC results are plotted in Figure 4.6. As in the
PCDA model, a sensitivity higher than 90% was chosen for all the combinations.
PC 1 PC 2 PC 3
PC 4 PC 5 PC 6
PC 7 PC 8 PC 9
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Table 4.2: Results of repeated holdout PLSDA classification on Barrett’s dataset using
various combinations of k (number of dimensions removed by EROS pre-treatment) and q
(number of PLS scores used in the LDA).
Prediction Accuracy
k (EROS) q (PLSDA)
Sensitivity (%) Specificity (%) AUC.mean AUC.sd
0 2 91 30 0.68 0.08
0 3 91 39 0.68 0.09
0 5 90 42 0.73 0.10
0 7 91 53 0.79 0.10
0 10 90 44 0.79 0.11
0 15 91 40 0.78 0.10
0 20 92 41 0.77 0.11
0 30 90 30 0.73 0.11
2 2 90 30 0.73 0.13
2 3 91 44 0.78 0.11
2 5 90 61 0.84 0.09
2 7 92 56 0.83 0.09
2 10 92 51 0.77 0.11
2 15 94 51 0.80 0.08
2 20 91 56 0.79 0.10
2 30 91 54 0.78 0.10
3 2 93 43 0.75 0.12
3 3 90 64 0.83 0.08
3 5 91 66 0.84 0.12
3 7 91 60 0.80 0.08
3 10 91 46 0.80 0.10
3 15 91 50 0.80 0.10
3 20 91 49 0.80 0.09
3 30 90 54 0.81 0.09
5 2 91 60 0.83 0.11
5 3 90 72 0.87 0.09
5 5 93 65 0.81 0.09
5 7 92 54 0.81 0.09
5 10 92 51 0.81 0.10
5 15 92 47 0.82 0.11
5 20 91 51 0.80 0.10
5 30 91 55 0.79 0.10
7 2 92 63 0.85 0.09
7 3 91 60 0.82 0.10
7 5 90 58 0.78 0.09
7 7 92 54 0.79 0.09
7 10 91 45 0.80 0.11
7 15 91 44 0.77 0.11
7 20 91 42 0.77 0.12
7 30 90 50 0.79 0.09
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Figure 4.6: Repeated holdout PLSDA classification accuracy of Barrett’s data as measured by
specificity and AUC. The five lines correspond to the choices of k, the x-axis to the choice of
q.
Compared with PCDA, PLSDA uses fewer latent variable components (factors)
for classification. Before pre-treatment with EROS (k = 0), the choice q = 7 gives the
best results with sensitivity and AUC of 91% and 79%, respectively. But the
specificity of 53% is not acceptable. After pre-treatment with EROS, the combination
k = 5, q = 3 gives best results using fewer factors, with sensitivity, specificity and
AUC of 90%, 72% and 87%, respectively, and subsequent discussion is based on this
choice. Other models with combination of k = 3, 5 and q = 3, 5 also give acceptable
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results. The PLSDA classification accuracy has improved after EROS pretreatment
although on the whole the accuracy is not as high as that of PCDA. The right hand
panel of Figure 4.7 shows the mean spectra for the high risk and low risk biopsy sites
after pre-treatment with EROS. The differences are much more evident than they were
before pre-treatment. Figure 4.7 shows the loadings for the PLSDA discriminant
functions using k = 0, q = 7 (no EROS) in the left panel and k = 5, q = 3 in the right
panel. After using EROS, and thus being able to attain acceptable levels of accuracy
with fewer factors in the classification model, the loading vector is much less noisy
and can be related much more easily to features in the spectra. Again, the most
prominent spectral feature lies in the region around the 760nm with highest PLSDA
loading, together with another two peaks of the PLSDA loading around 540 and
580nm. These features are similar to that from the PCDA model. A comparison
between the PCDA loading and the PLSDA loading for discrimination between low
risk and high risk sites can be seen in Figure 4.8. The PCDA loading vector shows
simpler features than the PLSDA loading vector.
Figure 4.7: PLSDA loadings for discrimination between low risk and high risk sites of
Barrett’s data. The PLSDA loading is shown in green, with the mean spectra for the two types
superimposed (low risk blue solid line, high risk red dotted line). The left panel is for k = 0,
q = 7 (no EROS) and the right panel is for k = 5, q = 3.
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Figure 4.8: Comparison of PCDA loading (blue line) and PLSDA loading (green line) for
discrimination between low risk and high risk sites of Barrett’s data.
Further exploration on how PLS components contribute to the classification in
this dataset can be done by looking at the PLS loading weights as described in Section
3.3.2. The PLS loading weights define the contributions of each wavelength to the
constructed components.
In this dataset, the loading weights of the first two PLS components in the top
row of Figure 4.9 show many of the same features as the PLSDA loading in Figure
4.7 which is a combination of the loading weights. Comparing these loading weights
with the PCA components’ loadings in the bottom row of Figure 4.9, PLS is choosing
different factors to PCA although more or less similar features can still be found in
some spectral ranges. The first three principal components seem to be modeling some
mixture of common spectral features and spectral differences between the two types
of tissue, though the first two PCs focus more on the latter feature after EROS
pretreatment. The first three PLS components seem to have specific focus on
between-type features. The comparison of PLS loading weight, PC loading, PLSDA
loading and PCDA loading might explain some connection between PLS and LDA
and why fewer factors can be chosen for PLSDA model. Further comparison between
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PLSDA and PCDA when they are working with EROS will be discussed in Section
4.7.2.
Figure 4.9: The loading weights (top row) of the first three PLS components and the first three
PC loadings (bottom row) based on the EROS pretreated spectra from Barrett’s data with
k = 5. The loadings are shown in green, with the mean spectra for the two types superimposed
(low risk in solid blue line, high risk in dotted red line).
4.4.2 Diagnosis of colon lesions (Colon data)
4.4.2.1 Data description
A colon dataset is presented here to illustrate the use of EROS with another
application relating to the discrimination between hyperplastic and adenomatous
polyps in the colon. Visible-NIR spectra covering the range from 320 to 920nm were
collected from 73 human colonic biopsy sites using an optical probe in vivo during
colonoscopy which was undertaken to assess patients for precancerous adenomatous
polyps (Dhar et al. 2006). Repeated measurements, on average 5 spectra per site, were
taken from each biopsy site. In total 402 spectra were analyzed, including 63 spectra
from 11 hyperplastic polyps and 339 spectra from 62 adenomatous polyps.
PLS component 1 PLS component 2 PLS component 3
PC 1 PC 2 PC 3
58
In clinical diagnosis of colon lesions by use of ESS, measurement variability is a
major source of variation. The procedure was done in lightly sedated patients and it
was difficult to place the optical probe in constant contact with the polyps. Movement,
pressure and other artefacts are therefore very likely to occur and these will influence
the experimental result but are irrelevant to classification. These problems are
reflected in considerable variability between the measured replicate spectra at a given
site. Ideally these measurement variations should be modelled and then removed from
the spectra, and this was attempted using EROS.
4.4.2.2 Data analysis
Before applying EROS pre-treatment and constructing a classification model,
standard data pre-processing as described in Section 4.4.1.3 was carried out on the
spectra to improve signal quality. This involved spectral smoothing using Savitzky-
Golay method (Savitzky and Golay 1964), cropping the noisy ends of the spectra, and
normalizing using the standard normal variate (SNV) method (Barnes et al. 1989).
Spectra from the two types of polyps are of very similar overall shape, with the
mean spectra showing small between-class differences (left panel of Figure 4.10).
Figure 4.10: Mean spectra from hyperplastic (solid blue line) and adenomatous (dashed red
line) polyps of colon data. Left: after standard pre-processing but before application of EROS.
Right: after standard pre-processing followed by EROS.
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The pooled within-sample covariance matrix was calculated using the replicated
spectra measured at each biopsy site, and the first k eigenvectors of this matrix were
used to construct P in Equation (4.1). EROS was applied by projecting the spectra
onto the subspace orthogonal to the main sources of measurement variability using
Equation (4.1).
Classification rules were derived using both principal component discriminant
analysis (PCDA) and partial least squares discriminant analysis (PLSDA).
EROS with PCDA or PLSDA was carried out for a grid of values of k and q, with
k ranging from 0 (no dimensions subtracted) to 7 and q from 2 to 30. Leave-out-one-
site cross-validation (LOOCV), which trains the algorithm on all the data except one
site which is then tested, was used to assess performance, the classification accuracy
being measured by sensitivity, specificity and AUC, the area under the ROC curve.
The construction of P was carried out inside the loop, i.e. with the replicates for the
omitted site not included in the procedure. The reason for not choosing the repeated
holdout validation used in the Barrett’s data is that the colon data is a small set, even
if we used repeated holdout validation the data randomly split off for testing would
not be sufficient to generate a AUC for the held-out set.
The same per-site analysis as described in Section 4.4.1.3 was used for the colon
data to classify each biopsy as a high risk site or a low risk site. Also since for
LOOCV mean value of the canonical scores on per site base gives better classification
results than maximum value (as shown in Figure 4.13 and Figure 4.17), we chose a
mean-score-per-site criterion for the analysis of the colon data. The sensitivity,
specificity, AUC, and the ROC curves were then calculated by pooling the mean
canonical score outputs determined on each biopsy site as described in Section 3.5.3.
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4.4.2.3 PCDA model
The leave-out-one-site cross-validation results for various combinations of k and q are
shown in Table 4.3, and the specificity and AUC results are plotted in Figure 4.11.
The ROC curves are given in Figure 4.13. Instead of choosing a balanced sensitivity
and specificity the cut off canonical score between the normal and abnormal sites was
adjusted in order to load towards a higher sensitivity (normally above 90% is
preferred) because in practice we don’t want to miss any high risk (abnormal) site.
Here a sensitivity of 85% was chosen considering the small size of the colon data.
Before pre-treatment with EROS (k = 0), the choice q = 15 gives the best results
with sensitivity, specificity and AUC of 85%, 64% and 86%, respectively. After pre-
treatment with EROS, the combination k = 5, q = 7 gives better results with fewer
factors, with sensitivity, specificity and AUC of 85%, 82% and 88%, respectively,
and subsequent discussion is based on this choice. The right hand panel of Figure
4.12 shows the mean spectra for the two types of polyp after pre-treatment with EROS.
The differences are much more evident than they were before pre-treatment. Figure
4.12 shows the loadings for the LDA discriminant functions using k = 0, q = 15 (no
EROS) in the left panel and k = 5, q = 7 in the right panel. After using EROS, the
loading vector is much less noisy and can be related much more easily to features in
the spectra.
What cannot be seen from the figure, because the spectra have rescaled, is that the
pretreatment has removed 94% of the variability in the original spectra, and that the
information for the classification appears to be in the remaining 6%. This gives
another example showing the most gain from EROS probably is to make the subtle
difference between two groups become much more prominent after the pre-treatment.
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Table 4.3: Results of leave-out-one-site cross-validation on colon dataset using various
combinations of k (number of dimensions removed by EROS pre-treatment) and q (number of
PCA scores used in the LDA).
Prediction Accuracy
k (EROS) q (PCDA)
Sensitivity (%) Specificity (%) AUC
0 2 85 27 0.70
0 3 85 18 0.68
0 5 85 36 0.79
0 7 85 27 0.76
0 10 85 27 0.68
0 15 85 64 0.86
0 20 85 45 0.78
0 30 85 55 0.77
2 2 85 18 0.52
2 3 85 36 0.69
2 5 85 18 0.67
2 7 85 36 0.69
2 10 85 9 0.71
2 15 85 73 0.84
2 20 85 55 0.82
2 30 85 64 0.83
3 2 85 27 0.71
3 3 85 27 0.69
3 5 85 45 0.70
3 7 85 64 0.85
3 10 85 64 0.83
3 15 85 73 0.84
3 20 85 64 0.84
3 30 85 45 0.79
5 2 85 45 0.71
5 3 85 36 0.71
5 5 85 55 0.76
5 7 85 82 0.88
5 10 85 73 0.86
5 15 85 73 0.89
5 20 85 55 0.84
5 30 85 55 0.84
7 2 85 18 0.66
7 3 85 64 0.86
7 5 85 64 0.85
7 7 85 64 0.84
7 10 85 64 0.86
7 15 85 45 0.84
7 20 85 45 0.81
7 30 85 27 0.77
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Figure 4.11: Leave-one-site-out cross-validation PCDA classification accuracy of colon data
as measured by specificity and AUC. The five lines correspond to the choices of k, the x-axis
to the choice of q.
Figure 4.12: LDA loadings for discrimination between hyperplastic and adenomatous polyps
of colon data. The LDA loading is shown in green, with the mean spectra for the two types
superimposed (hyperplastic solid blue line, adenomatous dashed red line). The left panel is for
k = 0, q = 15 (no EROS) and the right panel is for k = 5, q = 7.
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Figure 4.13: ROC curves from leave-one-out cross-validation on colon dataset by using
PCDA for discrimination between hyperplastic and adenomatous polyps. The left panel is for
k = 0, q = 15 (no EROS) and the right panel is for k = 5, q = 7.
4.4.2.4 PLSDA model
The leave-out-one-site cross-validation results on the per-site base for various
combinations of k and q from PLSDA model are shown in Table 4.4, and the
specificity, AUC results are plotted in Figure 4.14. The ROC curve is given in Figure
4.17. A sensitivity of 85% was chosen for all the combinations.
Compared with PCDA, PLSDA uses fewer parameters for EROS pretreatment.
Before pre-treatment with EROS (k = 0), the choice q = 7 gives the best results with
sensitivity, specificity and AUC of 85%, 73% and 83%, respectively. After pre-
treatment with EROS, the combination k = 2, q = 7 gives best results with fewer
factors, with sensitivity, specificity and AUC of 85%, 82% and 85%, respectively, and
subsequent discussion is based on this choice. Other models with combination of k =
5 and q = 5, and combination of k = 7 and q = 3 also give acceptable results with
sensitivity, specificity and AUC of 85% 73% and 84%; 85%, 73% and 86%,
respectively.
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Table 4.4: Results of leave-out-one-site cross-validation on colon dataset using various
combinations of k (number of dimensions removed by EROS pre-treatment) and q (number of
PLS scores used in the LDA).
Prediction Accuracy
k (EROS) q (PLSDA)
Sensitivity (%) Specificity (%) AUC
0 2 85 36 0.76
0 3 85 27 0.74
0 5 85 45 0.74
0 7 85 73 0.83
0 10 85 55 0.80
0 15 85 45 0.74
0 20 85 36 0.72
0 30 85 36 0.72
2 2 85 36 0.72
2 3 85 36 0.68
2 5 85 45 0.80
2 7 85 82 0.85
2 10 85 55 0.80
2 15 85 64 0.85
2 20 85 64 0.84
2 30 85 64 0.83
3 2 85 36 0.71
3 3 85 36 0.72
3 5 85 64 0.81
3 7 85 64 0.82
3 10 85 45 0.82
3 15 85 36 0.74
3 20 85 36 0.78
3 30 85 36 0.77
5 2 85 55 0.78
5 3 85 55 0.78
5 5 85 73 0.84
5 7 85 64 0.82
5 10 85 45 0.82
5 15 85 45 0.78
5 20 85 27 0.77
5 30 85 27 0.76
7 2 85 64 0.79
7 3 85 73 0.86
7 5 85 36 0.82
7 7 85 55 0.80
7 10 85 36 0.76
7 15 85 45 0.77
7 20 85 45 0.72
7 30 85 36 0.69
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Figure 4.14: Leave-one-site-out cross-validation PLSDA classification accuracy of colon data
as measured by specificity and AUC. The five lines correspond to the choices of k, the x-axis
to the choice of q.
Panels (b), (c) and (d) of Figure 4.15 show the mean spectra for the two types of
polyp after pre-treatment with EROS when k = 2, 5 and 7, respectively. The loadings
for the PLSDA discriminant functions of (b) (c) (d) models all show high peaks in the
region between 450 and 600nm. After using EROS, the (b) model with best accuracy
shows a loading vector with simpler features than others. Also in Figure 4.16 we
found in the case of the colon data that the loading vector of optimal models from
both PCDA and PLSDA showed similar features, especially in the region between 540
to 580 nm. The PLSDA loadings have more structure than the PCDA loadings. The
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important regions for classification indicated by the loadings are consistent with the
tissue absorption knowledge described in Chapter 2. It was found in a pilot study that
by comparing the normalized backscattered signal between 540 and 580 nm with that
found between 400 and 440 nm, it was possible to differentiate between adenomatous
and dysplastic areas from other non-neoplastic areas of the colon. In these regions of
spectra the major spectral differences between the tissues are caused by the changes in
blood volume, and oxygen saturation of haemoglobin. Most of these variables are due
to absorption rather than scattering, which underlies the complexity of interpreting
these data.
Figure 4.15: PLSDA loadings for discrimination between hyperplastic and adenomatous
polyps of colon data. The LDA loading is shown in green, with the mean spectra for the two
types superimposed (hyperplastic solid blue line, adenomatous dashed red line). a) The top
left panel is for k = 0, q = 7 (no EROS); b) the top right panel is for k = 2, q = 7; c) the bottom
left panel is for k = 5, q = 5; d) the bottom right panel is for k = 7, q = 3.
a) b)
c) d)
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Figure 4.16: Comparison of PCDA loadings and PLSDA loadings for discrimination between
hyperplastic and adenomatous polyps of colon data.
Figure 4.17: ROC curves from leave-one-out cross-validation on colon dataset by using
PLSDA for discrimination between hyperplastic and adenomatous polyps. The left panel is
for k = 0, q = 7 (no EROS) and the right panel is for k = 2, q = 7.
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4.5 Experiment
4.5.1 Purpose of experiment
In order to understand the measurement variability modelled and removed by EROS,
an experiment was designed to determine how experimental variation affects optical
spectra collected under controlled conditions.
Two major potential sources of measurement variability when collecting data in
vivo include differences in pressure of the probe on the tissue and the angle at which
the probe is held to the tissue. These factors are difficult to control during
measurement. In the experiment they were deliberately varied in a controlled fashion
in order to investigate their effect on the spectra.
4.5.2 Materials, instruments and methods
Two different types of tissues, squamous lined pig oesophagus and columnar lined pig
stomach, were resected (we used a portion of approximately 4cm2 of each tissue),
extended on a small piece of cork and fixed with pins. This preparation was placed on
an electronic balance as illustrated in Figure 4.18. All measurements were carried out
with a 2.5 mm (outer diameter) optical biopsy probe. Data were collected at 10
random sites for each tissue. At each site 10 replicate measurements were taken under
the conditions of all possible combinations of four pressures (0kPa, 10kPa, 20kPa,
30kPa) and four angles (0°, 15°, 30°, 45°). The total number of spectra measured for
each tissue was 1600. The probe was fixed to a micro-manipulator and pushed
downwards until the balance gave a reading close to the desired pressure level. The
data for each type of tissue were pooled to mimic the in vivo situation. The same
spectral pretreatment procedures (smoothing, reduction, cropping and normalization
by SNV) as described in Section 4.4.1.3 were carried out this data. We then extracted
the first few principal components based on the pooled within-site covariance matrix
(Equation (4.2)) using all 160 spectra at each site. By looking at these PC loadings,
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we can see how pressure and angle affect the experimental spectra. These loadings
were then compared to the loadings obtained by EROS from the in vivo Barrett’s data
with the aim of gaining some understanding of the causes of within-site variability in
spectra taken at endoscopy.
Figure 4.18: Schematic representation of the experimental set-up.
4.5.3 Experimental data
Our laboratory data show that different levels of pressure and angle have a substantial
effect on the spectra. There is a clear ordering in the mean spectra in Figure 4.19. The
first three principal component loadings based on the pooled within-site covariance
matrix are plotted for both the experimental data and in vivo Barrett’s data for
comparison. For each principal component, there is quite a good match between the
experimental and in vivo data as shown in Figure 4.20. For the experimental data, the
pooled within-sample covariance captures the variation caused by pressure and angle
under controlled laboratory conditions. For the in vivo Barrett’s data, it describes the
variability between replicate measurements. The similarity in the loadings supports
the contention that the measurement variability removed by EROS comes from
differences in pressure and angle when measurements were taken in vivo.
ESS box
Laptop
10 g
Probe
Display
Tissue sample
Digital balance
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Figure 4.19: Spectral pattern of squamous tissue. Left: blue, red, green and orange lines: mean
spectra at pressures 0kPa, 10kPa, 20kPa, 30kPa, respectively (Results are combined for all
angles). Right: blue, red, green and orange lines: mean spectra at angles 0°, 15°, 30°, 45°,
respectively (Results are combined for all pressures).
Figure 4.20: The first three principal component loadings of experimental data (dotted blue
line) and in vivo Barrett’s data (solid red line).
4.6 Prospective prediction
A new Barrett’s dataset with a total of 68 matched optical and histological biopsies
(corresponding to 276 spectra) was later collected from another 20 patients. It
includes 50 biopsies (corresponding to 202 spectra) from low grade dysplasia or no
dysplasia (low risk) and 18 biopsies (corresponding to 74 spectra) from high grade
dysplasia or cancer (high risk). To test the robustness of the EROS models introduced
in the Section 4.4.1.4, the classification rules trained on the Barrett’s dataset described
in Section 4.4.1.3 were applied to this independent test set.
The same spectral pretreatment procedures were implemented on the test data as
on the training data and the classification rules were applied using the cutoffs learnt
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from the training data.
All the models (i.e. all the choices of k and q) were applied on the test set. The
prospective prediction results are shown in Table 4.5. In general, the models with
EROS give higher prediction accuracy than that without using EROS. The models
with fewer number of PC scores in LDA, q, are the ones that work best with EROS.
The comparisons of the two best validation models using 0k , 20q (no EROS)
and 5k , 5q (EROS) (described in Section 4.4.1.4) show that the model with
5k , 5q (EROS) gives much better prediction results with sensitivity of 83% and
specificity of 84%, while the model with 0k , 20q (no EROS) gives prediction
results with sensitivity of 83% and specificity of 68%. The prediction results here
show some evidence that the simple EROS model with fewer parameters gives more
robust prediction accuracy for discrimination between spectra from high risk and low
risk sites.
Table 4.5: Results of prospective testing prediction on an independent Barrett’s dataset by
applying the classification rules trained on the training set using various combinations of k
(number of dimensions removed by EROS pre-treatment) and q (number of PC scores used in
the LDA).
Prospective Prediction Accuracyk
(EROS)
q
(PCDA) Sensitivity (%) Specificity (%)
0 5 83 28
0 10 100 28
0 20 83 68
0 30 78 66
2 5 83 67
2 10 72 80
2 20 67 84
2 30 72 82
3 5 83 76
3 10 72 86
3 20 78 84
3 30 89 74
5 5 83 84
5 10 67 86
5 20 78 80
5 30 72 80
7 5 78 78
7 10 83 58
7 20 83 64
7 30 89 42
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4.7 Discussion and conclusions
EROS works well as an effective pre-treatment for both Colon and Barrett’s in vivo
data, characterising the measurement variability between the spectra from repeated
measurement, and ameliorating the effect of it. In comparison to using the original
spectra for classification we can extract the most useful information from the first few
principal components after eliminating this structured measurement variation from the
total variation of the spectra. The designed experiment gave a plausible explanation
for the measurement variability that much of the measurement variability comes from
the differences of pressure and angle of the probe. The remaining variation left in the
spectra contributed the most to the classification. The LDA loadings derived from the
pre-treated spectra show a very smooth and simple structure while the LDA loading of
the original spectra looks quite noisy. The simple structure is likely to be much more
meaningful and instructive for the physical interpretation of the loadings. The
approach, which was successful in this application, is quite general, and could be used
in many other situations.
4.7.1 How EROS works
EROS worked well in the diagnostic application described above because the spectra
contain a substantial amount of structured noise that can be removed by a simple
projection without destroying the information of interest. This is only possible
because the spectra are high-dimensional observations, but it will not always hold.
The approach makes no attempt to orthogonalise the subtracted dimensions to y, and
could thus remove some or all of the signal along with the noise. If there is a lot of
interfering variability in the same dimensions as the signal of interest, then neither
EROS nor any other mathematical treatment is likely to help. If it is in different
dimensions, EROS will help. The situation in which EROS will have a negative effect
is when it is used to remove small amounts of interfering variability that coincide in
direction with the signal. In any given application, the best approach is to try it and
see what happens.
An alternative approach to constructing calibrations robust to replication
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variability is to include replicate spectra in the training set, all with the same reference
value. The fitting process then rewards prediction formulae that ignore the replication
variability and tends to produce calibrations robust to this variability. The problem
with this approach is that it interacts badly with the use of factor-based methods such
as principal components regression or PLS to construct calibrations. Including the
variability in the training set results in factors being constructed that describe it.
These factors may then be downweighted in the regression part of the procedure, but
the damage is already done in terms of complexity and interpretability. Removing the
variability, as EROS does, removes it from the constructed factors, reducing
complexity and improving interpretability.
The EROS pre-treatment is a subtraction. It removes entirely the targeted
dimensions in the spectral space, but leaves the rest unaffected. It cannot therefore
play the same role as a multiplicative scatter correction, and it will often be beneficial
to use such a correction as well as EROS, as in the applications of Section 4.4.
An alternative approach to cope with effect of replicates by hierarchical mixed
models to model structured within-sample variability in a nested or hierarchical
fashion might also be interesting, but could become much more complicated, and has
not been tried.
4.7.2 How EROS works with PCDA and PLSDA
Although neither the Barrett’s data set nor the colon data set is large, we can still draw
some conclusions about the comparison of PCDA and PLSDA. Figures 4.21-4.22 (top
panels) show that before EROS pretreatment, PLSDA uses many fewer components
(7) than PCDA (about 15-20) to achieve the best accuracy. The optimal results from
both Barrett’s and colon data seem vary with the method. This is probably because
before EROS the variations extracted from the data using different methods to
construct the components are different, and most probably neither method is
completely successful in extracting the relevant information since results from both
methods are improved after EROS. This also gives an example that PLSDA/PLSR
does not always do better than PCA in discrimination, especially when there exist
large within-group variations.
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However after EROS pretreatment (as shown in the bottom panels of Figures
4.21-4.22), for the Barrett’s data using 3~5 factors gives the best results for both
PCDA and PLSDA models; for the colon data using 7 factors give the best results for
both PCDA and PLSDA models. Both PCDA and PLSDA models can achieve
comparable accuracy using a similar small number of components. This is especially
the case for the colon data which shows highly consistent pattern of classification
accuracy varying with model complexity. This gives some evidence that when the
difference between two groups is subtle and there exist large variabilities within the
groups, using EROS to eliminate large within-group variations before constructing
classification models results in prominent distinction between groups and enables
PCDA and PLSDA to achieve comparable discrimination results.
Figure 4.21: Classification accuracy of Barrett’s data as measured by AUC and specificity
before and after EROS pretreatment (k = 5 for both PCDA and PLSDA) by using PCDA (in
blue) and PLSDA (in red).
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Figure 4.22: Classification accuracy of colon data as measured by AUC and specificity before
and after EROS pretreatment (k = 5 for PCDA, k = 2 for PLSDA) by using PCDA (in blue)
and PLSDA (in red).
In general, before EROS pretreatment, it’s always worthwhile to try different
classification models since their performance is variable. After EROS, the models are
more parsimonious and how much variation of interest can be extracted from the
EROS pre-treated data seems not to be method-dependent.
4.7.3 How to choose components used in EROS
According to our practical experience, the number of dimensions removed by EROS
pretreatment should normally be small, in most cases using the first 3~5 PCs does best.
This is evidence that the first few principal components stand a good chance to have
contained the most undesirable variation for classification. This is to some extent
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warranted with reflectance spectra. For example the first PC often relates to a varying
baseline of the spectra (Næs et al. 2002). Although in the applications above we
always use the first few PCs to construct the projection matrix, it is not necessarily the
only option. Two models from the colon example are compared here. One is the
PCDA model with k = 5 and q = 7. The other is a PCDA model with q = 7 after EROS
removed four dimensions corresponding to the first three components and the fifth
component.
Figure 4.23 shows that the pretreated spectra by the second model show clearer
differences and more structure (especially in the region of 400~450nm and
600~650nm) in the difference between two kinds of tissue than that for the first model.
As to the PCDA loadings of both models, the second model gave the simpler structure
than the first one. Removing fewer dimensions by EROS in the second model does
not seem to decrease the prediction performance, as shown in Table 4.6. This is some
evidence that the fourth principal component of the original spectra matrix, though
capturing more measurement variability than the fifth one, might also contain
information about the diagnosis. No attempt has been made to pursue this line of
research any further, but there is scope for further investigation of how to select
components to construct an optimal model and how to interpret them.
Figure 4.23: PCDA loading of the EROS pretreated spectra from colon data. Left panel is for
k = 5, q = 7. Right panel is for the model with first 3 and 5th PC used for dimension removing
in EROS and q = 7; Green line: PCDA loading; Red line: mean spectra from adenomatous
polyps; Blue: mean spectra from hyperplastic polys.
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Table 4.6: Results of leave-one-out cross-validation on colon dataset using various
combination of dimension k (number of dimensions removed by EROS pre-treatment) and q
(number of PCA scores used in the LDA)
Prediction Accuracyk
(EROS)
q
(PCDA) Sensitivity (%) Specificity (%) AUC
1:5 5 63 64 0.74
- 7 82 82 0.85
- 10 81 82 0.83
- 15 82 82 0.87
20 71 73 0.82
30 72 73 0.76
1:3, 5 5 66 64 0.67
- 7 81 82 0.86
- 10 82 82 0.84
- 15 77 82 0.85
- 20 81 82 0.86
- 30 71 73 0.77
4.7.4 Wavelength selection
As can be seen in Figure 4.24, for the Barrett’s data after pretreatment by EROS the
PCDA loadings show much more importance in the spectral region where there are
bigger differences between normal and cancer spectral intensity, especially in the
region 500~800nm, which make it reasonable that we should interpret the LDA
loading as importance of the wavelengths for interpretation.
According to the importance it appears to have for the classification, the
wavelength range from 600 ~ 800 nm was selected for the PCDA model with
pretreatment by EROS for k = 5, q = 5. The results of repeated holdout validation
shown in Table 4.7 demonstrated that using only the information from the selected
spectral interval with the range of 600 ~ 800 nm did not decrease by much the
classification accuracy. This implies there exist strong spectral features in this region
for classification model building. Although performance is not improved by selecting
wavelength regions, the contribution of the wavelength selection to clinical diagnosis
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may be much more meaningful. If a small number of specific wavelengths can be
found which give as much information as a full spectrum when used for classification,
ESS point measurement then may possibly be developed for in vivo field imaging
detection, which would become an invaluable tool to endoscopists.
Figure 4.24: PCDA loadings for discrimination between low risk and high risk sites of
Barrrett’s data. The PCDA loading is shown in green line, with the mean spectra for the two
types superimposed (low risk solid blue line, high risk dotted red line). The PCDA model is
for k = 5, q = 5.
Table 4.7: Results of repeated holdout validation on both whole range and selected range of
Barrett’s data by using EROS pretreatment and PCDA model with k = 5, q = 5.
whole range: 370 ~ 800 nm Selected range: 600 ~ 800 nm
EROS PCDA Sensitivity Specificity AUC Sensitivity Specificity AUC
5PCs 5PCs 92% 75% 0.87 92% 72% 0.85
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CHAPTER 5
PARTIALLY SUPERVISED BAYESIAN
CLASSIFICATION OF SCANNED SENTINEL
LYMPH NODES
5.1 Background and introduction
Breast cancer is the most common malignancy in women in the western world, with a
reported incidence of up to 1 in 8 women. The presence or absence of metastatic
cancer in the axillary lymph nodes in patients with breast cancer remains the most
powerful predictor of prognosis, and plays an important role in identifying patients
who are at risk of developing disease that spreads throughout the body, and thus likely
to benefit from chemotherapy. Traditionally, the presence of axillary lymph node
metastases has been determined by axillary lymph node dissection (ALND), which is
a surgical procedure that removes all the lymph nodes under the arm. This is a
substantial surgical procedure, however, which can be associated with several serious
side effects, the most significant being lymphoedema (persistent swelling of the arm)
and shoulder dysfunction, which adversely affect the patient’s quality of life. In
current surgical practice, most patients present with early disease as a result of
increased public awareness of breast cancer and mammography screening programs.
Hence most patients do not have axillary lymph node metastases at presentation, and
while the staging information is crucial for their future management, they get no
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therapeutic benefit from ALND, while still being at risk of developing the
complications associated with the procedure.
The sentinel node is the first node to be invaded by cancer spreading from the
breast as shown in Figure 5.1. It has been well documented that if cancer cannot be
detected in sentinel nodes, the chance of there being any cancer in nodes further down
the chain draining the breast is exceedingly small (Turner et al. 1997). Thus if the
sentinel node can be easily identified, removed, and examined for cancer and no
cancer is found, there is no need to remove the rest of the axillary nodes. This
markedly reduces the risk of complications associated with full axillary node
clearance (Veronesi 2003, Swenson 2002).
Axillary Lymph Nodes
Breast Cancer
Sentinel Lymph Node
Figure 5.1: Illustration of sentinel and axillary lymph node in breast cancer.
To get the maximum benefit from sentinel node biopsy, it is important to be able
to determine rapidly whether or not cancer is present. If the assessment of the node
cannot be completed intraoperatively (while the patient is still on the operating table),
the subsequent discovery of cancer in the node will necessitate a second operation to
perform the ALND. This is technically more difficult, delays the start of adjuvant
radiotherapy and chemotherapy, gives rise to additional costs and causes further
anxiety to the patient.
Conventional intraoperative analysis is undertaken by touch imprint cytology or
frozen section histology. Both require sample preparation and interpretation of the
findings by an experienced pathologist (Johnson et al. 2004).
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The lack of a more generally available and reliable intraoperative tool to establish
the sentinel node status remains an obstacle to the routine practice of sentinel node
biopsy. A real-time optical method for determining sentinel node involvement would
provide significant benefits to patients undergoing surgery for breast cancer.
Elastic scattering spectroscopy (ESS), as described in Chapter 2, when performed
using an appropriate optical geometry, is sensitive to the sizes, indices of refraction,
and structures of the subcellular components (e.g., nucleus, nucleolus, and
mitochondria) that change when cells become malignant (Mourant et al. 1998).
Employing multivariate statistical techniques on spectroscopic measurements may
enable in vivo examination and computer generated diagnosis without tissue
processing and pathologist interpretation.
We have shown in Chapter 4 that ESS manual measurements are able to detect
precancerous and early cancerous changes in Barretts oesophagus, and identify pre-
cancerous polyps in the colon. ESS is applied in this chapter to diagnose sentinel
lymph node metastases in breast cancer.
Conventional manually measured ESS spectra contain considerable experimental
variation caused by angle or pressure of the hand-held probe as described in Chapter 4.
To avoid this problem and to produce much more and reliable information for rapid
intraoperative diagnosis of sentinel node metastases, an automated two-dimensional
ESS scanning device was developed (as an advance on ESS manual measurements) to
take measurements from the entire cut surface of the excised nodes. Instead of
determining whether an individual point of tissue is abnormal or not, the ESS scanner
examines a larger area of tissue by taking measurements at 400 points (pixels) in a
2020 grid, and has the ability to produce diagnostic images (of any tissue that can
be optically scanned) to assess the cancer risk. The assumption is that more extensive
and reliable optical sampling of the tissue under examination should increase the
accuracy of diagnosis.
However additional problems arise in the analysis and interpretation of the ESS
scanned measurement data. The commonly used supervised classification methods,
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e.g., linear discriminant analysis, require training data to train the algorithm. Since the
histology data for sentinel lymph nodes is on a per node basis, there is no reference
pathology available for each pixel in the image. This causes problems when deriving a
classification algorithm for pixels. We do however have manual measurements on
totally normal and totally metastatic nodes from an earlier stage of this research. An
obvious approach is to use the manual measurement data to train the classification
algorithm for use with the scanning data. However, apart from the normal and
metastatic groups, the scan also includes a third group, which is a non-nodal group
from a background area, possibly contaminated by blood or lipid. There are no
training data available for this non-nodal group which varies considerably from node
to node, which causes further difficulty. Using the discriminant algorithm developed
from manual data, the spectra from background usually gives a canonical score
indicative of cancer. The non-node area may, as a result, be misclassified as metastatic
and impede the recognition of normal and metastatic nodes.
As well as the problems described above, there is also one interesting opportunity
arising in the ESS scanning data analysis. Since the scanner generates a spectral
image, and it should therefore be possible to use a smoothness assumption about the
image to improve the classification of individual pixels.
To solve the problems and make use of the advantage of having an image, a
partially supervised image classification model framework has been built to recognize
the non-nodal area automatically and enable clinicians to make a rapid intraoperative
diagnosis of sentinel node metastases from the images. The basic idea is that the
classification of points in the image will be done by clustering, using a mixture model,
with the training data providing prior distributions for the groups in this model.
To simplify the presentation and to demonstrate the effects of different aspects of
the model, the whole model framework is split into two parts. The first part, presented
in this chapter, concerns the dimension reduction and Bayesian multivariate finite
mixture image classification model. Without consideration of the spatial correlation in
the image, this part of the model generates a preliminary solution. The second part is
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addressed in Chapter 6 with additional information on spatial correlation in the image
added into the model. Taking into account the spatial correlation between contiguous
pixels in the image, this part of the model aims at generating a more realistic image.
All the results and discussions relevant to the joint model framework are illustrated in
Chapter 7.
A list of notations used throughout the Chapters 5-7 are listed in Appendix A.
5.2 Instrumentation system
In the case of this project, ESS is being developed as a technique to discriminate
between lymph nodes which contain metastatic tissue, and lymph nodes which are
normal. In the first stage of the work, spectra were collected from nodes using a hand-
held probe. Later on an automated two-dimensional ESS scanning device (an optical
scanner) was constructed to increase the sampling effort per-node. This takes
comprehensive measurements from the entire cut surface of the nodes. The ESS
scanner instrumentation consists of a xenon arc lamp, a static ESS probe, a mobile
stage, a spectrometer and a computer to control the various components and record
the spectra (see Figure 5.2).
After excision, nodes are bivalved along their long axis and touch imprint
cytology performed. ESS measurements are taken from the same cut surface. The cut
surface of the node is placed under a specially designed thin fibre optic plate attached
to a motorised stage that moves back and forth incrementally in two dimensions under
a stationary ESS probe in a raster scanning pattern (Figures 5.3-5.4) to enable multiple
ESS measurement of the cut surface of the node. The probe is optically coupled to the
fibre optic plate with a drop of immersion oil. Prior to use, the system response is
calibrated against a standard diffuse reflector as a reference (Spectralon) through the
fibre optic plate. A 1010 mm area of the cut surface of the each node is scanned as
the fibre optic plate repeats the procedure of “move, stop and measure” pixel by pixel.
84
Figure 5.2: ESS scanning system Figure 5.3: ESS scanner stage
Figure 5.4: Schematic diagram of elastic scattering spectroscopy scanning device system.
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A 2020 ESS measurement pixel image is generated by the system, i.e. 400 pixels,
each of size 0.50.5 mm. For each node a photograph with a microscopic view is
taken for its area being scanned, usually including some area of fibre optic plate
uncovered by the node. These photos will be later used in Chapter 7 to compare with
the images generated by our model proposed in this chapter and Chapter 6 for the
purpose of assessing the model’s success.
5.3 Data description
The study was conducted in two phases, generating two datasets. Initially spectra
taken manually from nodes known to be entirely normal or completely replaced by
cancer were gathered in order to develop an algorithm to distinguish cancer from
normal nodal tissue. In the second phase, an independent set of nodes was scanned,
giving a 2020  image for each node.
All spectra were recorded as a ratio to a calibration spectrum taken from the
spectrally flat material Spectralon (as a reference), thus rendering the data
independent of the spectral response of the system. The spectra are recorded at 1801
equidistant wavelengths in the visible and near infrared (NIR) region of 320-919 nm.
For the first part of the study, a total of 3,525 spectra from 404 nodes, 356 normal
nodes and 39 totally metastatic nodes, were collected by manual point measurement.
Each spectrum was measured by placing the optical probe manually at up to 16
random sites on the bivalved node. The mean spectra from these manual
measurements are shown in Figure 5.5. Each node, and therefore each point is
classified as normal or metastatic by histological experts. No spectra from background
area are available in this dataset.
For the second part of the study, to assess nodes comprehensively, a total of 48
axillary nodes, 21 normal nodes and 27 partially metastatic nodes or totally metastatic
nodes, with matched histology from 26 patients were scanned in our study, giving a
2020 pixel image of 400 spectra for each node. The reference pathology is only
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provided on per node base, but not available for individual pixels in the image.
Figure 5.5: Mean spectra from normal (blue solid line) and metastatic (red solid line) node
with one standard deviation on either side of the mean (dashed lines) after standard pre-
processing.
Figure 5.6: One example of ESS scanning measurement pixel image of one partially
metastatic node generated by spectral intensity at nine different wavelengths.
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Figure 5.7: Typical spectrum from normal tissue (blue), metastatic tissue (red) and non-nodal
area (black) of one partially metastatic node (the pixel position index (x,y) of each spectrum
refers to the pixel location in the image of Figure 5.6).
The cut surface of the node with bivalved shape is placed under a square fibre
optic plate as shown in Figure 5.4, and in most cases the scanning data contains not
only the areas from the normal or metastatic groups, but also a non-nodal group from
a background area, possibly contaminated by blood or lipid, which varies
considerably from node to node. No training set from the manual data are available
for this non-nodal group.
For illustration Figure 5.6 shows the image of one partially metastatic node at
nine different wavelengths with a colour map for intensity. Typical spectral patterns of
one pixel of normal tissue, metastatic tissue and non-nodal area from this node are
shown in Figure 5.7.
Figure 5.6 shows this is a three-way data with two spatial dimensions and one
wavelength dimension where the response is intensity. One approach to dealing with
this kind of data is to begin with a second-order calibration model (Linder and
Sundberg 1998). Instead of using this method, our analysis essentially ignored the
spatial dimensions to start the analysis and then later on takes them into account.
5.4 Theory
In this section we give a brief review of the relevant theory on multivariate finite
mixture models which will be employed in the partially supervised image
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classification model introduced in Section 5.5.
5.4.1 Multivariate finite mixture model
Finite mixture models, as an increasingly important tool in multivariate statistics, are
widely used in semi-parametric probability density function (PDF) estimation
problems or clustering tasks (e.g. McLachlan and Basford 1988, McLachlan and Peel
2000). The unknown PDF is approximated by a weighted sum of mixture distributions.
Finite Gaussian mixture models (FGM) are widely used, showing good performance
in many applications (McLachlan and Peel 2000, Fraley and Raftery 2002,
Titterington et al. 1985). However, finite Student’s t mixture models (FTM) are
efficient alternatives that can deal with a limited number of outliers.
In a finite mixture model for a k-dimensional random vector X the PDF is a
linear combination of g component densities )|( jxf  :
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where the mixing proportions j s are non-negative and must sum to one, and j s are
the parameters of the components in the mixture. Consider an i.i.d. realization
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where ),...,,,...,( 11 gg   summarizes the model parameters.
5.4.1.1 Multivariate Gaussian distribution
In multivariate analysis, a popular choice for the component density )|( jxf  is the k-
dimensional multivariate Gaussian distribution. The jth component in the mixture is
then characterized by its mean vector j and its covariance matrix j , so that
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5.4.1.2 Multivariate t distribution
An alternative choice is the multivariate t distribution. The family of t distributions
provides a heavy-tailed alternative to the normal family. Hence it provides a more
robust approach to the fitting of normal mixture models, as observations that are
atypical of a component are given reduced weight in the calculation of its parameters.
Also, the use of t components gives less extreme estimates of the posterior
probabilities of component membership of the mixture models, as demonstrated in
Peel and McLachlan (2000).
A random vector X is said to have a k-variate t distribution with location
parameter j , positive definite scale matrix j , and the degrees of freedom jv if its
joint probability density function is given by
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If 1jv , j is the mean of x, and if 2jv , jjj vv  1)2( is its covariance matrix.
The degrees of freedom parameter jv is also referred to as the shape parameter,
because the Kurtosis of Equation (5.4) depends on jv . When 1jv , it corresponds to
a k-variate Cauchy distribution for which neither the mean nor the variance exists. As
jv tends to infinity, x becomes multivariate normally distributed with mean vector j
and covariance matrix j . It can be fixed in advance or it can be inferred from the
data for each component thereby providing an adaptive robust procedure (Lange et al.
1989). In our applications we will fix, rather than estimate, jv , so the parameters are
},{ jjj   .
5.4.2 Maximum likelihood estimation (MLE)
The maximum likelihood approach to parameter estimation in finite mixture models
obtains a point estimate ˆ of the parameter  by attempting to maximize the log-
likelihood function in Equation (5.2), that is,
)(maxargˆ 

L . (5.5)
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Quantities of interest may then be estimated by “plugging in” the point estimates. For
example, the density )|( jxf  may be estimated by )ˆ|( jxf  .
Although popular, the maximum likelihood approach to mixture models suffers
from problems mostly caused by the fact that for many choices of parametric family f
the likelihood in Equation (5.2) is unbounded. Point estimates of the parameters
corresponding to singularities in the likelihood surface are of no real interest, and it is
usual to seek a parameter estimate which corresponds to a large local maximum of the
likelihood surface. Aside from the computational problems associated with finding
such maxima, there may be several reasonable local maxima between which to choose,
each of which may give quite different plug-in estimates for quantities of interest. In
many cases it will be difficult to justify choosing one of these point estimates of the
parameter above the others. Such problems have encouraged the development of a
Bayesian approach to the mixture models problem.
5.4.3 The Bayesian approach
In Bayesian paradigm, parameters are treated as random quantities, and point
estimates for parameters are replaced by distributions on the parameter space which
represent our knowledge or belief about the value of the parameters. A comprehensive
description is given by Bernardo and Smith (1994) and Gelman et al. (1995). Fully
Bayesian inference seeks quantities of interest by integration over the parameter space,
weighting by the posterior distribution of the parameters, which is implemented by
Markov chain Monte Carlo (MCMC). However when a spatial prior is taken into
account, the computation becomes very difficult for MCMC treatment. Here we just
use posterior modes as point estimates rather than using a fully Bayesian paradigm.
Since the posterior distribution is expected to contain multiple modes even in the
normal case, and much more critically in the student-t case, here we expect to find a
local maximum as the posterior mode. The choice of starting value is therefore
important. This is why the cluster analysis was used to provide a good starting point.
Using a Bayesian approach here allows us to incorporate prior information (from
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the manual measurements) into our model. Even though we only compute modes, this
will help with the problems described above. The informative prior distributions for
the j help to stabilize the computations. The realization of the Bayesian approach in
our classification model is given in Section 5.5.2.2, where priors for the parameters
j in the model are chosen for tractability.
5.4.4 Expectation maximization (EM) algorithm
Our model fitting is based on the expectation maximization (EM) algorithm. The EM
algorithm, first introduced by Dempster, Laird and Rubin (1977), is an iterative
method for finding maximum likelihood estimates (MLE) or posterior modes,
maximum a posteriori (MAP) estimates, in incomplete-data problems. In the mixture
application, the ‘missing data’ are the unknown group memberships. The E-step of
each iteration involves taking expectations of the complete-data log-likelihood
function, or log-posterior density function in Bayesian analysis, given the observed
data and the current parameter estimates. The M-step of each iteration re-estimates the
parameters by maximizing this (expected) complete data likelihood or posterior. The
EM algorithm has appealing properties relative to other iterative algorithms. Firstly, it
is typically easily implemented because it relies on complete-data computations,
which are often in a simple closed form. Secondly, its convergence is stable, with each
iteration increasing the likelihood or posterior density.
EM is widely used in imaging analysis with the finite mixture model. An early
EM algorithm applied to the Gaussian mixture model can be found in Little and Rubin
(1987) and subsequently in McLachlan and Krishnan (1997). An EM algorithm for
mixtures of t-distributions was presented by Peel and McLachlan (2000). This
algorithm introduces an additional set of weights, estimated during the E step, which
essentially performs a soft rejection of outliers. A significant advantage of using the t
distribution is the ability to tune the model’s robustness to a particular application or
even a particular data set, by varying the degrees of freedom parameter.
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5.5 Partially supervised image classification model
framework
Motivated by the misclassification problems described in Section 5.1, a partially
supervised image classification model employing a Bayesian multivariate finite
mixture model is developed in this chapter to recognize the non-nodal area in the
image and to further classify each node as normal or metastatic. Prior distributions
derived from manual data for normal and metastatic components are imposed onto a
multivariate mixture model derived from the scanning data, along the directions of a
low-dimensional space which, in one of the approaches, is constructed from both data
sets. Although the analysis is essentially a form of unsupervised clustering, it takes
place in a space partially determined by the manually measured training data, and uses
prior distributions derived from these data. It is therefore referred to as ‘partially
supervised’.
5.5.1 Dimension reduction and variable construction
In the context of hyperdimensional image classification using a multivariate finite
mixture model, some dimension reduction is essential to enable the feasibility of the
multivariate distribution fitting. Reduction to a very small number of dimensions will
also avoid excessive memory storage and speed up computation during the process of
model fitting and parameter estimation. The advantages of dimension reduction are
particularly apparent in the application of real-time prediction.
The high-dimensional spectra are projected into a low-dimensional space
constructed to include most of the variations in the original directions of data space.
Two different options for dimension reduction are explored here. One, which we call
PCA dimension reduction, applies PCA to the spectra from the node under study. The
other, which we call discriminant dimension reduction, takes as the first dimension the
canonical variate derived from the training data, and adds to this a small number of
dimensions derived from a PCA of the variability orthogonal to this in the spectra of
the node under study.
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In both cases we apply a preliminary PCA dimension reduction to the spectra
from the entire set of scanned nodes thus simplifying the calculation and storage of
training set means and variances for later use in prior distributions.
5.5.1.1 PCA dimension reduction by global PCA projection followed by
local PCA projection
A two-step PCA dimension reduction method projects the spectra of the scanned node
of interest onto a low-dimensional space through a global PCA projection followed by
a local PCA projection as described below.
A global PCA reduction step extracts the general features of normal, metastatic
and non-nodal spectra from all the scanned nodes by projecting the spectra via PCA
onto a low-dimensional space (typically with dimensions less than 20) capturing most
variations from all the scanned nodes. The global PCA loadings are then used to
project the manual measurement data onto the same low-dimensional space. With
known class membership for each spectrum in the manual data, the PC scores of
manual data are used to derive prior distributions for the parameters of the normal and
metastatic groups in the scanning data.
The only point of the global PCA reduction is to reduce the dimension before
calculating the priors. If the method is programmed and implemented for real time
prediction, these priors need to be stored, and the smaller the number of dimensions
the better so long as the space spanned by these dimensions captures most of the
important variability in the nodes. Instead of taking large memory space to store all
the high-dimensional spectral data, here we only need to store the mean and variance
of normal and metastatic groups of manual data in the reduced dimensions for later
use as priors for scanning data.
For each node, a local PCA reduction step starting with the scores from the
previous step extracts the individual features by finding a small number of axes,
typically less than 5 dimensions. The priors are then projected into the space spanned
by these axes.
We now describe the procedure in detail.
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Step 1: Global PCA projection
A principal component analysis is carried out on the spectra from all the scanned
nodes and the first gk , typically about 15 to 20, PCs are chosen to capture most of the
variability ( >99%) on all the nodes. The loadings for these PCs are applied to the
manually measured spectral data from normal and metastatic tissue as below, and the
PC scores are used to derive prior distributions (by calculating mean and variance of
the transformed spectral matrix in the space of these gk PCs) for parameters of the
normal and metastatic groups.
gnodesallnodesall LXZ ..  (5.6)
gtraintrain LXZ  (5.7)
where nodesallX . is a c pn spectral matrix of all the scanned nodes (n is the number of
observations from one scanned node, c is the number of scanned nodes, cn is the
number of observations from all the scanned nodes, p is the number of wavelength
points). Each row of nodesallX . is a p-dimensional spectral vector. gL is a gkp  global
PCA loading matrix of the first gk PCs of nodesallX . . nodesallZ . is a gkcn  score matrix,
the columns of which are the first gk PC scores of nodesallX . .
For the manual measurement data, trainX , a pm spectral matrix (m is the
number of spectra) is then converted into a gkm  score matrix trainZ using the global
PCA loading gL . The 1gk mean vectors
'
nm ,
'
cm and the gg kk  covariance
matrices 'nV ,
'
cV of trainZ are calculated for normal and metastatic spectra.
Step 2: Local PCA projection
For the node of interest, PC scores are calculated in the same gk -dimensional space
as those in step 1 by using the global PCA loadings gL as below
gnodeonenodeone LXZ ..  (5.8)
where nodeoneX . is a pn spectral matrix for this scanned node, nodeoneZ . is a
gkn  score matrix whose columns contain gk PC scores (actually the matrix nodeoneZ .
is a submatrix of nodesallZ . already calculated). nodeoneZ . is then considered as raw data
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for this node. A PCA is carried out on nodeoneZ . with the first lk , typically less than 5,
PCs extracted as below
lnodeonenodeone LZS ..  (5.9)
where lL is a lg kk  local PCA loading matrix of the first lk PCs of the score matrix
nodeoneZ . of the node, nodeoneS . is a lkn score matrix whose columns consist of lk PC
scores. Each row of nodeoneS . is a lk -dimensional spectral vector node.ones which will be
the spectral data used in our image classification model.
The local PCA loadings lL are then used as below to convert the 1gk means
'
c
'
n m,m and gg kk  variances
'' , cn VV derived in the global PCA step to 1lk means
''
c
''
n m,m and ll kk  variances
'''' , cn VV for later use in priors for the parameters of the
mixture distributions.
'''
n
T
ln mLm  ; ''' cTlc mLm  ; (5.10)
ln
T
ln LVLV '''  ; lcTlc LVLV '''  . (5.11)
5.5.1.2 Discriminant dimension reduction using an external LDA
loading and an internal PCA
The two-step discriminant dimension reduction method described here projects the
spectra of each scanned node onto a low-dimensional space composed of an external
variable and a small number of internal variables as described below.
The canonical variate derived from a linear discriminant analysis (LDA) on the
manually measured data is used as the first axis in the reduced dimensional space for
each node. This axis gives maximum separation between normal and metastatic
groups in the manual data.
To allow the method to adapt to each node, a small number (e.g., 1-3) of local or
internal variables will be added to this external one. However, as with the previously
described method, we proceed in two steps. First we extract and store a substantial
number (e.g., 15-20) of PCs derived from a PCA of the variance in all the scanned
nodes orthogonal to the external variable, capturing as far as possible the variations
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left by the external variable. As before the main reason from this step is to be able to
save in convenient form the means and variances from the manual data.
For each individual node, we then calculate its scores on these 15-20 global PCs
and take these as raw data to further extract a small number (e.g., 1-3) of PCs as local
variables. The loadings are then used to convert the 15-20 dimensional priors to 1-3
dimensional priors. The external variable and internal (local) variables are combined
for use in the image analysis.
We now describe the procedure in detail.
Step 1: Constructing the external variable
A PCDA (a PCA followed by a LDA) is carried out on the manual measurement
data, trainX , and the first extk principal components (carrying most of the variability of
manual data) are chosen to construct a scalar canonical variable, traint , as a common
dimension along which there is the maximum separation between the normal and
metastatic groups. The discriminant algorithm is developed by leave-one-out cross-
validation on the manual data. The scores on this variable are calculated as
exttraintrain qXT  , (5.12)
where each element of the vector trainT is a 1-dimensional canonical score for one
spectrum in the manual training data, and extq is a p-dimensional PCDA loading
vector.
By applying the PCDA loading, extq derived from the manual data to the spectral
data from the node of interest, we compute the external variable for this node
extnodeoneextnode qXT ..  (5.13)
where each point of ext.nodeT is a 1-dimensional canonical score, nodeoneX . is a pn
spectral matrix for the scanned node of interest (each row of nodeoneX . is a p-
dimensional spectrum). We call extq the external variable loading here.
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Step 2: Constructing the internal variable(s)
Before constructing the internal variables, the first 0.intk (e.g., 15-20) PCs of all the
scanned nodes are extracted from a space orthogonal to the external variable,
capturing as much as possible the variations left by the external variable. Thus
extnodesallextnodesall qXT ...  (5.14)
nodesall
T
extnodesallextnodesall
T
extnodesallextnodesallnodesall XTTTTIX ...1....... ))((
~ 
 (5.15)
0..0...
~
intnodesallintnodesall QXT  (5.16)
where I is a cncn  identity matrix extnodesallT .. is a vector of canonical scores for all
the scanned nodes, nodes.allX
~ is a pcn  spectral matrix whose columns lie in the
1p dimensional subspace orthogonal to the external variable, 0.intQ is a matrix, the
columns of which are the first 0.intk principal component loadings of nodes.allX
~ .
0..intnodes.allT is a 0.intkcn  score matrix whose columns contain 0.intk PC scores.
Then for the manual measurement data
0.0.. inttraininttrain QXT  (5.17)
converts trainX , a pm spectral matrix (m is the number of observations in the
manual data) into a 0.intkm score matrix 0..inttrainT . Means
'
nm ,
'
cm and variance
matrices 'nV ,
'
cV of the )1( 0.intk variables ),( 0..inttraintrain TT are calculated for later use in
constructing priors.
For the node of interest, its scores on the 0.intk PCs are calculated and subjected to
a further PCA to extract the first intk (e.g., 1-3) PCs as internal variable(s) by
intintnodeintnode QTT 0...  (5.18)
where 0..intnodeT is a 0.ntikn  submatrix of score matrix 0..intnodes.allT already calculated
in Equation (5.16) whose columns contain 0.intk PC scores, intQ is a matrix the
columns of which are the first intk PC loadings derived from a PCA of 0..intnodeT . Each
row of .intnodeT is intk -dimensional internal variable, .intnodet which is composed of the
first intk PCs in the subspace orthogonal to the direction of external variable ext.nodet .
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The dimension-reduced data vector used in the later data analysis is composed of
the external variable and 1-3 internal variables, given by ),( .. intnodeextnode ttx  with a
dimension of intkk 1 .
Using the internal variable(s) loadings intQ , the 1)1( 0.  intk means 'nm ,
'
cm and
the )1()1( 0.0. intint kk  covariance matrices 'nV ,
'
cV of ),( 0..inttraintrain TT are converted
into ( intk1 )-dimensional means
''
nm ,
''
cm and )1()1( intint kk  covariance matrices
''
nV ,
''
cV for later use in the priors for normal and metastatic groups of scanning data as
below:
'
int
''
0
01
nTn mQ
m 






 ; '
int
''
0
01
cTc mQ
m 






 ; (5.19)
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
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int
'
int
''
0
01
0
01
Q
V
Q
V nTn ; 















int
'
int
''
0
01
0
01
Q
V
Q
V cTc . (5.20)
By using the external variable we impose one dimension from the training data
which we believe can separate normal from metastatic tissue. Using internal variables
to add local features preserves the variability specific to this node, which is the
unsupervised aspect of the model.
All the models constructed below are based on the data reduced by either the
PCA dimension reduction method or the discriminant dimension reduction method.
5.5.2 Multivariate finite mixture model
5.5.2.1 The model
Suppose nxx ,...,1 are k-dimensional random observations generated independently
from a mixture of g underlying populations (groups) with unknown mixing
proportions g ,...,1 so that



g
j
jiji xfxf
1
)|()|(  (5.21)
where )|( jxf  denotes the conditional probability density function of x belonging to
the jth group, parameterized by j , and where each j is nonnegative and 11  
g
j j
 .
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Here ),...,,,...,( 11 gg   denotes the set of unknown parameters. In this thesis,
we assume that 3g with normal, metastatic and non-nodal groups, and ix is the
dimension-reduced spectral data measured at pixel i of the image for one node. We
will use multivariate Gaussian and t distribution for f, as described in Section 5.4.1.1
and 5.4.1.2
We introduce the membership indicator variable, ),...,( 1 igii zzz  , whole role is to
encode which component has generated the ith observation. This will be the ‘missing
data’ in the EM algorithm. The indicators iz )1( n,...,i  are a set of binary variables
}1,0{ijz )1( g,...,j  with




otherwise0
grouptobelongsnobservatioif1 ji
zij
and hence 1
1
 
g
j ij
z . If we knew iz we could write
 


g
j
z
jiii
ijxfzxf
1
)|(),|(  (5.22)
Given the mixing probabilities ),...,( 1 g  , the indicator variables nz,...,z1 are
independent, with multinomial densities,



g
j
z
ji
ijzf
1
)|(  , for n,...,i 1 . (5.23)
Then the joint density of ix and iz is given by
 


g
j
z
jijii
ijxfzxf
1
)|()|,(  (5.24)
5.5.2.2 Priors and posteriors for parameters j and j
We take a uniform prior for the mixing probability j . For the finite mixture model
the normal inverse Wishart prior (Gelman et al.1995) is used here as a prior for the
parameters j and j of both the k-dimensional multivariate Gaussian distribution
(Fraley and Raftery 2007) and the k-dimensional multivariate t distribution (Lin et al.
2004). We use normal priors on the mean vectors j conditional on the scale
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matrices j (Richardson and Green 1997, Stephens 1997):
),(~ 1 jjpjpjj N  
so that  






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

)()(
2
exp),,|( 1
1/2
jpjj
T
jpj
jp
jjpjpjjp 

 , (5.25)
and inverse Wishart priors on the scale matrices j , as suggested in Raftery (1996):
),(~ jpjpj vIW 
so that   .tr
2
1exp),( 112
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jpj
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jjpjpj
p
vp (5.26)
The hyperparameters jpjp  , and jpv ( )3,2,1j are called the mean, shrinkage
and degrees of freedom respectively, of the prior distribution. The hyperparameter
1
 jp , which is a matrix of the same dimension as j , is called the scale of the inverse
Wishart prior. Here the suffix p does not refer to the number of wavelength, but is
used to indicate a hyperparameter.
The joint prior density )( jp  is therefore
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jpj
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j
jpjpjpjpjj
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

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(5.27)
Integrating joint prior density in Equation (5.27) with respect to  we get the
marginal prior density for the mean:
)))1(/(,()( 11   kvtp jpjpjpjpkvj p  , (5.28)
where 1kvpt is a multivariate t-distribution with 1 kv p degrees of freedom.
In the case of the multivariate Gaussian distribution ),( jjN  the normal
inverse Wishart prior is conjugate so that the posterior can also be expressed as the
product of a normal distribution and an inverse Wishart distribution with different
parameters. Given data },...,{ 1 nxxx  from this Gaussian, i.e., data known to be from
this group, we have
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)~,~(~,| 1 jjpjpjj Nx   , (5.29)
),~,~(~| jpjpj vIWx  (5.30)
where
njpjp  ~ , nvv jpjp ~ , (5.31)
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which can also be expressed as
.)ˆ)(ˆ()ˆ)(ˆ(~
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jij
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jpjjpjjpjpjp xx   

 (5.34)
Here 


n
i
ixx
1
is sample mean of one scanned node, ix is the dimension-reduced
spectral data measured at pixel i of the image for one node, and n is the number of
observations from one scanned node.
The joint posterior modes of the mean vector and the covariance matrix are
jpj 
~ˆ  (5.35)
and
2~
~
ˆ
1




kv jp
jp
j . (5.36)
In the case of the multivariate t distribution ),,( jjj vt  , the normal inverse
Wishart prior is not conjugate. However an EM algorithm can be used to estimate j
and j . An additional set of weights, viewed as missing data here,
},...,1,{ niui  (5.37)
are introduced, one corresponding to each of the observations ix , so that
),/,(~| ijjii uNux  (5.38)
independently for ,,...,1 ni  and
)2/,2/(~ jji vvGu (5.39)
are independently distributed for ni ,...,1 .
102
The complete-data log-posterior density function (distribution) is
)(log)]|(log),|([log})}{{|(
1
jji
n
i
jiiiij Pvupuxpux  

 . (5.40)
In the E-step the conditional expectation of the complete-data log-posterior
function



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

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
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(5.41)
is with respect to the conditional distribution of }{ iu given }{ ix and current
estimates jˆ .
In general it is possible to estimate jv , but in our application to mixture models
we will take jv as fixed. In this case the part of )( jQ  in Equation (5.41) we have to
compute in M-step (i.e., ignoring the terms not involving j ) expands to








 )(log])()(||[log
1
1
2
12/1
j
n
i
jij
T
jiij PxxuE  ,
which has a linear dependence on iu . Thus in the (t+1)st iteration of the EM
algorithm, computing )( jQ  in the E-step involves replacing iu by its expectation
)ˆ,|( )(ti xuE  .
)ˆ,|(ˆ )()1( tji
t
i xuEu 
 . (5.42)
Since the gamma distribution is conjugate,
)))ˆ(ˆ)ˆ((),((~| )(1)()(2121
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In the M-step at the (t+1)st iteration of EM algorithm, we substitute )1(ˆ tiu for iu in
the first term on the right hand side of Equation (5.40), then the posterior estimates of
j and j are updated by computing the modal estimates:









 n
i
t
ijp
n
i i
t
ijpjpt
j
u
xu
1
)1(
1
)1(
)1(
ˆ
ˆ
ˆ


 (5.45)
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In the estimation of the mean and variance the observation ix is weighted by
)1( t
iu , the current estimate of the scale factor. When iu is equal to 1, Equations (5.45)
and (5.46) are equivalent to Equation (5.35) and (5.36), which makes the Gaussian
distribution a special case of t distribution.
For a single t distribution, the computations are more complicated than for a
single Gaussian, since we need to introduce an EM iteration. However in the mixture
model, the iterative estimation of iu can be incorporated in the EM we will be doing
anyway for the mixture, and so costs nothing extra.
5.5.3 Model fitting algorithm and parameter estimation
Since both the class label and the parameters are unknown and they are strongly inter-
dependent, the problem of parameter estimation is regarded as an “incomplete-data”
problem. Many techniques have been proposed to solve this problem, among which
the expectation-maximization (EM) algorithm described in Section 5.4.4 is the one
most widely used. Given initial values for the parameters  of the multivariate finite
mixture model, in the E-step we calculate the conditional probability that pixel i
belongs to the jth component in the mixture and use this to compute the conditional
expectation of the complete-data log posterior density function; in M-step we then
update the parameters by maximizing this log density. The process is iterated until
convergence. In this chapter the class membership iy of pixel i in the image is
assumed independent of all the other pixels, without considering the spatial
correlation of the image. The complete algorithm is described in a flowchart in Figure
5.8. To distinguish this algorithm from the one with spatial prior introduced in
Chapter 6 (Figure 6.3), we refer to the algorithm in this chapter as the first stage
algorithm and the one in Chapter 6 as the second stage algorithm.
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Figure 5.8: The first stage algorithm flowchart.
Initialize the parameters  )0()0()0( ˆ,ˆˆ jjj   using a single-link hierarchical
clustering analysis based on Euclidean distance between objects.
Initialize the vector )0(ˆ to give equal proportions in the mixture.
E-step: Calculate the conditional probability that pixel i belongs to the jth component by
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, for i = 1, 2, … , n and j = 1, … , g (g = 3 here).
These are the probabilities in Equation (5.52) used in calculating the conditional expectation of the
complete-data log posterior density function expressed in Equation (5.50).
For multivariate t distribution, also calculate the conditional expectation of weight iu by
)ˆ(ˆ)ˆ(
)ˆ,1,|(ˆ
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

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
 for i = 1, 2, … , n and j = 1, … , g.
M-step: Update the parameter )t(jˆ
1
 using Equation (5.55)
Update  )1()1()1( ˆ,ˆˆ   tjtjtj  , ,1,..., gj  using Equations (E1-E2) for Gaussian distribution
and Equations (E3-E4) for t distribution.
Is relative change in all
elements of jˆ and  jˆ ?
1st stage convergence is reached.
Estimate class label ij
j
i zy ˆmaxargˆ 
Mixture components order fixing and image correction rules
(refer to Section 5.5.3.2)
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5.5.3.1 EM for mixtures of multivariate Gaussian and t distributions
via Bayesian theory
(1) The E step evaluates the conditional expectation of the complete data log-posterior
density given the observed data and the current parameter estimates.
For the mixtures of multivariate Gaussian distribution, the “complete data” here
are }){},({ ii zx , where ),...,( 1 igii zzz  is the unobserved portion of the data (the
unknown class label), with ijz , a binary indicator variable which takes the value 1
when observation i came from mixture component j and zero otherwise. From
Equation (5.24) the complete-data likelihood for a mixture model with g components
is
 
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
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jijiimix
ijxfzxL
1 1
)|()|}{},({  . (5.47)
Thus the Bayesian posterior density is of the form
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and the log-posterior distribution is
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where )( jP  is the normal inverse Wishart prior distribution on the parameters
j and we have taken a uniform prior for the j .
The conditional expectation of the complete-data log posterior density function is
]}){},{([)( ii zxlEQ   =
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)(log)log)|((log  (5.50)
where the expectation is with respect to the conditional distribution of }{ iz given
}{ ixx  and the current estimate ˆ .
Since )(Q in Equation (5.50) has a linear dependence on ijz , calculating the
expectation of Q simply requires replacing ijz by their expectations,
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)ˆ,()ˆ,|(ˆ  xjyPxzEz iijij  , (5.51)
where ijzˆ is the conditional probability that pixel i belongs to the jth component given
data x and the current parameter estimates  ˆ,ˆ . At the (t+1)st iteration, the updating
equation for ijzˆ is as follows:
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For mixtures of multivariate t distributions, given additional missing data }{ iu as
defined in Equations (5.37)-(5.39), the “complete data” are }){},{},({ iii uzx . The
conditional expectation of the complete-data log posterior density function is
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Calculation of Equation (5.53) in the E-step can be effected by first taking the
expectation of iu conditional on }{ iz and }{ ix , and then finally over the iz given }{ ix .
For these calculations we need )ˆ,|( xzE ij as given in Equation (5.52) above and
)ˆ,1,|( )(tiji zxuE  for ni ,...,1 and gj ,...,1 ,
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(2) The M step for the multivariate Gaussian distribution involves maximizing
Equation (5.50) over j and j with ijz fixed at the values ijzˆ computed in the E step.
For j , let 
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The results for j are given in Equations (E1-E2) of Table 5.1.
For the multivariate t distribution, the conditional expectation function to be
maximized in Equation (5.53) involves the additional weight ijuˆ . The result for j is
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the same as in Equation (5.55). The results for j are given in Equations (E3-E4) of
Table 5.1.
The whole EM algorithm is judged to have converged when the relative changes
in all elements of j and j are less than  . Here we choose the value 0.1 for  in
order to achieve a weak convergence in this stage, which merely provides a stationary
configuration for the second stage.
An alternative procedure for fitting mixture models by using the classification
Expectation Maximization (CEM) (Celeux and Govaert 1992, Dean et al. 2006)
algorithm is almost identical to the EM algorithm, except that it incorporates a
classification step between the E-step and M-step replacing the ijzˆ by:

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(5.56)
That is, a discrete classification is made where each object is assigned to a unique
group. For example, if EM algorithm produces )15.0,05.0,8.0(ˆ )1( kijz then the
equivalent CEM step would transform this to a new )0,0,1(ˆ )1( kijz . These values of
)1(
ˆ
k
ijz are used in the M-step of the CEM algorithm.
The CEM algorithm converges faster, but has a tendency to eliminate genuine
small groups.
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Table 5.1: M-step estimators for the mean and variance of multivariate mixture models under the normal inverse Wishart conjugate priors. Here )1(ˆ tijz
is the conditional probability that observation i belongs to the jth component at (t+1)st iteration.
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5.5.3.2 Mixture components order fixing and image correction rules
The mixture components order fixing and image correction rules at the end of
algorithm as shown in Figure 5.8 came into existence here because of two problems in
the Bayesian mixture model, one is a label-switching problem, the other is a number
of components problem.
The existence of multiple MLE solution to the mixture problem, corresponding to
permutations of the labels, is well known (Titterington et al. 1985). A Bayesian
analysis with informative prior distributions is less prone to such problems, but our
use of a diffuse prior for the background component does cause difficulties here.
The number of components problem arises because we assume for each node
there are three components in the mixture. The model is thus trying to fit the data with
three components, which is usually but not always correct. This may result in the
misclassification of some small cluster of data which is actually not a separate group.
When a node is analysed, we first run the model described in this chapter, then
use the result as a starting point for the more sophisticated model of Chapter 6. In
between, we apply the rules described below to fix the problems of incorrect labelling
and spurious groups.
(a) Mixture component order fixing
Since non-nodal component is more likely to appear on the fringe area of the
node, in order to easily recognize the non-nodal component first, here we introduce a
distance id and a background score i . The id is used to measure the distance
between each pixel and the central point of the image at (10.5, 10.5), and varies from
0.7 for the most central points to 13.4 in the corners. As a function of id , i gives a
background score to each pixel as below:
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where ii sr , denote the row position (index) and the column position (index) of the
pixel i in the image, the power  (for which we have tried values in the range 1-5) is
used to emphasize the scores for the pixels on the edge. Here we choose
22 5.05.7  as a threshold for the piecewise function of id . This represents the
radius of a circle that reaches to two pixels from the edge of the image. By these
definitions, pixels on the corner or the edge of the image are given higher background
score than those in the centre. These scores will be used to identify the non-nodal
component in the mixture, as the one receiving the highest average background score.
Figure 5.9: The mapping of the position weight of each pixel with the scores of distance
parameter id plotted with false coded colour (red shows high probability being background
pixel, blue shows low probability being background pixel).
The effect of the choices of i on the probability of each pixel being background
is represented in Figure 5.9 with false coded color (red corresponding to pixel
indicative of background with high probability, blue corresponding to pixel indicative
of background with low probability). Here we use 5.1 ..Here we use
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The two nodal components can then be distinguished by comparing their mean
scores with prior means for the components: for the discriminant reduction, the prior
mean of the first dimensional variable (external variable) of the metastatic component
is higher than that of normal component; for PCA reduction, the reverse is true. These
rules work well for the situation where there exist three components in the mixture
and they are all sizable groups.
However there are some situations where a very small nodal group concentrated
on the fringe of the image will have higher average background scores than a more
spread out non-nodal group, and the nodal component might then be misclassified as a
non-nodal component. To avoid this situation, we make some adjustments to the
background score for small groups. For the situation where only one sizable nodal
component exists, we find its class label by comparing its mean score with the prior
means of both nodal components. The complete rules for mixture component order
fixing are given in detail in Figure 5.10.
Step 1: Mixture components order fixing
2 sizable groups
3 sizable groups
How many
sizable groups*
in the mixture?
R1
1 sizable group
(therefore nodal)
R1
R3
2 small groups
1 small group
R1
R1
R2
no small group
1 small group
with background
no background
R2
R2
R3
R3
* Sizable group refers to the group with size larger than or equal to 30.
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Figure 5.10: Mixture components order fixing algorithm flowchart. The set of 3 labels {1, 2, 3}
corresponds to normal, metastatic and non-nodal groups, respectively.
(b) Image correction rules
Given three components in the mixture, the model will try to find three groups in the
image. However, when there are really only one or two components in the node, some
misclassification might happen, especially to some small nodal groups.
The image correction rules attempt to detect and rectify this situation. For the
case where there is one sizable normal group and one small metastatic group, if
amongst the pixels from fitted metastatic group the maximum conditional probability
of a pixel belonging to metastatic group is very low, then we consider the metastatic
group actually belongs to normal group or non-nodal group. For the case where both
normal and metastatic groups are sizable, if the mean score on the first dimension of
R1 Calculate j
i
ij ng /  , with background score i at pixel i , summed over the
jn points assigned to the thj component of the mixture. If exactly 2 sizable
groups exist and 1 small group with current label k, then adjust kk g.g 70 .
Background index = }{maxarg jj g .
R2 Let 1k , 2k be the labels of the two nodal groups. For discriminant reduction, meta
index = }ˆ{maxarg [1]
21 ,
jkkj


; for PCA reduction, meta index = }ˆ{minarg [1]
21 ,
jkkj


.
R3 For one sizable nodal group with current label k , if 1|}ˆˆ{|minarg ]1[[1]
21,


jpkj
 ,
then normal index = k ; if 2|}ˆˆ{|minarg ]1[[1]
21,


jpkj
 , then meta index = k .
If 1 small group also exists, and if its current label is background, leave it; if not
background, it belongs to the other nodal group.
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the metastatic component is much closer to the mean score of its neighbour
component than to the prior mean of metastatic component, we will consider the fitted
metastatic group may belong to normal group.
For the PCA dimension reduction method, since for each node the spectra and the
prior means are all projected onto a different low-dimensional space, especially for
the variable non-nodal component, the image correction rules given here also depend
on the different relative positions of the first dimensional scores of the non-nodal
component in the mixture. The image correction rules are given in detail in Figure
5.11.
S1: If 1 sizable normal group and 1 small meta group with current label k ,
if kik
i
nz ˆ/4.5)(max  , then merge meta group to the closest group, either normal or non-
nodal group.
How many
sizable groups
in the mixture?
S1
S2
sizable normal and small meta groups
sizable normal and meta groups
Step 2: Image corrections (Discriminant dimension reduction )
What is the
relative position
of the 1st PC
scores of
background in
the mixture?
meta < background < normal
S1
S2
sizable normal
& meta groups
sizable normal
& small meta groups
sizable background
& meta groups
background < meta < normal
or meta < normal < background
Step 2: Image corrections ( PCA dimension reduction )
S3
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Figure 5.11: Image correction algorithm flowchart for discriminant dimension reduction and
PCA dimension reduction.
S3: Both meta and background sizable groups with labels of 2k and .3k If
|ˆˆ||ˆˆ| [1][1][1][1]
223 2 kpkk
  , then merge meta group to background group.
S2: Both normal and meta sizable groups with labels of 1k and .2k If
|ˆˆ||ˆˆ| [1][1][1][1]
221 2 kpkk
  , then merge meta group to normal group.
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CHAPTER 6
IMAGING CLASSIFICATION WITH SPATIAL
PRIOR ON SCANNED SENTINEL LYMPH
NODES
6.1 Introduction
The imaging model presented in Chapter 5 takes the class memberships of the pixels
in the image to be independent, thus ignoring the spatial contextual information. In the
true image adjacent pixels tend to belong to the same group. The model in this chapter
takes into account the spatial correlation in the image by adding a Markov random
field spatial prior to the previous model. Since the property of neighbourhood
contiguity of the image is now considered, the classification model framework aims at
generating an image with smooth pattern, comparable to the real tissue structure of the
node.
6.2 Theory
6.2.1 Markov random fields
MRF theory
Markov random fields (MRF) provide a powerful and robust framework for modeling
spatial interactions between neighboring or nearby pixels. The local correlations
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provide a mechanism for modeling a variety of image properties (Chellappa and Jain
1993, Li 2001). In medical imaging, they are typically used because most pixels
belong to the same class as their neighboring pixels. In physical terms, this implies
that any anatomical structure that consists of only one pixel has a very low probability
of occurring.
In an MRF, the sites in S are related to one another via a neighbourhood system,
},,{ SiNN i  where iN denotes the set of neighbours of i . The system is
symmetric, so that ij NjNi  and no site is its own neighbour, so that iNi .
A random field Y is said to be an MRF on S with respect to a neighborhood system
N if and only if
)|()|( }{\ iNiiSi yypyyp  (6.1)
0)( yp , Yy (6.2)
where }{\ iSy denotes a realization of the field restricted to },{}{\ ijSjiS  .
The neighbour set of ),( jis  for a regular lattice S is commonly defined as
ojlikSlkrN s 
22 )()(0:),({ , (6.3)
where o is the order of the neighbourhood system. Figure 6.1 shows the typical
examples used in image analysis, the two dimensional lattice with a first order and
second order neighbourhood systems.
Figure 6.1: MRF neighbourhood systems for site Ss . Left: first-order; Right: second-order.
Property (6.1) means that in an MRF, the interactions between site i and the other sites
actually reduce to interactions with its neighbours, and that according to the
Hammersley-Clifford theorem, established by Hammersley and Clifford (1971) and
further developed by Besag (1974), the joint probability distribution of a MRF (an
ss
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image labeling configuration) can be characterized by a Gibbs distribution given by
)),(exp()( 1 yUZyP   (6.4)
where Z is a normalizing constant called the partition function, and )( yU is an
energy function which is a sum of clique potentials over all possible cliques c . A
clique c for ),( NS is a subset of pixels in S chosen to represent the spatial interaction.
The computation of Z involves all possible realizations y of the MRF, and therefore,
it is in general not computationally feasible. More detail on MRFs and the role of the
Gibbs distribution can be found in the paper by Geman and Geman (1984)
Hidden Markov Random Fields (HMRF)
The HMRF model is popular in the statistical analysis of pixellated images (Geman
and Geman 1984). In image analysis, problems involving incomplete data are
common. As described in Chapter 5, the complete data here include the observations
representing measurements, e.g. multivariate variables recorded for each pixel of an
image, and the missing data (hidden data) consisting of unknown class assignment to
be estimated from the observations for each pixel. The complete likelihood is given
by
)|(),|(),|,(  yPyxfyxf  (6.5)
where  are parameters of the distribution generating X , and  are parameters of the
MRF.
In hidden Markov models, the observations X are assumed to be conditionally
independent given the image configuration yY  , we then have the joint conditional
probability of x given y
),|(),|(  ii
Si
yxfyxf 

 . (6.6)
Equation (6.5) is then expressed as
)},|(log)|(exp{),|,( 1  i
Si
i yxfyUZyxf 


 , (6.7)
Thus the conditional field Y given xX  is a Markov field as is Y , with posterior
energy function:
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),|(log)|(),,|(  i
Si
i yxfyUxyU 

 . (6.8)
For known parameters  , , the maximum a posteriori (MAP) estimation of the
image is equivalent to minimizing the posterior energy function
)},,|({minargˆ xyUy
Yy
 (6.9)
The difference between the concept of an HMRF and that of an MRF is that the
former is defined with respect to a pair of random variables ),( XY while the latter is
only defined with respect to Y .
6.2.2 Parameter estimation in HMRF-based models
In a typical application of an HMRF-based model we face the problem that both
the class labels and the parameters are unknown and are strongly interdependent. A
major difficulty of parameter estimation then arises due to the introduction of the
dependence in the MRF. In our application we will take the parameters  of the MRF
to be fixed, thus avoiding some complications. However, even with this restriction, it
is not simple to estimate  . The classical EM algorithm applied to the situation in
Chapter 5 runs into problems because the conditional expectations required in the E-
step cannot be simply and directly calculated.
Various approximations have been introduced in order to make the problem
tractable. Techniques such as simulated annealing with Gibbs sampling (Geman and
Geman 1984), and a Monte Carlo method based on the Gibbs sampler (Chalmond
1989) have been proposed to attempt to compute the true mode of )(yp , thereby
obtaining the MAP restoration.
The iterated conditional modes (ICM) algorithm proposed by Besag (1986) does
not claim to find a global maximum. It uses an iterative local minimization for which
convergence is rapid, but will be to a local mode only. Given the data x and the other
labels ,)( }{\k iSy the algorithm sequentially updates each )(kiy into
)1( k
iy by minimizing
),|( }\{iSi yxyU , i.e. maximizing the conditional posterior probability, with respect to
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iy .
Other approximation techniques have been suggested. The mean field
approximation (Celeux et al. 2003, Alfo et al. 2008) implements a standard EM
algorithm after approximating the hidden field of class labels. A similar strategy
underlies the EM algorithm given by Zhang et al. (2001) which estimates the missing
data as yˆ given the current  estimate by ICM and then uses it to form the complete
data },ˆ{ xy followed by a new  estimation via E-M steps.
A number of approaches are suggested by Qian and Titterington (1991) for the
image-analysis context. These are based on iterative restoration of the true scene,
perhaps using the ICM algorithm, alternating with parameter estimation, with the use
of Besag’s pseudolikelihood (1975) when the parameter  of )(yp is to be estimated.
There are many suggested approaches in the literature, and in some cases
distinguishing between them is not easy. However in the case where  is not
estimated they generally alternate between estimating the image, using approaches
that vary in their level of sophistication, and estimating the parameters  using an
EM-type algorithm. Here we will adopt the simplest version of such a scheme, as
described below.
6.3 Partially supervised Bayesian imaging classification
with Markov random field prior
6.3.1 Markov random field model
We assume that the true configuration y is a realization of a locally dependent Markov
random field (MRF). Following the suggestions of Besag (1986) we model the
conditional prior probability of pixel i having class label j, given the class labels of all
other pixels, in the following way:
)}({exp)( yyjyp ijijiiij    (6.10)
where i is the set of neighbours of i, and )(yij is the proportion of neighbours
120
having class memberships different to j. In our model we always consider a second
order neighbourhood, that is, the eight pixels surrounding each single pixel of the
image.
In Equation (6.10),  is a fixed regularization parameter (smoothness parameter),
which, when positive, discourages neighbours having different labels. In this model,
the size of the parameter  will decide the local smoothness imposed by the prior
distribution. Figure 6.2 shows the effect of  on the prior probability ij by plotting
the relationship between the prior probability and the number of neighbours having
different labels when different  are given, fixing 1ij .
Using the background score, i , already defined in Equation (5.57) of Chapter 5,
the position parameter ij is defined using the form given by Equation (6.11). The
label coding is 1, 2 and 3 for normal, metastatic and background (non-nodal)
components, respectively. The ij allows the probability that the pixel is
background )3( j to depend on its position in the image (measured by its distance
id from the centre of the image, using the function )( idf in Equation (5.57) with
fixed 5.1 ). The remaining probability is split equally between the two nodal
groups.
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Figure 6.2: The relationship between the prior probability and the number of neighbours
having different labels as  varies.
Priorprobability
Number of neighbours having different labels
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 1 2 3 4
β=1
β=2
β=3
β=5
121
Yes
R-step:
(a) Calculate spatial prior })ˆ({-expˆ )()( kijij
k
ij y  , for i = 1, 2, … , n and j = 1, 2, 3, where
)ˆ( )(kij y is the proportion of neighbours having class labels different to j in the current configuration
of image )(ˆ ky . See Equation 6.16.
(b) Compute the posterior probability of the unknown labels using the current estimates of )k(jˆ ,
)(
ˆ
k
iy by
,
)ˆ(ˆ
)ˆ(ˆ
ˆ
)()(
)()(
)1(



j
k
ji
k
ij
k
ji
k
ijk
ij
xp
xp
w

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for i = 1, 2 , … , n and j = 1, 2, 3.
(c) Update class labels )1()1( ˆmaxargˆ   kij
j
k
i wy . See Section 6.3.3.2.
(d) If using RM algorithm, let )1()1( ˆˆ   kij
k
ij wz ;
Use converged estimators of parameter ˆ and image configuration yˆ from the first stage
algorithm in Figure 5.8 as starting values )0(ˆ , )0(yˆ in this second stage.
M-step:
Update the parameter vector  )1()1()1( ˆ,ˆˆ   kj
k
j
k
j  using Equations E1-E4 in Table 5. 1.
number of pixels changing label in the
current configuration of image < cn ?
The 2nd stage convergence is reached.
No
6.3.2 Model fitting algorithm and parameter estimation
We extend the fitting algorithm of Chapter 5 to incorporate the locally dependent
MRF prior as shown in Figure 6.3.
Figure 6.3: The second stage algorithm flowchart.
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6.3.3.1 Details of the algorithm
A restoration maximization (RM) algorithm and classification RM algorithm are used
here for fitting the multivariate finite mixture model with MRF prior.
The joint probability of the observations x and pixel labels y is
),|(),|()|,(  ijypyxfyxf  (6.12)
where ),|(  ijyp is joint density of MRF model from a Gibbs distribution, defined in
Equation (6.4) and (6.10), and },...,{ 1 g  are the parameters of the component
distributions in the mixture.
As described in Chapter 5, the binary membership indicator variable,
),,...,( 1 igii zzz  was introduced as ‘missing data’ in the EM algorithm, indicating
which component the ith observation belongs to. If iy is known (that is, iz is known),
the ix are conditionally independent, using Equation (5.24) we have

 

n
i
g
j
z
ji
ijxfyxf
1 1
)}|({),|(  . (6.13)
Incorporating the joint prior density )( jP  defined in Equation (5.27), the complete-
data log-posterior density function is
}){},{( ii zx = ),|(log)(log)|(log
1 1 1
 ij
n
i
g
j
g
j
jjiij ypPxfz  
  
, (6.14)
which reduces to the expression in the form of Equation (5.49) when the iy ’s are
independent of each other.
The EM algorithm applied in Chapter 5 will not work here. The M-step is
straightforward, since we are only estimating  and not ij or  , but the E-step
requires the ijz in Equation (6.14) to be replaced by their conditional expectation
given the current parameter estimate ˆ and the observed data x ,
)ˆ,(ˆ )1()1(   kij
k xzEz
ij
 . (6.15)
This is non-trivial, because of the dependence structure introduced by the MRF.
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In order to deal with the above situation, a practicable approach called the
restoration-maximization (RM) algorithm by Qian and Titterington (1991) is used
here. This generates a sequence of pairs },{ )1()1(  kk y of iterates for  and y such that
)1( ky is updated on the basis of x and )(k , and )1( k is updated from x and )1( ky .
Given the current },{ )()( kk y , the general procedure of the RM algorithm is as follows,
(1) The R-step (the E-like step) updates )1( ky from ),|( )(kxyp  .
In order to update each pixel iy , we adopt the approach suggested by Besag (1986) in
his iterated conditional modes (ICM) algorithm. Given the data x and the current
realization of the neighbourhood iy , the algorithm updates each pixel iy by the class
label which maximizes the conditional posterior probability:


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k
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k
jij
k
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ij
xp
xp
w
1
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)()(
)1(
)ˆ(ˆ
)ˆ(ˆ
ˆ


for j=1,2,…,g and i=1,2,…,n. (6.16)
where )}ˆ(exp{)|( )()( kijijii
k yyjyp
ij
 

. (6.17)
Thus )1()1( ˆmaxargˆ   kij
j
k
i wy (6.18)
Then ijz in Equation (6.14) is replaced by either )1(ˆ kijw , for an EM-type algorithm or by


 



otherwise,0
ˆif,1
ˆ
)1(
)1( jyz
k
ik
ij (6.19)
for a CEM-type algorithm.
(2) The M-step updates )1( k by maximizing Equation (6.14) with ijz replaced by
ijzˆ with respect to  .
For mixtures of multivariate Gaussian or t distributions we have the same update
equations as given in Chapter 5 (Equations E1-E4 in Table 5.1) for jj ˆ,ˆ  .
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6.3.3.2 Some issues in the implementation of the algorithm
1) Image updating by ICM
The R-step corresponds to a single cycle of Besag’s ICM, where each pixel is updated
by the class label which has maximum conditional probability. Here a synchronous
updating is used in which all the pixels are updated simultaneously rather than cycling
through the image. The main advantage of this approach is computational simplicity.
Also the updating results will not be affected by the updating sequence of pixels.
However convergence can no longer be guaranteed and small oscillations may occur.
One possible modification to this pixel updating would be to update them
sequentially. Another would be to use a number of cycles of updating the image
before updating the estimators of the parameters. Neither of these has been tried since
the option chosen appears to work satisfactorily.
2) Parameter updating
Two approaches are used to update the estimators of the parameters. One is to use
conditional posterior probability ijwˆ given the spectral records x and the current
realization of the neighbourhood iy to replace the ijz in Equation (6.14). The other,
CEM-type approach is to use a ijz that corresponds to iyˆ , via Equation (6.19). The
former method keeps the algorithm converging smoothly. The latter method can be
very much affected by the initial estimate yˆ . If the initial crude estimate of the image
from the first stage algorithm is plausible and close to the true image convergence will
be reached quickly, otherwise it may take a long time or be very difficult to work up
to the true scene.
Because it assigns each pixel definitely to one group for parameter estimation, the
CEM algorithm tends to produce more compact and non-overlapping distributions. In
some applications this may be an advantage. Here it is not cleat that it will be.
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CHAPTER 7
APPLICATION OF IMAGE CLASSIFICATION
METHODS TO SCANNED SENTINEL LYMPH
NODES
In Chapters 5 and 6 two customized dimension reduction methods have been
described to project the spectral data from the scanned lymph nodes into a low-
dimensional space and a partially supervised image classification algorithm
employing a Bayesian multivariate finite mixture model with Markov random field
spatial prior has been developed on the low-dimensional data to model the three
unknown groups in the image. In this chapter we explore the application of this image
classification model to the diagnosis of sentinel lymph node metastases in breast
cancer from the ESS images. The models are studied by exploring the two dimension
reduction methods, choosing model parameters and priors, assessing classification
performance and analyzing model sensitivity. A hierarchical structure of the model
framework is shown in Figure 7.1.
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Figure 7.1: Hierarchical structure of observations, parameters, priors, and values of constants
used in our analysis of the sentinel lymph node data. In the square boxes are tuning
parameters or choices, in the ellipses are data or fixed constants.
7.1 Data description and pre-processing
As described in Chapter 5, two datasets collected in different way were used in this
study and each performs its own function in training the classification algorithm. One
is the ESS manual measurement data, including 3,523 spectra measured from 365
totally normal nodes and 39 totally metastatic nodes from 241 patients, all with
known reference pathology. For each node spectra were manually measured at up to
16 random sites on the bivalved node with one spectrum taken at one site. Reference
pathology is available on a per-site (or per-spectrum) basis. The mean spectral pattern
of the manual data is shown in Figure 5.5. The other is the ESS scanning data,
including another 48 sentinel lymph nodes from 26 patients of which 21 are normal
and 27 partially metastatic or totally metastatic, with a 2020 pixel image of 400
spectra for each node. Reference pathology is available on a per-node basis, but not
on a per-spectrum basis for individual pixels in the image. For each node, the
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nodesallX .
Choose dimension reduction approach
discriminant reduction: int0.int ,15, kkkext 
or PCA reduction: lg kk ,15
Multivariate finite mixture model
stv1 = 1 to 20, normalNormal-Inverse
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ndv2 = 1 to 20, normal,  = 0 to 8, p = 1 to 5.
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Reduced scanning data kX
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Classification results
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scanning data contains not only normal or metastatic nodal group, but usually a third
group which is a very variable non-nodal group from a background area, possibly
contaminated by blood or lipid. No training data are available for this group.
Standard data pre-processing was carried out on spectra from both manual
measurements and scanning measurements to improve signal quality. This involved
spectral smoothing using the Savitzky–Golay filter (Savitzky and Golay 1964),
cropping the noisy ends of the spectra before 400nm and after 800nm and normalizing
using the standard normal variate (SNV) method (Barnes et al. 1989).
A preliminary analysis on the manual measurement data was first carried out by a
PCA followed by a LDA to find the canonical variate, the direction maximizing the
discrimination between normal and metastatic nodes. Leave-out-one-site cross-
validation was undertaken to access the accuracy of the LDA analysis on a per-site
basis. Figure 7.2 shows the distribution of canonical scores from normal (blue) and
metastatic spectra (red) in the manual measurement data derived from a LDA using 20
principal components. There are two dominant peaks, the first at a score of 0,
corresponding to normal nodes and some part of metastatic nodes, and the second at 4
corresponding to metastatic nodes. Scores from metastatic nodes have a multimodal
distribution. It may be that despite the selection of totally metastatic nodes, there
remains a mix of normal and metastatic spectra, presumably related to remaining
normal structures within the metastatic nodes, or it may be that the metastatic areas
are genuinely very variable.
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Figure 7.2: Distribution plot of LDA canonical scores of spectra from manual measurement
data. The frequency is plotted as a proportion of class. Normal nodes shown in blue,
metastatic nodes in red.
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7.2 Dimension reduction
The two different options for dimension reduction described in Section 5.5.1 were
explored on both manual and scanning data.
7.2.1 Discriminant dimension reduction
For the discriminant dimension reduction method, a variable external to the scanning
data was constructed by projecting each scanned node data onto the direction of the
canonical variable derived from the LDA on the first extk PC scores of the manual data
(using Equations 5.10-5.11). Internal variable(s) were constructed in two steps. First
do a preliminary PCA to extract the first 0.tink PCs of all the scanned nodes in a
subspace orthogonal to the direction of the external variable (using Equations 5.12-
5.14). Then for the node of interest its scores on the 0.tink PCs are calculated for
further extracting the first tink PCs as internal variable(s) (using Equations 5.16-5.17).
The dimension-reduced scanning data of each node thus contain one external variable
and one or more internal variable(s), with dimensions reduced from pn  (n = 400, p
= 1801 here) to )1(  tinkn .
The manual data were then projected into the space spanned by the directions of
the external and internal variables for this node. Along these directions means and
variances derived from normal and metastatic spectra were calculated to be used in
the priors for normal and metastatic components (using Equations 5.12, 5.19-5.20). In
the first dimension the prior mean is -0.21 for the normal component, and 2.44 for the
metastatic component. More details about these priors can be found in Section 7.3.
External and internal variables were constructed on each scanned node for a grid
of values of extk , the number of principal components constructing the external
variable by using LDA , and tink , the number of internal variable(s), with extk ranging
from 10 to 20 and tink from 1 to 5. Here we fix 0.tink at 15 since this preliminary PCA
is really just used to reduce the dimension for convenience and 15 PCs capture the
variability of the data in the subspace orthogonal to the external variable.
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7.2.2 PCA dimension reduction
The PCA dimension reduction method was carried out in two stages as described in
Section 5.5.1.1. A global PCA first projected each scanned node data into a space
spanned by the first gk PCs derived from a preliminary PCA reduction on the pooled
scanning data (using Equations 5.6-5.7); then a local PCA projection used a PCA on
the gk PC scores of the node of interest to extract the local variables, the first lk PCs
for each node (using Equation 5.9). After this, the dimension-reduced scanning data of
each node contain lk PC scores, with dimensions reduced from pn (n = 400, p =
1801 here) to lkn  .
The manual data were first converted into the same gk -dimensional space as
above for calculating means and variances for normal and metastatic components.
These means and variances were then converted into the same lk -dimensional space
(using Equations 5.10-5.11) as that from the node of interest for later use in the priors
for normal and metastatic components.
A global PCA and a local PCA were carried out on each scanned node with
gk fixed at 15 and lk varying from 2 to 5.
7.3 Bayesian multivariate finite mixture model
application (stage 1)
The partially supervised image classification algorithm employing a Bayesian
multivariate finite mixture model described in Chapter 5 was then applied to the low-
dimensional data (reduced by either PCA dimension reduction method or discriminant
dimension reduction method) to model the three unknown groups (normal, metastatic
and non-nodal) in the images from the scanned measurements.
Both the multivariate Gaussian distribution and multivariate t distribution with
degrees of freedom v ranging from 3 to 20 were tried for the component density of
the mixture model. For both the Gaussian and t distributions, the normal inverse
Wishart prior with parameters derived from the manual measurements was used as a
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prior on the parameters of the components of the mixture, with Gaussian prior for
component mean vector  conditional on scale matrix  and inverse Wishart prior
for  (Equations 5.26-5.27).
The following choices were made following the suggestions from Fraley and
Raftery (2007) for the prior hyperparameters for multivariate mixtures. Here the prior
hyperparameters, mean p , scale p and shrinkage p are different for each
component of the mixture with ),,(),,,( 321321 pppppppp  
and ),,( 321 pppp   for normal, metastatic and non-nodal components respectively.
 ppp 321 ,,  : For the normal and metastatic components, we take '''' , cn mm , the
mean of normal and metastatic groups from the manual data (Equations 5.10
and 5.19) as prior means pp 21 ,  . For discriminant reduction, the first
dimension mean is 21.0]1[1 p for the normal component, and
44.2]1[2 p for the metastatic component; for PCA reduction, the prior
distributions for the parameters of normal and metastatic groups are projected
into a different space for each individual scanned node. To aid interpretation
and simplify the image correction rules described in Section 5.5.3.2 the sign of
the first PC was chosen so that ]1[]1[ 12 pp   . For the non-nodal component,
a few spectra selected by an experienced physicist from a non-nodal area of a
scanned node were used to generate a prior mean p3 .

1
3
1
2
1
1 ,,   ppp : For the normal and metastatic components, we take as prior
scales kcpknp gVgV /2''12/2''11 ,   , i.e., the empirical covariance matrix of
normal and metastatic groups from the manual data (Equations 5.11 and 5.20)
divided by the square of the number of components, g ( 3g ), to the power
1/k, k being the reduced dimension of the spectra. For the non-nodal
component, the same selected spectra from a non-nodal area as described
above for prior mean were used to generate a prior scale 13 p (more details are
given in Section 7.7.2.3).
 pv : The marginal prior distribution of  is a multivariate t distribution
centred at p with 1 kv p degrees of freedom. The mean of this distribution
is p provided that kv p  , and it has a finite covariance matrix provided that
1 kv p (Schafer 1997). Here we choose 2 kv p , the smallest integer
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value for the degrees of freedom that gives a finite covariance matrix, using
the same degrees of freedom for all components.
 p : The shrinkage vector of the prior distribution, ),,( 321 ppp  , gives
weights on the contributions of the means of the prior distribution to the
posterior means (as shown in Equation 5.45).
o For discriminant dimension reduction, there are considerable variations
in the metastatic group, with two obvious peaks for the distribution of
the canonical scores in Figure 7.2 for example. Therefore more
certainty is made about the prior information on the normal component
than that on the metastatic one by choosing the prior weight vector
)1.0,1.0,2(p with a larger value, 2, for the normal component and a
smaller value, 0.1, for both metastatic and non-nodal components.
o For PCA dimension reduction (after a change of sign where necessary,
as described above) the first dimension PC scores of normal spectra
show positive values while the scores of metastatic spectra vary
considerably in the negative region. Thus a stronger prior for the
normal component and weaker priors for both metastatic and non-
nodal components are chosen for the mixture model by giving p the
values of (5, 2, 1) for normal, metastatic and non-nodal components,
respectively. These specific values were arrived at by experiments.
The model fitting was implemented by the iterated EM algorithm of Figure 5.8.
Rather than using the discrete classification result (via CEM), here the M-step uses
the conditional expectation as the value of )1(ˆ k
ij
z . This was suggested by some
preliminary results running both algorithms. Although CEM may converge faster, the
EM algorithm seems always to give an image closer to the real picture.
7.4 Markov random field spatial prior (stage 2)
Spatial interactions between neighbouring or nearby pixels modelled by a Markov
random field were then imposed onto the Bayesian multivariate finite mixture model
using the prior in Equation (6.10) with smoothing parameter  ranging from 0 to 30,
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and with position parameter ij as specified in Section 6.3.1. The other prior
specifications were unchanged from the model without spatial interaction.
The model fitting was implemented by the RM (the EM-like) algorithm of Figure
6.3 starting from the configuration reached after the stage 1 fitting. In this stage also
the conditional expectations were used in the M-step for the values of )1(ˆ k
ij
z instead of
the classification values (via CEM). Apart from the fact that EM generates a better
image, this is also because the CEM result can depend strongly on the initial estimate
from the stage 1.
7.5 Image classification performance assessment
Since reference pathology is not available for individual pixel of the images, but only
available for each node, the classification was carried out on a per node basis. To
define conditions for labelling each node as metastatic or non-metastatic, we simply
counted the number of positive (metastatic) pixels in the node. The likelihood of
scattered false positive pixels occurring over a node is very slim since the spatial
correlation between adjacent pixels of image has been taken into consideration in the
model fitting, hence we classify a node as metastatic if it has even one pixel thus
classified.
Leave-out-one-node cross-validation was used to assess performance, the
classification accuracy being measured by sensitivity, specificity and AUC, the area
under the ROC curve. The global dimension reduction was carried out inside the loop,
that is, on the pooled scanning data with the omitted node not included in the
procedure. An image was generated by plotting a 2020  matrix of probabilities with
the following colour codings. Black indicates the pixels classified as non-nodal
component; for normal or metastatic component we used the posterior probability of
the pixel belonging to the metastatic component to generate a colour between red
(represents positive) and blue (represents negative) for each pixel. This image was
compared by eye with the photograph of the node to assess the method’s success in
reconstructing its shape.
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7.6 Classification results
7.6.1 Using discriminant dimension reduction
For discriminant dimension reduction, in order to search for optimal combinations of
extk , intk , stv1 , ndv2 and  (with  fixed at 1.5 as mentioned in Section 5.5.3.2), instead
of an exhaustive searching of all the possible combinations of these parameters, a
more restricted approach was adopted. First we varied combinations of extk and intk for
a restricted number of values of ndst vv 21 and, , and then we fixed extk = 20 and intk =
1, the values which gave the best results in this limited search. The leave-out-one-
node cross-validation results for the various combinations of stv1 and ndv2 (the number
of degrees of freedom of the multivariate t distribution or multivariate Gaussian
distribution in the first and second stage algorithms) and  with these fixed values of
extk and intk are shown in Table 7.1. The whole computation is very time-consuming,
even just for generating the results in Table 7.1 with one combination of extk and intk it
took several weeks and several computers to run the algorithm with many times.
During the experiments, we found when ndv2 is smaller than stv1 , the algorithm does
not always converge, so results are only given for the combinations with ndst vv 21  .
For discriminant dimension reduction, the combination extk = 20, intk = 1, 41 stv ,
42 ndv with a wide range of  starting from 8 (or other choices with ndv2 = 10, 20 and
a correspondingly higher  ) gave the best results, with sensitivity, specificity and
AUC of 81%, 90.4% and 0.86, respectively. The scanned nodal spectra data are here
reduced to a space with two dimensions, one external variable, and one internal
variable. In the rest of the chapter we will refer to the combination of extk = 20, intk =
1, 41 stv , 42 ndv and 8 as the optimal model for the discriminant reduction
method, with a ROC curve shown in the left panel of Figure 7.5. Some examples of
the mapping images of metastatic nodes and normal nodes generated by this optimal
model are shown in Figure 7.3.
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Figure 7.3: Examples of the mapping images from three partially or totally metastatic nodes
(first three rows) and two totally normal nodes (last two rows) using the partially supervised
image classification model via discriminant reduction. The left column shows the photographs
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of the nodes (red dotted line circles the supposed metastatic area of the partially metastatic
node). The middle and right columns are the 1st stage and 2nd stage resulting maps of the
scanned nodes, with posterior probability scores plotted as colours. Red corresponds to
spectra indicative of metastases, blue corresponds to spectra indicative of normal lymph tissue,
and black corresponds to non-nodal spectra.
Table 7.1: Accuracy results for discriminant reduction method using various combinations of
stv1 and ndv2 (degrees of freedom of t or Gaussian distribution in the 1st and 2nd stage
algorithms respectively) and  (the smoother parameter) with 20extk and 1intk .
Accuracy
stv1 ndv2 
Sensitivity (%) Specificity (%) AUC
4 4 4 78 90 0.84
4 4 5 81 90 0.85
4 4 6 81 90 0.85
4 4 8 81 90 0.86
4 4 10 81 90 0.86
4 4 15 81 90 0.86
4 4 20 81 90 0.86
4 4 30 81 90 0.86
4 10 4 78 90 0.84
4 10 5 78 90 0.84
4 10 6 78 90 0.84
4 10 8 78 90 0.84
4 10 10 78 90 0.84
4 10 15 81 90 0.86
4 10 20 81 90 0.86
4 10 30 81 90 0.86
4 20 4 78 76 0.80
4 20 5 78 76 0.81
4 20 6 78 81 0.83
4 20 8 78 86 0.83
4 20 10 78 86 0.83
4 20 15 78 90 0.84
4 20 20 78 90 0.84
4 20 30 81 90 0.86
4 norm 4 78 76 0.82
4 norm 5 78 76 0.82
4 norm 6 78 76 0.82
4 norm 8 78 76 0.82
4 norm 10 78 76 0.82
4 norm 15 78 90 0.84
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4 norm 20 78 90 0.84
4 norm 30 78 90 0.84
10 10 4 78 71 0.77
10 10 5 78 71 0.77
10 10 6 78 71 0.77
10 10 8 78 71 0.78
10 10 10 78 71 0.79
10 10 15 81 71 0.80
10 10 20 81 71 0.81
10 10 30 81 71 0.81
10 20 4 78 71 0.78
10 20 5 78 71 0.77
10 20 6 78 71 0.77
10 20 8 78 71 0.78
10 20 10 78 71 0.79
10 20 15 78 71 0.79
10 20 20 78 71 0.79
10 20 30 81 71 0.81
10 norm 4 78 62 0.75
10 norm 5 78 62 0.77
10 norm 6 78 62 0.77
10 norm 8 78 62 0.77
10 norm 10 78 62 0.78
10 norm 15 78 71 0.78
10 norm 20 78 71 0.79
10 norm 30 78 71 0.79
20 20 4 78 67 0.78
20 20 5 78 67 0.78
20 20 6 78 67 0.79
20 20 8 78 67 0.80
20 20 10 78 67 0.80
20 20 15 78 67 0.79
20 20 20 78 71 0.80
20 20 30 81 71 0.81
20 norm 4 78 62 0.77
20 norm 5 78 62 0.78
20 norm 6 78 62 0.78
20 norm 8 78 62 0.79
20 norm 10 78 62 0.79
20 norm 15 78 67 0.79
20 norm 20 78 67 0.79
20 norm 30 78 67 0.79
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norm norm 4 70 43 0.76
norm norm 5 70 43 0.76
norm norm 6 70 43 0.76
norm norm 8 70 43 0.76
norm norm 10 70 43 0.77
norm norm 15 70 43 0.77
norm norm 20 70 43 0.77
norm norm 30 70 43 0.76
7.6.2 Using PCA dimension reduction
For the PCA dimension reduction method, the same procedure as used in discriminant
reduction was used to search the optimal combinations of gk , lk , stv1 , ndv2 and  , that
is, gk and lk were first decided by experiment using restricted choices of ndst vv 21 , and
 , and then fixed to explore the other parameters in more detail. Among all the
choices, the model worked best in a two-dimensional space with 15gk and 2lk .
Table 7.2 Shows the leave-out-one-node cross-validation results for various
combinations of stv1 , ndv2 and  for these choices of dimension. As in discriminant
reduction, the results here are only given for combinations with ndst vv 21  since
otherwise the model may fail to converge. For PCA dimension reduction, the
combination gk = 15, lk = 2, stv1 =10, 102 ndv and 20 gave the best results, with
sensitivity, specificity and AUC of 88.9%, 76% and 0.81, respectively, and a ROC
curve shown in the right panel of Figure 7.5. Some examples of the mapping images
from metastatic nodes and normal nodes generated by this optimal image
classification model via PCA reduction method are shown in Figure 7.4. The same
nodes as shown in Figure 7.3 are used here for convenience of comparison.
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Figure 7.4: Examples of mapping images from three partially or totally metastatic nodes (first
three rows) and two totally normal nodes (last two rows) using the partially supervised image
classification model via PCA reduction. The left column shows the photographs of the node (red
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dotted line circles the supposed metastatic area of the partially metastatic node). The middle and
right columns are the resulting maps of spectra using the 1st and 2nd stage algorithms of the model,
with posterior probability scores plotted as colours. Red corresponds to spectra indicative of
metastases, blue corresponds to spectra indicative of normal lymph tissue, and black corresponds
to non-nodal spectra.
Table 7.2: Accuracy results for PCA reduction method using various combinations of stv1 and
ndv2 (degrees of freedom of t or Gaussian distribution in the 1st and 2nd stage algorithms
respectively) and  (the smoother parameter) with gk = 15 and lk = 2 .
Accuracy
stv1 ndv2 
Sensitivity (%) Specificity (%) AUC
3 3 4 85 62 0.76
3 3 5 85 62 0.77
3 3 6 85 62 0.78
3 3 8 85 62 0.79
3 3 10 85 62 0.79
3 3 15 85 62 0.79
3 3 20 85 62 0.79
3 3 30 81 62 0.77
4 4 4 78 67 0.68
4 4 5 78 67 0.68
4 4 6 78 67 0.68
4 4 8 78 67 0.68
4 4 10 78 67 0.69
4 4 15 78 67 0.68
4 4 20 78 67 0.68
4 4 30 74 67 0.66
4 10 4 78 62 0.66
4 10 5 78 67 0.68
4 10 6 78 67 0.68
4 10 8 78 67 0.67
4 10 10 78 67 0.68
4 10 15 78 67 0.69
4 10 20 78 67 0.68
4 10 30 78 67 0.67
4 20 4 78 48 0.63
4 20 5 78 48 0.63
4 20 6 78 48 0.63
4 20 8 78 48 0.65
4 20 10 78 52 0.66
4 20 15 78 52 0.67
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4 20 20 78 67 0.69
4 20 30 78 67 0.68
4 norm 4 78 33 0.64
4 norm 5 78 33 0.65
4 norm 6 78 33 0.65
4 norm 8 78 33 0.65
4 norm 10 78 33 0.67
4 norm 15 78 38 0.67
4 norm 20 78 38 0.67
4 norm 30 78 38 0.67
10 10 4 89 71 0.80
10 10 5 89 71 0.79
10 10 6 89 71 0.79
10 10 8 89 71 0.80
10 10 10 89 71 0.80
10 10 15 89 71 0.81
10 10 20 89 76 0.81
10 10 30 85 71 0.80
10 20 4 89 62 0.79
10 20 5 89 62 0.78
10 20 6 89 67 0.79
10 20 8 89 67 0.79
10 20 10 89 62 0.79
10 20 15 89 71 0.81
10 20 20 89 71 0.81
10 20 30 89 71 0.81
10 norm 4 89 38 0.76
10 norm 5 89 38 0.79
10 norm 6 89 43 0.78
10 norm 8 89 43 0.80
10 norm 10 89 43 0.80
10 norm 15 89 43 0.81
10 norm 20 89 43 0.81
10 norm 30 89 48 0.81
20 20 4 85 67 0.78
20 20 5 85 67 0.78
20 20 6 85 67 0.78
20 20 8 85 67 0.78
20 20 10 85 67 0.78
20 20 15 85 67 0.79
20 20 20 85 67 0.80
20 20 30 85 71 0.80
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20 norm 4 85 43 0.77
20 norm 5 85 43 0.78
20 norm 6 85 48 0.78
20 norm 8 85 48 0.78
20 norm 10 85 48 0.78
20 norm 15 85 48 0.80
20 norm 20 85 48 0.80
20 norm 30 85 57 0.80
Figure 7.5: ROC curves from leave-out-one-node cross-validation using the optimal image
classification model after discriminant dimension reduction (left, extk = 20, tink = 1, 41 stv ,
42 ndv and 8 ) and PCA dimension reduction (right, gk = 15, lk = 2, 101 stv ,
102 ndv and 20 ).
7.6.3 Discussion of the results
The method gives acceptable accuracy using both of the dimension reduction
approaches. Some conclusions that apply in either case are:
 Although the spaces themselves are different, two dimensions are sufficient to
separate the three groups using either of the dimension reduction approaches.
 In both stages of the model, the multivariate t distribution gives better results,
with higher AUC and specificity than the multivariate Gaussian distribution
(This is discussed further in Section 7.7.4).
 Higher degrees of freedom for the t distribution in the first stage of the model,
stv1 , require at least the same level of degrees of freedom in the second stage
of the model, ndv2 . The algorithm may run into problems when ndv2 < stv1 , not
always converging.
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 Higher degrees of freedom for the t distribution in the second stage of the
model need to be combined with a stronger spatial prior with higher smoother
parameter  to work well.
 Large stv1 with subsequently large ndv2 gives high sensitivity; small stv1 with
small ndv2 gives high specificity.
 The image generated by the first stage of the model contains scattered spots
that are probably not genuine. Introducing spatial priors in the second stage of
the model normally does not improve the classification accuracy in terms of
sensitivity, specificity and AUC on per-node basis, but does improve the image
quality in terms of image smoothness and probable closeness to the real
picture.
Some specific conclusions and comparisons for the two dimension reduction
options are drawn as follows:
 For the PCA dimension reduction method, classification models with good
accuracy result from using moderate or high degrees of freedom for the
multivariate t distributions and a spatial prior with a high value of the
smoother parameter  . The combinations of 101 stv with 102 ndv and
4 (or with 202 ndv and )15 give the better accuracy than other
choices with sensitivity, specificity and AUC of 89%, 76% (or 71%) and 0.81.
 For the discriminant dimension reduction method, classification models with
good accuracy result from lower degrees of freedom of the multivariate t
distribution for a wide range of values of  . The combinations of stv1 = 4 with
ndv2 = 4, 10, 20 all give good accuracy with sensitivity, specificity and AUC of
81%, 90% and 0.86, respectively. Some interactions between ndv2 and  can
be seen from Table 7.1. For the model with stv1 = 4, as ndv2 increases from 4 to
20, the minimum value for a strong enough smoother  to give good accuracy
increases from 8 to 30.
 In general the discriminant dimension reduction method works better than the
PCA dimension reduction method.
o Using discriminant dimension reduction, the two extracted dimensions
are feature-oriented and thus more interpretable. The external variable
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works in a direction capturing most of the variation between the
normal and metastatic groups, and the internal variable works in a
direction capturing most of variation between the nodal and non-non-
nodal groups. Using PCA dimension reduction, the separation of the
three groups by the first two dimensions of the local PCA projection
varies with different nodes, the first dimension can be either the
direction capturing most of the variation between the nodal and non-
nodal groups or the direction capturing most of the variation between
the normal and metastatic groups. More details can be found in Section
7.7.1. One consequence is the need to use higher degrees of freedom in
the t-distribution to impose the prior grouping more tightly.
o Models using PCA dimension reduction and higher degrees of freedom
tend always to find three components in the mixture although in some
cases there are only one or two components. It may give a better
representation of a node with all three of normal, metastatic and
background components, and thus gives higher sensitivity. However,
there is also the possibility to misclassify some of the normal pixels as
metastic when in fact there are only normal and background groups,
thus it gives lower specificity.
o An option that works well is to use lower degrees of freedom in the
first stage of the model with the discriminant dimension reduction
method. This results in rapid convergence of the first stage to a rough
solution. With an appropriate choice of degrees of freedom and
smoother parameter in the second stage of the model this stage then
converges to a good image.
o The image results generated by the model following the discriminant
reduction method are closer to the real picture than that generated by
the model following PCA reduction method.
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7.7 Parameter tuning, model sensitivity, and comparison
of model choices
7.7.1 Comparison of the dimension reduction methods
The classification models described in Section 7.6 derived from two-dimensional data
extracted by either discriminant or PCA dimension reduction method, though built in
the same way, work in a completely different space. Two examples are given here to
show how the classification works in the two different two-dimensional spaces
constructed from the same scanned node data.
Figure 7.6(a) demonstrates how the three groups of a partially metastatic node are
classified in a two-dimensional space constructed by discriminant dimension
reduction method. The classification of the pixels in these figures is that resulting
from the application of the model: there is no reference pathology at a pixel level.
Along the first dimension, the external variable (in the left panel), the metastatic
component can be discriminated from the normal and non-nodal components; along
the second dimension, the only internal variable here (in the right panel), the non-
nodal component can be discriminated from the normal and metastatic components.
The peak of the distribution of the external variable scores from the metastatic
component is close to the higher mode of the distribution of canonical scores from
metastatic spectra in Figure 7.2.
For the same partially metastatic node Figure 7.6(b) illustrates how three groups
are classified in the different two-dimensional space constructed by the PCA
dimension reduction method. Along the first dimension, the metastatic component can
be discriminated from normal and non-nodal components; along the second
dimension only some of the spectra from the non-nodal component can be
discriminated from the nodal component, and some misclassification of the nodal
component as non-nodal component occurs in this case. The mapping image derived
from the data reduced by discriminant dimension reduction method is much closer to
the real picture of the node than that derived from the data reduced by the PCA
dimension reduction method.
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Another example given in Figure 7.7 (a) shows three groups from a metastatic
node being fairly well separated in the two-dimensional space constructed by the
discriminant dimension reduction method. In Figure 7.7 (b) the spectra from the same
node are projected to a two-dimensional space via PCA dimension reduction method.
Along the direction of the first dimension in Figure 7.7 (b), the three groups are
already well separated.
Using either reduction method, the best performing models all use a two-
dimensional space. Using two dimensions in directions orthogonal to each other
seems to be a reasonable and sufficient choice to do discrimination between three
groups. Following the discriminant dimension reduction method, the first and second
dimensions (i.e. the external and internal variables) typically work as two classifiers,
the first discriminates between the two nodal (metastatic and normal) components and
the second between non-nodal and nodal components, Following the PCA dimension
reduction method, the first and second dimensions (i.e. the two local variables) work
in a different two-dimensional space for each node, and how three components in the
mixture are separated in this two-dimensional space really depends on the features of
each individual node, especially the behaviour of the variable non-nodal component.
The first dimension itself may or may not be enough to discriminate one of three
components from the others, or may even be good enough for the discrimination
between three components.
In these two examples, using discriminant reduction the peak of the distribution
for the metastatic component from the scanning data is either around a score of 4.5
(Figure 7.6(a)) or around 0 (Figure 7.7(a)). This is consistent with the appearance of
two dominant peaks in the LDA analysis of the manually measured metastatic nodes
(as shown in Figure 7.2).
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Figure 7.6 (a): Plots of external variable scores (left panel) and internal variable scores (right
panel) of spectra from a partially metastatic node (sc8471) after discriminant dimension
reduction. In rows 2, 3, 4 histogram of normal spectra (i.e. spectra classified as normal) is
shown in blue, metastatic in red and non-nodal in green. Last row shows the photograph (left)
and the mapping image (right, red indicative of metastatic spectra, blue of normal and black
of non-nodal) of this node.
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Figure 7.6 (b): Plots of the 1st dimension PC scores (left panel) and the 2nd dimension PC
scores (right panel) of spectra from a partially metastatic node (sc8471) after PCA dimension
reduction. In rows 2, 3, 4 histogram of normal spectra (i.e. spectra classified as normal) is
shown in blue, metastatic in red and non-nodal in green. Last row shows the photograph (left)
and the mapping image (right, red indicative of metastatic spectra, blue of normal and black
of non-nodal) of this node.
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Figure 7.7 (a): Plots of external variable scores (left panel) and internal variable scores (right
panel) of spectra from a metastatic node (sc8841) after discriminant dimension reduction. In
rows 2, 3, 4 histogram of normal spectra (i.e. spectra classified as normal) is shown in blue,
metastatic in red and non-nodal in green. Last row shows the photograph (left) and the
mapping image (right, red indicative of metastatic spectra, blue of normal and black of non-
nodal) of this node.
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Figure 7.7 (b): Plots of the 1st dimension PC scores (left panel) and the 2nd dimension PC
scores (right panel) of spectra from a metastatic node (sc8841) after PCA dimension reduction.
In rows 2, 3, 4 histogram of normal spectra (i.e. spectra classified as normal) is shown in blue,
metastatic in red and non-nodal in green. Last row shows the photograph (left) and the
mapping image (right, red indicative of metastatic spectra, blue of normal and black of non-
nodal) of this node.
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7.7.2 Choice of prior and sensitivity of results to prior
assumptions in mixture model
Choice of prior distributions can be a contentious issue in any situation where
Bayesian methods are applied, and the mixture model and our application provide
particular problems in this aspect. As described in Section 7.3, in our application,
informative priors based on the manual data are given for the normal and metastatic
components, although the prior for the metastatic component makes no attempt to
model the apparent multimodal distribution seen in Figure 7.2. For the non-nodal
component a diffuse prior distribution was used with a prior mean derived from some
non-nodal spectra selected from the scanned nodes by an experienced physicist and a
large prior variance. A shrinkage parameter (prior weight) is also included for each
component in the mixture with a relatively strong value for the normal component and
weak values for both metastatic and non-nodal components.
However, we found that even when the priors are relatively diffuse, inference can
still be influenced by the priors. The sensitivity of the Bayesian inference to the priors
is investigated here by comparing the effect of different choices.
7.7.2.1 Sensitivity to the shrinkage parameter, p , of the prior
distribution
As described in Equations (5.32)-(5.33), the conditional posterior mean
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~ is a weighted average of the prior mean jp and the
sample mean x of one scanned node (n is the number of pixels from one scanned
node, n = 400), which can be viewed as adding jp observations with value jp to
group j in the data. The shrinkage parameter of the prior distribution, jp , also called
the prior weight here, thus gives the weight on the contributions of the prior mean jp
to the posterior mean jp~ . It is standard to refer to jp as the shrinkage parameter, as
it governs the extent to which the sample mean x is shrunk toward its prior mean, jp .
The choices of jp will crucially influence the posterior distribution of means and
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variances as in Equations (5.32)-(5.33). Strong weight (larger jp ) on the priors will
aid convergence and help to avoid the label switching problem. However, too strong a
weight will not allow enough flexibility for components that vary from node to node.
To reflect the variability of the metastatic and non-nodal components, we chose a
larger prior weight for normal component and a smaller one for metastatic and non-
nodal components. As described in Section 7.3 for the discriminant dimension
reduction method we give ),,( 321 pppp   the values of (2, 0.1, 0.1) for normal,
metastatic and non-nodal components, and for the PCA dimension reduction method
we chose the values of (5, 2, 1).
One example is given in Figure 7.8 to demonstrate how different choices of prior
weight affect the results of the imaging classification. Since the analysis following the
dimension reduction via the discriminant method is the same as that PCA reduction
method, but works in different spaces, here the example is given using the analysis via
discriminant reduction method using the optimal model described in Section 7.6.1
with a combination of parameters extk = 20, tink = 1, 41 stv , 42 ndv and 8 . In the
first dimension (the external variable), the prior mean was given a value of -0.21 for
the normal component, and a value of 2.44 for the metastatic component. For the non-
nodal component, the first dimension prior mean, with a value of 2.42, is very close to
that for the metastatic component.
Figure 7.8 shows an example of a partially metastatic node with three
components in the mixture and the non-nodal component being very similar to the
normal component, on the first dimension at least. From the top row in Figure 7.8 we
can see that given prior weights of (2, 0.1, 0.1) for the three components, the normal
component (solid blue line) converged to a value very close to its prior distribution
(dotted blue line). For the metastatic and non-nodal components, although their prior
means are very close to each other, their posterior distributions (solid red line and
solid green line) depart substantially from their prior distributions (dotted red line and
dotted green line) converging to what seem to be correct values because the resulting
image is plausible.
When the prior weights p rise (row 2 in Figure 7.8) the posterior density of the
152
non-nodal component on the first dimension starts shifting to the right, and the area
from the non-nodal component in the image reduces. When p increases to (3, 3, 3),
rather than the correct posterior shown in row 1, here a posterior distribution between
the normal and metastatic components is fitted to the non-nodal component as shown
in row 3 of Figure 7.8. As a result, some areas from both normal and metastatic
groups are taken up by the non-nodal component while the real non-nodal group
which should appear at the top of the image has been completely misclassified as
normal. When p increases to (5, 5, 5) and (20, 20, 20), the non-nodal component
further shifts to the right, closer to its prior distribution, and more areas from the
metastatic component rather than from the normal component are then graduately
encroached by the non-nodal component. Hence, with jp increasing to a higher value,
it tends to cause the severe problem of misclassifying a metastatic node or partially
metastatic node as a normal node with non-nodal area.
Our experimental experiences show that weak prior weights on prior mean of
metastatic and non-nodal components combined with a strong prior weight for the
normal component gives the most satisfactory image classification results.
)5.2,5.2,5.2(p
)1.0,1.0,2(p
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Figure 7.8: Posterior density plots and the mapping image of multivariate mixture model on the
spectra from one partially metastatic node showing the model sensitivity to the prior weight. The
left and middle columns show the histograms for the 1st and the 2nd variable scores of
discriminant-dimension-reduced spectral data. The prior (dotted line) and posterior (solid line)
densities are superimposed on the histogram for the three components with red for metastatic, blue
for normal, green for non-nodal component and grey for the converged curve of the whole mixture
model. The right column shows the mapping image from the 2nd stage algorithm with colour
coding at each pixel (red for metastatic, blue for normal and black for non-nodal spectra). The
rows 1-5 correspond to the results when the shrinkage parameter p takes values of (2, 0.1, 0.1),
(2.5, 2.5, 2.5), (3, 3, 3), (5, 5, 5) and (20, 20, 20), respectively for prior mean of normal, metastatic
and non-nodal components. The last row shows a photograph of this node.
)5,5,5(p
)20,20,20(p
)3,3,3(p
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7.7.2.2 Sensitivity to prior distribution of mean for the non-nodal
component
An important component of the mixture model is the prior model for the means j ,
which is taken to be a multivariate normal distribution ),( 1 jjpjpN 

 conditional on
the covariance matrix j .
Different choices of prior means jp may affect the result of the image
convergence. Since the prior means for normal and metastatic components are given
by manual measurement data we are not going to explore the choices of these prior
means. However, the prior mean of non-nodal component, which is constructed from
some spectra selected from the non-nodal areas of scanned nodes by an experienced
physicist as described in Section 7.3, is much more speculative so that different
choices of prior mean for the non-nodal component are worth exploring.
Two examples of partially metastatic nodes in Figures 7.9-7.10 show how
different choices of prior mean for the non-nodal component affect the image
classification results, taking some plausible values of -10, -5, 0, 5 and 10 for both
dimensions of p3 (a two-dimensional prior mean vector for the non-nodal
component). The analysis here is based on the optimal classification model via
discriminant dimension reduction method with the prior weight )1.0,1.0,2(p
described in Section 7.6.1.
From Figure 7.9 we can see that along the axis of the external (1st) variable the
group of non-nodal component is almost covered by the normal group but the two
nodal components can separate from each other. The non-nodal component can be
separated from nodal components along the axis of of the 2nd, internal, variable.
Different choices of prior mean p3 do not seem to have much impact on the image
results.
In contrast, in Figure 7.10, when neither external nor internal variable can easily
discriminate the non-nodal component from the nodal components, we see that taking
different values of the prior mean really affect the image results of the non-nodal
component, and also the metastatic component which seems easier to confuse with
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non-nodal than does the normal component.
Although the real mean for the non-nodal component varies tremendously from
node to node, when the prior mean takes values around 0 or between 0 and the real
mean for both external and internal variable, the parameters for the non-nodal
component converge well to a sensible looking picture, as do those for the nodal
components (which can be seen from a good match between the mapping image and
the real picture shown in the bottom row of Figure 7.9). The two-dimensional prior
mean for the non-nodal component constructed from some selected non-nodal spectra,
with a value around 2.42 for the external variable, is a reasonable compromise choice
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Figure 7.9: Posterior density plots and the mapping image of multivariate mixture model on the
spectra from one partially metastatic node for investigating the model sensitivity to the prior mean.
The left and middle columns show the histograms for the 1st and the 2nd variable scores of
)10,10(3 p
)5,5(3 p
)0,0(3 p
)5,5(3 p
)10,10(3 p
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discriminant-dimension-reduced spectral data with prior (dotted line) and posterior (solid line)
densities superimposed for three components in the mixture with red for metastatic, blue for
normal, green for non-nodal area and grey for the converged curve of the whole mixture model.
The right column shows the mapping image from the 2nd stage algorithm with colour coding at
each pixel (red for metastatic, blue for normal and black for non-nodal). Rows 1-5 correspond to
the results when the prior mean for the non-nodal component takes values
of ,] 105,0,5,-10,-2[]1[ 33  pp  with the shrinkage parameter )0.10.1,2,(p . The last row
shows a photograph of this node.
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Figure 7.10: Posterior density plots and the mapping image of multivariate mixture model on
the spectra from one partially metastatic node for investigating the model sensitivity to the
)5,5(3 p
)0,0(3 p
)5,5(3 p
)10,10(3 p
)10,10(3 p
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prior mean. The left and middle columns show the histograms for the 1st and the 2nd variable
scores of discriminant-dimension-reduced spectral data with prior (dotted line) and posterior
(solid line) densities superimposed for three components in the mixture with red for
metastatic, blue for normal, green for non-nodal area and grey for the converged curve of the
whole mixture model. The right column shows the mapping image from the 2nd stage
algorithm with colour coding at each pixel (red for metastatic, blue for normal and black for
non-nodal). Rows 1-5 correspond to the results when prior mean for non-nodal component
takes values of 10,5,0,5,--10,]2[]1[ 33  pp  with the shrinkage parameter )0.10.1,2,(p .
The last row shows a photograph of this node.
7.7.2.3 Sensitivity to prior distribution of variance for the non-nodal
component
Three possible choices of prior scale 1 were investigated for the non-nodal
component : (a) using the total variation of all the dimension-reduced scanning data
with three unlabelled components; (b) using the variation of the selected background
spectra determined by the physicist expert; or (c) using )( 121113   ppp c , where c
is a coefficient (taking the value of 1 or 0.5) and 11 p and 12 p are the scale matrices
of the prior distributions for normal and metastatic components, respectively, derived
from the manual data as described in Section 7.3. Both (a) and (c) result in a widely
spread prior distribution.
Investigations, not reported in detail here, suggest that the eventual classification
and image are not particularly sensitive to its choice, and we have settled for using
method (b) in our analysis.
7.7.2.4 Interactions between the shrinkage parameter p and the prior
mean p for the non-nodal component
The interactions between the shrinkage parameter (prior weight) p and the prior
mean p are investigated here on an example of a partially metastatic node.
When weak prior weight is given to the prior mean, especially for metastatic and
non-nodal components, different choices of the prior mean don’t have much impact
on the posterior mean, at least for this node, as shown in Figure 7.11 (a). When strong
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prior weight is imposed on the prior mean, different choices of prior mean do have an
effect on the posterior distributions and, as a result, in the mapping image the
component far away from its prior mean might disappear or be misclassified as an
other component with closer mean, as shown in Figures 7.11 (b)-(d).
With a relatively strong prior weight of 2 for all three components in the mixture
as shown in Figure 7.11 (b) , when the 1st dimensional value of prior mean for non-
nodal component rises from -10 to 0 (first 3 rows of Figure 7.11 (b)) a non-nodal
component appears at the top of the image. When the prior mean increases from 0 to 5
(rows 3 and 4 of Figure 7.11 (b)), the non-nodal component begins to interfere with
the metastatic component and at the same time the metastatic component encroaches
on some of the area of the normal component. When this prior mean increases from 5
to 10 (rows 4 and 5 in Figure 7.11 (b)), the non-nodal component disappears
altogether.
When the prior weight is getting stronger with pk3 increasing to 5 and 10 as
shown in Figure 7.11 (c) (d), the non-nodal component only appears when its prior
mean takes values close to the data mean.
A strong prior weight allows less flexibility and adaptation of the data to the
choices of prior mean (and variance). As a result, there are problems when the prior
and data do not agree. When modest prior weight is given, observations give greater
contributions to the updating of the posterior mean and variance, and some bias in the
choices of priors won’t spoil the image results. Although this may result in a relatively
slow convergence, it enables the parameters converge in a proper and accurate way,
especially with the preferred choices of strong prior weight for normal component and
weak prior weight for metastatic and non-nodal components as shown in Figure
7.11(a).
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Figure 7.11 (a): Posterior density plots and the mapping image of multivariate mixture model
on the spectra from one partially metastatic node for investigating the interactions between
)10,10(3 p
)5,5(3 p
)0,0(3 p
)5,5(3 p
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shrinkage parameter and prior mean. Here the shrinkage parameter )2,0.1,0.1(p . The left
and middle columns show the histograms for the 1st and the 2nd variable scores of
discriminant-dimension-reduced spectral data with prior (dotted line) and posterior (solid line)
densities superimposed for the three components in the mixture with red for metastatic, blue
for normal, green for non-nodal area and grey for the converged curve of the whole mixture
model. The right column shows the mapping image from the 2nd stage algorithm with colour
coding at each pixel (red for metastatic, blue for normal and black for non-nodal). Rows 1-5
correspond to the results with prior mean for non-nodal component taking values of
105,0,5,-10,-]2[]1[ 33  pp  . The last row shows a photograph of this node.
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Figure 7.11 (b): Posterior density plots and the mapping image of multivariate mixture model on
the spectra from one partially metastatic node for investigating the interactions between shrinkage
parameter and prior mean. Here the shrinkage parameter )22,2,(p . Rows 1-5 correspond to the
results with prior mean for non-nodal component taking values of
105,0,5,-10,-]2[]1[ 33  pp  . The last row shows a photograph of this node.
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Figure 7.11 (c): Posterior density plots and the mapping image of multivariate mixture model on
the spectra from one partially metastatic node for investigating the interactions between shrinkage
parameter and prior mean. Here the shrinkage parameter )55,5,(p . Rows 1-5 correspond to the
results with prior mean for non-nodal component taking values of 105,0,5,--10,]2[]1[ 33  pp  .
The last row shows a photograph of this node.
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Figure 7.11 (d): Posterior density plots and the mapping image of multivariate mixture model on
the spectra from one partially metastatic node for investigating the interactions between shrinkage
parameter and prior mean. Here the shrinkage parameter )1010,10,(p . Rows 1-5 correspond to
the results with prior mean for non-nodal component taking values of
105,0,5,--10,]2[]1[ 33  pp  . The last row shows a photograph of this node.
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7.7.2.5 How the two-stage model fitting algorithm works for image
classification
Two examples are given here to show how the two-stage algorithm works. The
images are generated from two scanned nodes data after discriminant dimension
reduction.
Figure 7.12 gives an example of a partially metastatic node with three
components. Points in blue, red and green refer to the pixels classified as normal,
metastatic and non-nodal component, respectively, at the current stage.
The model uses prior distributions derived from manual data for normal and
metastatic components as described in Section 7.3, and a widely spread prior
distribution for the non-nodal component as shown in the top panel of Figure 7.12.
Guided by the prior information, the centres of the three components develop along
the directions of the external (1st) and internal (2nd) variables, being updated by the
observed data from the individual node. After the first stage fitting, shown in the
middle panel of Figure 7.12, all three groups, but especially the metastatic one, have
moved substantially from the prior positions. The groups seem to be fairly well
separated from each other, although the variances are still large for each group.
In this stage the features of the three components are seen from their distributions
to have fairly well separated means (the peak of the posterior distribution of the 1st
variable scores from the metastatic component matches one of the two modes of the
distribution of canonical scores from metastatic spectra in Figure 7.2) and a relatively
concentrated dispersion for the non-nodal component. The image configuration at this
stage shows a rough match to the photograph, with some background spots on the
upper left corner being misclassified as normal or metastatic.
In stage 2, on incorporating the spatial information into the model the groups do
not move very much, but isolated pixels are tidied up, and those misclassified pixels
from the background area all recover as shown in the bottom panel of Figure
7.12. Although the fitted posterior distributions of the three components show some
overlap with each other, the resulting image from this stage shows a much better
match to the photograph. This example shows clearly the effect of incorporating
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spatial information into the model. The estimated groups become less concentrated
and overlap more, but the resulting image is a better one.
Figure 7.13 gives an example of a node including only normal and non-nodal
components. Given relatively informative prior distributions for two nodal
components and a diffuse prior distribution for non-nodal component, three groups
are fitted in stage 1 with generally more concentrated posterior distributions. However,
when compared with the photograph, the image result (on the mid-right panel of
Figure 7.13) shows that normal and non-nodal components are separated well, but the
observations in between classified as metastatic are all false positives since metastatic
group does not exist in this node.
After stage 2 converges, all the misclassifications from stage 1 are corrected with
the effect that the whole fitted metastatic group disappears and three scattered normal
spots misclassified as non-nodal in stage 1 all flip back to normal. With spatial
information incorporated in this stage, the improvement here is significant, but not
surprising, since the smoothing parameter can eliminate a scattered small group
(misclassified metastatic group). With no class membership in the metastatic group in
stage 2, the posterior distribution for the metastatic component is the same as its prior
distribution. The between-stages image correction rules described in Section 5.5.3.2
which might also have removed the metastatic group were not applied here in order to
show clearly that the stage 2 algorithm can also fix the problem of some small group
misclassifications in the stage 1.
From both examples we can see that the two-stage algorithm works well here in a
flexible way. Stage 1 focuses on the distribution convergence with the result of tight
fitted groups, and a rough convergence is enough to generate plausible starting points
for the stage 2 fitting, avoiding wasting time in fitting a partial model at this stage.
With the MRF spatial prior incorporated in stage 2, although the distribution density
fitting might be not as good as the previous stage, the image becomes much smoother
and some misclassification caused by the small group fitting and distribution density
fitting might be able to recover. When small groups survive this stage, they are
probably real. In both cases, priors calculated from manual measurement data for the
normal component seem fairly informative and plausible. The prior for the metastatic
component seems to be less useful, or at least rather wide of the mark in Figure 7.12.
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Figure 7.12: Plot of the two-stage imaging result from a partially metastatic node after
discriminant dimension reduction. Two-dimensional prior (top left panel) and posterior (middle
and bottom left panels) probability density contour plots showing the effect of stage 1 (middle
panel) and stage 2 (bottom panel) model fitting for a mixture of three components (normal in blue,
metastatic in red and non-nodal in green). The points show the fitted class membership of each
pixel at current stage, the stars show the prior mean and posterior mean, and the ellipses represent
(95%) probability contours of the estimated probability distribution for each component. The right
panel shows the photograph of the node and the fitted images from stage 1 and stage 2 with red
indicative of metastases, blue of normal, and black of non-nodal spectra.
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Figure 7.13: Plot of the two-stage imaging result from a totally normal node after discriminant
dimension reduction. Two-dimensional prior (top left panel) and posterior (middle and bottom left
panels) probability density contour plots showing the effect of stage 1 (middle panel) and stage 2
(bottom panel) model fitting for a totally normal node with two components (normal in blue and
non-nodal in green) in the mixture. The points show the estimated class membership of each pixel
at current stage, the stars show prior and posterior means, and the ellipses represent (95%)
probability contours of the estimated probability distribution for each component. The right panel
shows the photograph of the node and the two mapping images from 2 stages with red indicative
of metastases, blue of normal, and black of non-nodal.
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7.7.3 Sensitivity of second-stage results to MRF prior
distribution
In the MRF spatial prior distribution, )}(exp{)( yuyjyp ijijiiij    , as
described in Equation (6.10),  rewards smoothness, and ij reflects the position of
each pixel in the image, giving more probability to the non-nodal group for the pixels
on the corner or edge than that in the centre, according to the definition of ij in
Equations (5.56) and (6.11).
Figure 7.14 gives an example of a partially metastatic node to show how the two-
stage algorithm works when  varies. When 0 and 1ij , it is equivalent to
generating the result from the 1st stage algorithm, which we use to initialize the 2nd
stage algorithm. When  increases, the area of metastatic component extends, as
does the normal component. Some isolated pixels, generally associated with the
metastatic component, vanish. When single pixels have different labels from their
contiguous pixels, only the ones with large posterior probability of occurrence can
keep the current label. Once  reaches 8 or 10 the image is as smooth as the pixel
size will allow. Here we take the value of 8 for discriminant dimension reduction and
the value 4 for PCA dimension reduction as compromise choices of  to keep the
mapping images closer to the real pictures in general.
Figure 7.15 shows the effect of the position parameter ij (defined by Equations
(6.11) and (5.57)) on the image as the power parameter  in Equation (5.57) is varied.
For a given value of  , when the value of  increases, more non-nodal component
appears, especially in the lower right corner of the image. Here we chose 5.1 .
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Figure 7.14: Second-stage results for one partially metastatic node after discriminant reduction
with  0, 2, 4, 6, 8, 10, 20, 30, 50. ( 1ij for the 1st image and 5.1 for the others.) The
first three rows are the resulting maps of the spectra with red indicative of metastatic, blue normal
and black non-nodal. The last row is a photograph of the node.
1,0  ij 0
4 8 10
20 30 50
2
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Figure 7.15: Second-stage results for one partially metastatic node with all the combinations of
 0, 4, 8 and  = 1, 2, 3, 5. The first three rows are the resulting maps of the spectra with red
indicative of metastatic, blue normal and black non-nodal. The last row is a photograph of the
node.
3,4  2,4  1,4   5,4  
1,8   2,8   3,8   5,8  
3,0  2,0  1,0   5,0  
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7.7.4 Sensitivity to the choices of multivariate t distributions
or multivariate normal distributions
In this image analysis, our experiments show that the multivariate t-distribution with
heavier tails, as an alternative to multivariate Gaussian distribution, shows robustness
towards outliers by minimizing their impact on the estimation of the model
parameters, which increases flexibility and robustness of the model. In general the
multivariate t-distribution provides an overall more accurate image classification
result than multivariate Gaussian distribution for the scanning data.
An example of a totally normal node after discriminant dimension reduction is
given in Figure 7.16. The rows correspond to different choices of degrees of freedom
of t distribution (varying from 4 to 20) and normal distribution. It shows that using
multivariate normal distributions or multivariate t distributions with large degrees of
freedom leads to the appearance of three components in the mixture. The second stage
eliminates some of the isolated areas, but at least one clump always persists.
Although the multivariate normal distribution always gives better fitting to the
histogram of the data than the multivariate t distribution, it gives worse classification
accuracy. Good histogram convergence doesn’t mean goodness of model fitting since
the histogram only reflects the marginal distribution and does not include spatial
information.
When using large degrees of freedom stv1 of t or a normal distribution in the first
stage, we should be very careful with the model fitting and the choice of prior. When
there are three components in the mixture, the metastatic group is unlikely to be
missed by the classification and this gives high sensitivity. However when there are
fewer than three components in the mixture, the extra component misclassified in the
first stage using a large stv1 is usually difficult to remove in the second stage algorithm
since a degrees of freedom, ndv2 , larger than that in the first stage will be used in the
second stage for the reasons of model convergence as described in Section 7.6.3. In
this case small stv1 will be preferred and thus lead to a high specificity. However in the
real prediction we won’t be able to know how many components there are in the
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mixture, using a modest stv1 in the 1
st stage to achieve a vague model fitting may give
more possibility for further accurate fitting in the 2nd stage.
Figure 7.16: Histogram for the 1st (1st column) and the 2nd (2nd column) variable scores of spectral
data from one totally normal node after discriminant reduction, with prior (dotted line) and
posterior (solid line) densities superimposed for three components of multivariate mixture model
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with red for metastatic, blue for normal and green for non-nodal component. The corresponding
mapping images from the 1st stage and 2nd stage algorithms are shown in the last two columns with
colour coding at each pixel (red for metastatic, blue for normal and black for non-nodal spectra).
The rows correspond to different choices of t distribution with degrees of freedom varying from 4
to 20, and normal distribution. The last row is a photograph of this node.
7.7.5 Label-switching problem
The label switching problem, mainly due to the use of a diffuse prior for the
background has been described in Section 5.5.3.2.
Figure 7.17: Histogram for the 1st (1st column) and the 2nd (2nd column) variable scores of spectral
data from one partially metastatic node after discriminant dimension reduction, with prior (dotted
line) and posterior (solid line) densities superimposed for three components of multivariate
mixture model with red for metastatic, blue for normal and green for non-nodal component. The
corresponding mapping images from the 1st stage and the 2nd stage are shown in the last two
columns with colour coding at each pixel (red for metastatic, blue for normal and black for non-
nodal). The 1st and 2nd rows show the results without and with class label correction rule applied
between two stages. The last row shows a photograph of this node.
Without label correction
1st stage 2nd stage
1st stage 2nd stage
With label correction
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Figure 7.17 shows an example of a partially metastatic node with all three
components mislabeled after discriminant dimension reduction. This is essentially
because on the external variable the non-nodal and metastatic components are given
similar prior means with a large prior variance for the background and low prior
weights. The non-nodal component is incorrectly identified, and the other two groups
then remain in the same relative positions as suggested by the prior means, but both
wrong, as shown in the top panel of Figure 7.17. Even though the second stage
algorithm introduces the position parameter ij which should help it to identify the
background, it is still unable to recover.
The class label correction rules described in Section 5.5.3.2 fix the mislabeling
problems in between stages. By giving higher scores to the pixels on the corner or
edge, the non-nodal component can usually be recognized, followed by the
recognition of the other two groups. This gives correct starting points to the smooth
fitting in the second stage as shown in the bottom panel of Figure 7.17.
Although they are easy to implement, having to use these rules is not ideal. One
possible alternative would be to improve the first stage fitting by incorporating a prior
using ij .
7.7.6 Number of components problem
Although our model can deal successfully with the nodes with less than three
components, it often attempts to find an extra group, normally with only a small
number of pixels.
Figure 7.18 is an example of a totally normal node (with two components of
normal and non-nodal in the mixture). The results and image are generated from the
optimal model via PCA reduction described in Section 7.6.2, with gk = 15, lk = 2,
101 stv , 102 ndv and 20 . Without using the image correction rules of Section
5.5.3.2 between the stages three components were fitted by the two-stage model, some
pixels from the normal component being misclassified as metastatic ones in the first
stage algorithm, and persisting in the second stage as shown in the top panel of Figure
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7.18. For both dimensions, the PC score distribution of the false positive spectra looks
like a tail of the score distribution of the normal spectra. Although the scores of both
nodal components are very close, the large prior variance given to the metastatic
component, especially in the second dimensional scores, allows its convergence to a
separate component in the mixture. Different parameter choices were tried on this
node: using a heavy-tailed multivariate t distribution with lower degrees of freedom
did not seem to help; building the model in a space with more dimensions gave more
chance to fit the unnecessary multimodality of the spectra data.
Figure 7.18: Histogram for the 1st (1st column) and the 2nd (2nd column) variable scores of spectral
data from one normal node after PCA dimension reduction, with prior (dotted line) and posterior
(solid line) densities superimposed for three components of multivariate mixture model with red
for metastatic, blue for normal and green for non-nodal component. The corresponding images
from the 1st stage and the 2nd stage are shown in the last two columns with colour coding at each
pixel (red for metastatic, blue for normal and black for non-nodal). The 1st and 2nd rows show the
results without and with image correction rules applied between two stages. The last row shows a
photograph of this node.
1st stage
1st stage 2nd stage
Without image correction
With image correction
2nd stage
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To avoid encouraging the small group fitting in the mixtures with a very close
mean to that of another sizable group, the image correction rules described in Section
5.5.3.2 are applied. The false positive metastatic component is thus merged to the
normal component at the end of the first stage algorithm and the model fitting
continues working in a right way in the second stage algorithm.
7.8 Discussions and conclusions
In Chapters 5 and 6, a partially supervised image classification algorithm based on a
composite Bayesian multivariate finite mixture model with MRF spatial prior was
developed to represent a scanned node image. This chapter has applied the model to
the scanned nodes and explored its behaviour.
Two datasets with different structure and knowledge have been used for model
construction: one is the manual measurement data with known reference for spectra
from totally normal and totally metastatic nodes; the other is scanning data with three
unknown groups (normal, metastatic and non-nodal) in the images from scanned
measurements.
A traditional supervised classification method applied directly to the scanned data
is not suitable here to derive an algorithm to classify pixels, since there is no reference
pathology available for individual pixels in the image and, furthermore, the required
training set for the non-nodal group from background areas is not available, and these
background areas are very variable from node to node.
The key issues addressed in Chapters 5-7 are the representation of knowledge and
inference methods for using the available knowledge to infer the correct image. The
main idea is to enable an integration of a priori knowledge from manual measurement
data, with accumulated evidence from scanning data, encoded in terms of a joint
posterior probability distribution with Markov random field, through a Bayesian
formalism.
The spectral data are high-dimensional and are reduced to a low dimensional
space, two dimensions work best, before constructing an image classification model.
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Two customized dimension reduction methods have been explored. The model on
two-dimensional data reduced by discriminant dimension reduction works better than
that via PCA dimension reduction. For discriminant reduction, the two axes (of
external and internal variables) are function-specific and interpretable. Typically the
first axis separates the normal and metastatic groups; the second axis allows the model
to capture the remaining individual nodal features, particularly from the non-nodal
component. For PCA reduction, the directions of both axes vary for different scanned
nodes. How the model works in this two-dimensional space depends on the individual
features of the node. Since the model via PCA reduction has more flexibility we need
put more constraint on it by using high degrees of freedom for the multivariate t
distributions representing the components.
Based on the low-dimensional data, the image classification model is fitted in two
stages. In the first stage, a Bayesian multivariate finite mixture model is employed to
model three unknown groups (normal, metastatic and non-nodal) in the images from
scanned measurements. The normal inverse Wishart prior distributions for the
parameters of normal and metastatic groups derived from the manual data are
projected into the low-dimensional model space. Since the class memberships in the
mixture here are not interchangeable, the prior knowledge given here works as
identifiability constraint for normal and metastatic groups. In the second stage,
considering the spatial correlation between adjacent pixels of image, a spatial prior
based on a Markov random field (MRF) is then incorporated into the model from the
first stage to represent the continuity of the image, and the first stage result used as a
starting point for fitting this model.
Some recommendations may be made on the choices of distributions, prior
distributions and parameters of these distributions in an attempt to balance flexibility
and the incorporation of prior information:
(a) The multivariate t distribution works better than the normal distribution. For
discriminant reduction, using low degrees of freedom in stage 1, 41 stv ,
combined with a modest or at least the same degrees of freedom in stage 2,
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20,10,42 ndv , may achieve optimal accuracy. For PCA reduction, using modest
or high degrees of freedom in both two stages, 101 stv and 20,102 ndv , may
achieve good accuracy. The t distribution gives higher classification accuracy and
increases the flexibility and robustness of the model by minimizing the impact of
outliers on the model parameters estimation. Especially the rough convergence
achieved in the first stage algorithm using the t distribution gives more flexibility
for model fitting in the second stage.
(b) The choice of prior distributions on the parameters of non-nodal component is
more difficult than that for the nodal groups because of variability in this
component and lack of training data. Here we chose a fairly flat prior to make the
model more flexible.
(c) The prior weight for three components is a combination of a strong value for
normal component and weak values for metastatic and non-nodal components,
which makes the model more flexible to variability in these components between
nodes.
(d) Weak convergence in the first stage leaves more flexibility for model fitting in the
second stage and does not waste time.
(e) Some interactions exist between different parameters of the model. Optimising the
parameter choices requires careful experimentation.
Label switching and an incorrect number of components are two common
problems from mixture models for image classification. Misclassifications do happen,
especially to some small groups of pixels but occasionally to whole groups. Some
proposed correction rules have been applied between the two stages of the model
fitting algorithms to deal with these problems. These work, but it has to be admitted
that this is not an elegant solution. It would be nicer to construct a first-stage model
that avoided the problems in the first place. Better modeling of the distribution of the
metastatic spectra, perhaps even as a mixture itself, would be one possible approach.
Incorporating the positional prior, via ij , into the first stage model would also be
worth investigating.
Our experiments show that good classification results can be achieved by
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different options. Working in a PCA reduced two-dimensional space with multivariate
t distributions on moderate degrees of freedom gives higher sensitivity. Working in a
discriminant reduced two-dimensional space with lower degrees of freedom
multivariate t distribution gives higher specificity. The model with higher degrees of
freedom for the multivariate t distributions requires a higher value of the smoother
parameter  to modify the discontinuity of the image pattern. For the models with
lower degrees of freedom, a lower value of  is more suitable. Although the high
degrees of freedom and smoother normally give better convergence to any arbitrary
distribution with multimodal structure, we attempt to keep the balance between
preserving the nodal structure of each node (with the feature of multimodality) and
not misclassifying normal as metastatic spectra.
Our results so far suggest that this model can be successful in recognising the
variable non-nodal areas automatically and distinguishing between normal and
metastatic nodes with sort of accuracy required to enable clinicians to make a rapid
intraoperative diagnosis of sentinel node metastases in breast cancer. As a general
method, this model may also be applied to many other situations for both
noise/background recognition and multi-group tissue classification.
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CHAPTER 8
CONCLUSION
In this chapter, a summary of the achieved objectives in this work is given, focussing
on the specific statistical issues in the context of elastic scattering spectroscopy (ESS)
applications, as well as some brief comments on the possible directions for future
methodological research.
8.1 Summary of thesis
This thesis has focused on the statistical issue of how to eliminate irrelevant
variations in high-dimensional ESS data and extract the most useful information to
enable the classification of tissue as normal or abnormal. The classification models,
either built on an individual spectrum basis or further developed for an image analysis,
have been employed for detection of pre-cancerous and early cancerous changes in
human tissue, with applications in Barrett’s oesophagus, colon lesions and sentinel
lymph nodes.
ESS, as a non-invasive and real-time in vivo optical diagnosis technique, is
sensitive to changes in the physical properties of human tissue resulting from
dysplasia. The evidence given in Chapter 2 that normal and abnormal tissues have
different spectral patterns of scattering and absorbance makes it possible to use
measured spectra to classify areas of tissue as normal or abnormal for purpose of
cancer diagnosis.
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Multivariate statistical methods reviewed in Chapter 3 are used in ESS spectral
analysis, amongst which principal component discriminant analysis (PCDA) and
partial least squares discriminant analysis (PLSDA) are the most explored methods
throughout the thesis as general tools for dimension reduction and supervised
classification. Based on these classical methods, customized multivariate methods are
proposed in this thesis driven by two ESS clinical diagnosis applications: One
application is gastrointestinal cancer diagnosis in Barretts esophagus and colon
lesions, to which the major statistical contribution is a spectral pretreatment method
called error removal by orthogonal subtraction (EROS) as described in Chapter 4.
This is proposed for the situation where there exists large measurement variability
while the differences between normal and abnormal tissues are subtle. The other
application is breast cancer diagnosis in scanned sentinel lymph nodes, to which the
main statistical contributions are two customized dimension reduction methods and a
partially supervised image classification model as presented in Chapters 5-7. This is
proposed for the situation where there exist large variations for the components of the
mixture model and the reference pathology for algorithm training are not completely
available.
Spectral pretreatment (EROS)
Spectral pretreatment works as an important step to eliminate the irrelevant
variations from spectra before constructing an effective regression or classification
model. When ESS spectra are measured in vivo by a hand-held optical probe, small
changes in angle and pressure may cause considerable measurement variability which
should be removed or at least reduced from the spectra.
A customized spectral pre-treatment called error removal by orthogonal
subtraction (EROS) was designed to model the measurement variability and to
ameliorate the effects of it from the spectra in the following way. Data on replicate
measurements were analysed by PCA to identify the dominant structure in the
variability, and the corresponding factors were subtracted from the spectra by
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orthogonal projection. Pre-treatment with EROS improved the classification accuracy
and substantially reduced the model complexity, resulting in the use of a small total
number of factors to attain good levels of accuracy in the classification. The success
of the model has been proved in two applications with clinical diagnosis in Barrett’s
oesophagus and colon lesions. The robustness of the classification model after EROS
pretreatment is also proved by a maintained improvement in an independent
prospective prediction. The nature and possible causes of measurement variability
were better understood by a laboratory experiment for helping with the model
interpretation. This approach, as a general pretreatment method, can be used in many
other situations.
However the success of any spectral pretreatment method is always subject to the
sources of the interfering variability and the spectral structure. In our situation EROS
worked well because the spectra contain a substantial amount of structured noise
(interfering variability) in the different dimensions as the signal of interest that can be
removed with targeted dimensions without destroying the useful information.
However, if the situation is that interfering variability coincides in the same direction
of the signal, neither EROS nor any other mathematical pretreatment will help.
Dimension reduction
Dimension reduction has been a fundamental topic of this thesis. Several approaches
to looking for a representation of high-dimensional data in a low-dimensional space
have been considered. A classical linear projection approach by principal components
analysis (PCA) has been used throughout the thesis to reduce the number of
spectroscopic variables. PCA plays a key role in constructing a multivariate
classification/discrimination model by solving the collinearity and overfitting
problems. Based on PCA, two customized dimension reduction options have been
developed to solve the problems in ESS image analysis. An automated ESS scanner
was developed to take measurements from a larger area of tissue to produce ESS
images for cancer diagnosis. Problems arise due to the existence of background area
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in the scanned image with considerable between-node variation and no training data
available. Our customized methods for dimension reduction try to capture as much as
possible the structured nodal (normal and metastatic) variations by new components.
One called discriminant dimension reduction uses an external variable, the canonical
variable from a linear discriminant analysis on a separate set of manual data for which
we do have reference pathology, to capture variations between normal and metastatic
groups, and uses a small number of internal variables, the principal components on the
individual scanning data orthogonal to the external variable, capture the remaining
individual nodal features, particularly from the non-nodal component. The other,
called PCA dimension reduction, uses a global PCA projection to capture most of the
common information from all the scanned nodes followed by a local PCA projection
to extract individual nodal features. In our application, discriminant reduction works
better than PCA reduction in image classification model. Although both methods
allow adaptation to individual nodal features, discriminant reduction has one common
direction, adding extra model robustness, while the directions extracted by PCA
reduction all depend on the individual features of each node.
The PCA dimension reduction methods provide a general option for a preliminary
dimension reduction. The discriminant dimension reduction methods can be used in a
general situation where some specific direction can be used as a guide for constructing
a low-dimensional space.
Image classification
As an extension of the point measurement, ESS imaging generated by ESS
scanning device examines a larger area of tissue and here smoothness assumptions
make it possible to improve the classification of individual pixels. A partially
supervised image classification model based on a Bayesian multivariate finite mixture
model with a Markov random field (MRF) spatial prior was developed to represent
the scanning data of each node by a statistical image containing information on both
between-group features and spatial correlation features. The main idea of the
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composite model is to enable an integration of a priori knowledge, via normal inverse
Wishart priors, from manual measurement data on the two main components, normal
and metastatic, with observational evidence from the scanning data of the individual
node. The smoothness of the image is modeled by a spatial prior using a Markov
random field. The whole model fitting is implemented in two stages by EM and ICM
algorithms, with the feature priors and the spatial prior imposed onto the model space
in turn. In the first stage, a multivariate finite mixture model with three components
uses informative prior distributions derived from the manually measured data for the
parameters of the normal and metastatic components in the mixture, and a diffuse
prior distribution for the variable non-nodal component. This allows the flexibility
and adaptation to the background component varying from node to node. In the
second stage, with a MRF spatial prior incorporated into the model to represent the
spatial correlation between adjacent pixels of image, a rough image generated from
the first stage then develops to an image showing the quality of continuity and
smoothness with a good match to the nodal shape and good accuracy in diagnosis.
Our results show that from the mapping image the variable non-nodal areas can
be recognized automatically and normal and metastatic nodes can then be
distinguished easily with sort of accuracy required to help clinician with a rapid
intraoperative diagnosis of sentinel nodal metastases in breast cancer. As a flexible
and robust model, this can also be applied to many other multi-group image
classification situations with incomplete information, such as group features and class
memberships.
8.2 Future work
The subject of this thesis being extensive, we do not pretend to have covered it
exhaustively. Several interesting issues arising from classification by ESS analysis
could not be dealt with, due to lack of time. We mention some of them.
Spectral wavelength selection for classification is of essential interest. The LDA
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loading, which measures how intensity at each wavelength contributes to the
classification, shows more important weight on certain regions of the wavelength
range for discrimination between normal and abnormal tissue. The challenge is how to
select the most informative spectral features with minimum redundancy and noise to
enhance the classification performance without losing useful information. The
wavelength regions with high-ranked loadings selected by the model for the
classification task could be highly correlated among themselves. Simply combing one
effective variable or region with another doesn’t necessarily form a better subset,
because it might contain certain redundant features. Also calculations of all possible
wavelength combinations require enormous computations. This concern is of
particular interest for dimension reduction, and for the purpose of building cheaper
instruments.
The topic of ordered multi-group classification needs to be explored with the aim
of grading the level of abnormality. A sequential multi-group classification based on
the two-way classification model described in Chapter 4 has already been put into
practice for the real-time clinical prediction. However it would be of great interest to
classify the different groups simultaneously enabling a better understanding of
misclassification errors and helping a rapid real-time diagnosis. One possible
approach is using the Soft Independent Modeling of Class Analogy (SIMCA) (Wold
and Sjöström 1977) to capture the local structure of each group to train the
classification model. However, this supervised model is very sensitive to the training
data, especially when the between-group differences are subtle. Further study will
focus on how to balance the flexibility and robustness of the model, avoiding
misclassifications.
Concerning imaging classification methods, several aspects of the model can be
further investigated. In the multivariate Gaussian or t mixture model, we have, so far,
used separate and unstructured covariance matrices for each group. Choosing a
common covariance matrix or a diagonal but different covariance matrix may give the
opportunity to use more dimensions in the model. Although some problems of label-
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switching and incorrect number of components can be tackled by our model, some
rules in between stages are still applied to correct some problems. Ideally the first
stage model should be improved to make these rules unnecessary. Since the model
fitting is implemented by a composite two-stage algorithm, it is possible to use
different fitting algorithms in the two stages and alternatives could be explored.
Another issue for further study relates to classification assessment stimulated by
the problems occurring when AUC and ROC curves are used in conjunction with
cross-validation. The assumption made in the pooling strategy that the classifier
outputs are comparable across all the left-out segments is generally not valid and thus
large biases can be caused. How to estimate AUC and ROC curves with less bias for
the purpose of model selection and comparison in practice is of potential interest.
There is also a need for defining general measures for assessing multi-group
classification accuracy, perhaps via an appropriate 3D-ROC curve. Also there is scope
for exploring the assessment of the image classification, for the cases with both
discrete and continuous values for each pixel.
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APPENDIX A
NOTATION
Throughout the Chapters 5-7, the notations commonly used are listed as below:
n : the number of observations from one scanned node.
m: the number of observations from point measurement data.
c: the number of scanned nodes.
p : the number of wavelength point.
nodesallX . : a pcn spectral matrix of all the scanned nodes.
trainX : a pm spectral matrix of point measurement spectral data.
nodeoneX . : a pn spectral matrix of one scanned node.
extk : the number of principal components constructing the external variable by
discriminant reduction method (the dimension of external variable).
0.intk : the number of principal components capturing most of the variations left by the
external variable by discriminant reduction method (before constructing the
internal variables).
intk : the number of principal components constructing the internal variables by
discriminant reduction method (the dimension of internal variable).
gk : the number of principal components constructing the global variables by PCA
reduction method (the dimension of global variable).
lk : the number of principal components constructing the local variables by PCA
reduction method (the dimension of local variable).
190
k : the dimension of spectral matrix of one scanned node when projected to a low
dimensional space ( lkk  for PCA reduction, intkk 1 for discriminant
reduction).
kX : a kn spectral matrix of one scanned node with reduced dimensions of k.
nodesallZ . : a gkcn score matrix whose columns are the first gk PC scores of nodesallX . .
trainZ : a gkm score matrix whose columns are the first gk PC scores of trainX , for the
use of gk -dimensional priors.
nodeoneZ . : a gkn score matrix whose columns contains the first gk PC scores of
nodeoneX . , a pn spectral matrix for one scanned node, each row of which is a
p-dimensional spectrum.
nodeoneS . : a lkn matrix whose columns consist of lk PC scores.
gL : the global PCA loadings of the first gk PCs of all the scanned nodes nodesallX . .
lL : the local PCA loadings of the first lk PCs of the scores matrix nodeoneZ . .
trainT : a 1n dimensional canonical score vector of the spectra from manual data.
extnodeT . : a 1n dimensional external variable score vector of the spectra from one
scanned node.
extnodesallT .. : a 1cn dimensional external variable score vector of the spectra from all
the scanned nodes.
nodesallX .
~ : a pcn spectral matrix whose columns lie in the 1p dimensional
subspace orthogonal to the external variable extnodesallT .. .
0... intnodesallT : a 0.intkcn score matrix whose columns contain 0.intk PC scores.
0..inttrainT : a 0.intkm score matrix whose columns contain 0.intk PC scores.
0..intnodeT : a 0.intkn score matrix whose columns contain 0.intk PC scores.
intnodeT . : a intkn -dimensional internal variable score matrix.
extq : the 1p -dimensional PCDA loading vector of manual data trainX .
ortQ : a cncn projection matrix constructing nodesallX .
~ .
0.intQ : a 0.intkp loading matrix, the columns of which are the first 0.intk principal
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component loadings of nodesallX .
~ .
intQ : a intint kk 0. loading matrix, the columns of which are the first intk PC loadings
derived from a PCA of 0..intnodeT .
'''' , cn mm : k -dimensional means derived from manual data for use with priors on
normal and metastatic groups of scanning data.
'''' , cn VV : kk  variances derived from manual data for later use with priors on normal
and metastatic groups of scanning data.
stv1 : the degree of freedom of multivariate t distribution in the 1
st step EM algorithm.
ndv2 : the degree of freedom of multivariate t distribution in the 2
nd step EM algorithm.
iy : a multi-dimensional variable with reduced dimensions at pixel i.
j : the proportion of the jth component in the mixture.
j : the mean vector of jth component in the mixture of multivariate t distribution or
multivariate Gaussian distribution.
j : the covariance matrix of jth component in the mixture of multivariate t
distribution or multivariate Gaussian distribution.
p : the mean of the normal priors (of normal inverse Wishart priors) on the mean
vectors j conditional on covariance matrices j of multivariate t distribution
or multivariate Gaussian distribution.
p : the scale of the inverse Wishart priors (of normal inverse Wishart priors) on the
covariance matrices j of multivariate t distribution or multivariate Gaussian
distribution.
p : the shrinkage parameter of the normal inverse Wishart prior for multivariate t
distribution or multivariate Gaussian distribution.
pv : the degrees of freedom of the normal inverse Wishart prior for multivariate t
distribution or multivariate Gaussian distribution.
 : a regularization parameter (smoothness parameter) used in spatial label prior
expression.
ij : a position parameter used in spatial label prior expression.
id : a distance score measuring the distance between each pixel and the central point
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of the image.
i : a background score of each pixel i emphasizing the scores for the pixels on the
edge.
 : a power parameter used in background scores and spatial label prior expression.
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